0001493152-22-013013.txt : 20220512 0001493152-22-013013.hdr.sgml : 20220512 20220512160203 ACCESSION NUMBER: 0001493152-22-013013 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220512 DATE AS OF CHANGE: 20220512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEA Industries Inc. CENTRAL INDEX KEY: 0001482541 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] IRS NUMBER: 273911608 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41266 FILM NUMBER: 22917648 BUSINESS ADDRESS: STREET 1: 1780 55TH STREET, SUITE C CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-993-5271 MAIL ADDRESS: STREET 1: 1780 55TH STREET, SUITE C CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Surna Inc. DATE OF NAME CHANGE: 20100128 10-Q 1 form10-q.htm
0001482541 false Q1 2022 --12-31 Yes Yes 0001482541 2022-01-01 2022-03-31 0001482541 CEAD:CommonStock0.00001ParValueMember 2022-01-01 2022-03-31 0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2022-01-01 2022-03-31 0001482541 2022-05-12 0001482541 2022-03-31 0001482541 2021-12-31 0001482541 2021-01-01 2021-03-31 0001482541 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001482541 us-gaap:CommonStockMember 2021-12-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2021-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001482541 us-gaap:RetainedEarningsMember 2021-12-31 0001482541 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-12-31 0001482541 us-gaap:CommonStockMember 2020-12-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2020-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001482541 us-gaap:RetainedEarningsMember 2020-12-31 0001482541 2020-12-31 0001482541 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-03-31 0001482541 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2022-01-01 2022-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001482541 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-03-31 0001482541 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2021-01-01 2021-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001482541 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001482541 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001482541 us-gaap:CommonStockMember 2022-03-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2022-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-03-31 0001482541 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-03-31 0001482541 us-gaap:CommonStockMember 2021-03-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2021-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001482541 us-gaap:RetainedEarningsMember 2021-03-31 0001482541 2021-03-31 0001482541 2022-02-14 2022-02-15 0001482541 2021-12-30 0001482541 CEAD:TwoThousandAndTwentyThreeMember 2022-03-31 0001482541 srt:MinimumMember 2022-01-01 2022-03-31 0001482541 srt:MaximumMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember 2022-01-01 2022-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2022-01-01 2022-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerOneMember 2021-01-01 2021-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerTwoMember 2021-01-01 2021-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember CEAD:CustomerThreeMember 2021-01-01 2021-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2022-01-01 2022-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2022-01-01 2022-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerThreeMember 2022-01-01 2022-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerOneMember 2021-01-01 2021-03-31 0001482541 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember CEAD:CustomerTwoMember 2021-01-01 2021-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-01-01 2022-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2021-01-01 2021-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-01-01 2022-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2021-01-01 2021-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2021-01-01 2021-03-31 0001482541 CEAD:TwoThousandAndTwentyTwoMember 2022-03-31 0001482541 us-gaap:CostOfSalesMember 2022-01-01 2022-03-31 0001482541 us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-01-01 2022-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2021-01-01 2021-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2022-01-01 2022-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2021-01-01 2021-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-03-31 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28 0001482541 CEAD:NewFacilityLeaseMember 2021-07-24 2021-07-28 0001482541 2021-01-01 2021-12-31 0001482541 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001482541 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001482541 us-gaap:VehiclesMember 2022-03-31 0001482541 us-gaap:VehiclesMember 2021-12-31 0001482541 us-gaap:LeaseholdImprovementsMember 2022-03-31 0001482541 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001482541 us-gaap:CostOfSalesMember us-gaap:PropertyPlantAndEquipmentMember 2022-01-01 2022-03-31 0001482541 CEAD:InventoryMember us-gaap:PropertyPlantAndEquipmentMember 2022-01-01 2022-03-31 0001482541 2021-02-10 0001482541 2021-02-09 2021-02-10 0001482541 2021-11-30 0001482541 2021-11-29 2021-11-30 0001482541 us-gaap:OtherExpenseMember 2022-01-01 2022-03-31 0001482541 CEAD:SeriesBRedeemableConvertiblePreferredStockMember 2021-09-28 0001482541 us-gaap:ConvertiblePreferredStockMember 2021-09-28 0001482541 2021-09-26 2021-09-28 0001482541 2021-11-01 2021-11-04 0001482541 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001482541 us-gaap:SeriesBPreferredStockMember 2021-09-27 2021-09-30 0001482541 us-gaap:SeriesBPreferredStockMember 2021-09-30 0001482541 us-gaap:SeriesBPreferredStockMember 2022-02-14 2022-02-16 0001482541 2022-02-14 2022-02-16 0001482541 us-gaap:CommonStockMember us-gaap:SeriesBPreferredStockMember 2022-02-14 2022-02-16 0001482541 us-gaap:WarrantMember us-gaap:SeriesBPreferredStockMember 2022-02-14 2022-02-16 0001482541 CEAD:WarrantOneMember CEAD:IndefiniteTermMember us-gaap:SeriesBPreferredStockMember 2022-02-14 2022-02-16 0001482541 CEAD:WarrantOneMember CEAD:IndefiniteTermMember us-gaap:SeriesBPreferredStockMember 2022-02-16 0001482541 us-gaap:WarrantMember 2022-02-14 2022-02-16 0001482541 us-gaap:WarrantMember 2022-02-16 0001482541 us-gaap:SeriesBPreferredStockMember 2022-02-16 0001482541 us-gaap:SeriesBPreferredStockMember 2022-02-15 0001482541 us-gaap:SeriesBPreferredStockMember CEAD:DecreaseInCommonStockConversionPriceMember 2022-02-16 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:JanuarySeventeernTwoThousandTwentyTwoMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:JanuarySeventeernTwoThousandTwentyThreeMember 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember CEAD:TwoDirectorsMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-12 2022-01-17 0001482541 2021-12-29 0001482541 srt:BoardOfDirectorsChairmanMember 2021-12-31 0001482541 us-gaap:CommonStockMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-15 0001482541 us-gaap:WarrantMember CEAD:UnderwritersMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember CEAD:UnderwritersMember 2022-02-15 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandAndTwentyOneEquityPlanMember 2021-03-22 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:EmployeesMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:DirectorsMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:RestrictedSharesIssuedMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:NonQualifiedStockOptionMember 2022-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:IncentiveStockOptionMember 2022-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:IncentiveStockOptionMember us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0001482541 CEAD:EmployeesMember 2022-01-01 2022-03-31 0001482541 CEAD:ThreeNewEmployeesMember 2022-01-01 2022-03-31 0001482541 CEAD:CheifFinancialOfficerMember 2022-01-02 2022-03-30 0001482541 CEAD:OneFormerEmployeeMember 2022-01-01 2022-03-31 0001482541 CEAD:OneFormerEmployeeMember 2022-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesAndConsultantsMember 2021-01-01 2021-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2021-01-01 2021-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndTwentyOnePlanMember CEAD:NonQualifiedStockOptionsMember 2022-01-02 2022-01-03 0001482541 CEAD:TwoThousandAndTwentyOneEquityPlanMember CEAD:NonQualifiedStockOptionsMember 2022-01-02 2022-01-03 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-16 2022-01-17 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember CEAD:VestedMember 2022-03-31 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:DirectorsMember 2022-01-01 2022-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2021-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2021-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:DirectorsMember 2020-01-01 2020-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2021-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember CEAD:EmployeesAndConsultantsMember 2022-03-31 0001482541 CEAD:DirectorsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2021-12-31 0001482541 CEAD:DirectorsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0001482541 CEAD:WarrantsRangeMember 2022-03-31 0001482541 CEAD:WarrantsRangeMember 2022-01-01 2022-03-31 0001482541 CEAD:WarrantsRangeOneMember 2022-03-31 0001482541 CEAD:WarrantsRangeOneMember 2022-01-01 2022-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2022-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2022-01-01 2022-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2022-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2022-01-01 2022-03-31 0001482541 CEAD:WarrantsRangeFourMember 2022-03-31 0001482541 CEAD:WarrantsRangeFourMember 2022-01-01 2022-03-31 0001482541 us-gaap:SeriesBPreferredStockMember CEAD:SecuritiesPurchaseAgreementMember 2021-09-26 2021-09-28 0001482541 us-gaap:SeriesBPreferredStockMember CEAD:SecuritiesPurchaseAgreementMember 2021-09-28 0001482541 us-gaap:SeriesBPreferredStockMember CEAD:SecuritiesPurchaseAgreementMember srt:MaximumMember 2021-09-28 0001482541 us-gaap:SeriesBPreferredStockMember CEAD:SecuritiesPurchaseAgreementMember 2021-09-27 2021-09-28 0001482541 us-gaap:PrivatePlacementMember CEAD:PlacementAgentWarrantsMember 2021-09-28 0001482541 CEAD:TwoThousandTwentyTwoInvestorWarrantsMember 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoInvestorWarrantsMember 2022-02-13 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoOverAllotmentWarrantsMember 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoOverAllotmentWarrantsMember 2022-02-13 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoOverAllotmentWarrantsMember 2022-02-10 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoUnderwriterWarrantsMember 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoUnderwriterWarrantsMember 2022-02-13 2022-02-15 0001482541 us-gaap:SeriesBPreferredStockMember 2022-02-12 2022-02-16 0001482541 us-gaap:CommonStockMember 2022-02-12 2022-02-16 0001482541 CEAD:SeriesBPreferredSharesPreFundedConversionWarrantsMember 2022-02-12 2022-02-16 0001482541 CEAD:SeriesBPreferredSharesPreFundedConversionWarrantsMember 2022-02-16 0001482541 CEAD:SeriesBPreferredSharesConversionWarrantsMember 2022-02-12 2022-02-16 0001482541 CEAD:SeriesBPreferredSharesConversionWarrantsMember 2022-02-16 0001482541 CEAD:SeriesBPreferredSharesConversionWarrantsMember 2022-02-15 0001482541 CEAD:ConsultingAgreementMember 2022-01-01 2022-03-31 0001482541 us-gaap:SubsequentEventMember CEAD:TwentyOneEmployeesMember CEAD:EmploymentAgreementMember 2022-03-29 2022-04-01 0001482541 us-gaap:SubsequentEventMember CEAD:EmploymentAgreementMember 2022-03-29 2022-04-01 0001482541 us-gaap:SubsequentEventMember CEAD:EmploymentAgreementMember 2022-04-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares utr:sqft xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 000-54286

 

CEA INDUSTRIES INC.

(formerly known as Surna Inc.)

(Exact name of registrant as specified in its charter)

 

Nevada   27-3911608

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

385 South Pierce Avenue, Suite C

Louisville, Colorado 80027

  80027
(Address of principal executive offices)   (Zip code)

 

(303) 993-5271

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.00001 par value   CEAD   Nasdaq Capital Markets
Warrants to purchase common stock   CEADW   Nasdaq Capital Markets

 

Securities registered pursuant to Section 12(g) of the Act:

 

None

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer, “accelerated filer,” “non-accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer Accelerated Filer
Non-accelerated Filer Smaller Reporting Company
    Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO

 

As of May 12, 2022, the number of outstanding shares of common stock of the registrant was 7,784,444.

 

 

 

 

 

 

CEA Industries Inc.

Quarterly Report on Form 10-Q

For the Quarterly Period Ended March 31, 2022

 

Table of Contents

 

  Page
Cautionary Statement ii
   
PART I — FINANCIAL INFORMATION  
   
Item 1. Financial Statements (Unaudited)  
   
Condensed Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021 1
   
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2022 and 2021 2
   
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit) for the Three Months Ended March 31, 2022 and 2021 3
   
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021 4
   
Notes to the Condensed Consolidated Financial Statements 5
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 25
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk 34
   
Item 4. Controls and Procedures 34
   
PART II — OTHER INFORMATION  
   
Item 1. Legal Proceedings 35
   
Item 1A. Risk Factors 35
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 35
   
Item 3. Defaults Upon Senior Securities 35
   
Item 4. Mine Safety Disclosures 35
   
Item 5. Other Information 35
   
Item 6. Exhibits 35
   
SIGNATURES 36
   
EXHIBIT INDEX 37

 

i

 

 

In this Quarterly Report on Form 10-Q, unless otherwise indicated, the “Company”, “we”, “us” or “our” refer to CEA Industries Inc. and, where appropriate, its wholly owned subsidiary.

 

CAUTIONARY STATEMENT

 

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2, contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical fact but are based on current management expectations that involve substantial risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or our future financial performance. We generally identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other similar words. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements including, but not limited to, any projections of revenue, gross profit, earnings or loss, tax provisions, cash flows or other financial items; any statements of the plans, strategies or objectives of management for future operations; any statements regarding current or future macroeconomic or industry-specific trends or events and the impact of those trends and events on us or our financial performance; any statements regarding pending investigations, legal claims or tax disputes; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing.

 

These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. These forward-looking statements are based on assumptions regarding our present and future business strategies and the environment in which we operate. Important factors that could cause those differences include, but are not limited to:

 

  our business prospects and the prospects of our existing and prospective customers;
     
  the impact on our business and that of our customers of the current and future response by the government and business to the COVID-19 pandemic, including what is necessary to protect our staff and the staff of our customers in the conduct of our business;
     
  our overall financial condition, including our reduced revenue and business disruption, due to the COVID-19 pandemic business and economic response and its consequences;
     
  the inherent uncertainty of product development;
     
  regulatory, legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws;
     
  increasing competitive pressures in the CEA (Controlled Environment Agriculture) industry;
     
  the ability to effectively operate our business, including servicing our existing customers and obtaining new business;
     
  our relationships with our customers and suppliers;
     
  the continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance payments from our customers;
     
  general economic conditions, our customers’ operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, adversely affecting demand for the products and services offered by us in the markets in which we operate;

 

ii

 

 

  the continuation of normal supply of products from our suppliers;
     
  changes in our business strategy or development plans, including our expected level of capital expenses and working capital;
     
  our ability to attract and retain qualified personnel;
     
  our ability to raise equity and debt capital, as needed from time to time, to fund our operations and growth strategy, including possible acquisitions;
     
  our ability to identify, complete and integrate potential strategic acquisitions;
     
  future revenue being lower than expected;
     
  our ability to convert our backlog into revenue in a timely manner, or at all; and
     
  our intention not to pay dividends.

 

Although we believe that we use reasonable assumptions for these forward-looking statements, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Quarterly Report on Form 10-Q should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021, as updated from time to time in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”). You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Quarterly Report on Form 10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q. The forward-looking statements and projections contained in this Quarterly Report on Form 10-Q are intended to be within the meaning of “forward-looking statements” in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”).

 

iii

 

 

PART I — FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

CEA Industries Inc.

Condensed Consolidated Balance Sheets

(in US Dollars except share numbers)

 

   March 31,   December 31, 
   2022   2021 
    (Unaudited)      
ASSETS          
Current Assets          
Cash and cash equivalents  $22,033,664   $2,159,608 
Accounts receivable (net of allowance for doubtful accounts of $159,744 and $181,942, respectively)   191,002    179,444 
Other receivables   50,762    - 
Inventory, net   1,005,918    378,326 
Prepaid expenses and other   1,774,219    1,273,720 
Total Current Assets   25,055,565    3,991,098 
Noncurrent Assets          
Property and equipment, net   77,239    77,346 
Goodwill   631,064    631,064 
Intangible assets, net   1,830    1,830 
Deposits   14,747    14,747 
Operating lease right-of-use asset   540,444    565,877 
Total Noncurrent Assets   1,265,324    1,290,864 
           
TOTAL ASSETS  $26,320,889   $5,281,962 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)          
           
CURRENT LIABILITIES          
Accounts payable and accrued liabilities  $1,389,028   $1,345,589 
Deferred revenue   5,485,416    2,839,838 
Accrued equity compensation   83,625    83,625 
Other liabilities   37,078    37,078 
Current portion of operating lease liability   112,072    100,139 
Total Current Liabilities   7,107,219    4,406,269 
           
NONCURRENT LIABILITIES          
Operating lease liability, net of current portion   459,482    486,226 
Total Noncurrent Liabilities   459,482    486,226 
           
TOTAL LIABILITIES   7,566,701    4,892,495 
           
Commitments and Contingencies (Note 7)   -    - 
           
TEMPORARY EQUITY          
Series B Redeemable Convertible Preferred Stock, $0.00001 par value; 0 and 3,300 issued and outstanding, respectively   -    3,960,000 
Total Temporary Equity   -    3,960,000 
           
SHAREHOLDERS’ EQUITY (DEFICIT)          
Preferred stock; 25,000,000 and 150,000,000 shares authorized, respectively   -    - 
Common stock, $0.00001 par value; 200,000,000 and 850,000,000 shares authorized, respectively; 7,784,444 and 1,600,835 shares issued and outstanding, respectively   78    16 
Additional paid in capital   48,958,618    25,211,017 
Accumulated deficit   (30,204,508)   (28,781,566)
Total Shareholders’ Equity (Deficit)   18,754,188    (3,570,533)
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)  $26,320,889   $5,281,962 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

1
 

 

CEA Industries Inc.

Condensed Consolidated Statements of Operations

(in US Dollars except share numbers)

(Unaudited)

 

   2022   2021 
   For the Three Months Ended March 31, 
   2022   2021 
Revenue, net  $1,744,427   $2,366,529 
           
Cost of revenue   1,653,919    2,021,923 
           
Gross profit   90,508    344,606 
           
Operating expenses:          
Advertising and marketing expenses   251,015    177,145 
Product development costs   138,918    112,638 
Selling, general and administrative expenses   1,311,777    740,473 
Total operating expenses   1,701,710    1,030,256 
           
Operating loss   (1,611,202)   (685,650)
           
Other income (expense):          
Other income (expense), net   185,000    (107,000)
Interest income (expense),net   3,260    (718)
Total other income (expense)   

188,260

    (107,718)
           
Loss before provision for income taxes   (1,422,942)   (793,368)
           
Income taxes   -    - 
           
Net loss  $(1,422,942)  $(793,368)
           
Convertible preferred series B stock dividends   (35,984)   - 
Deemed dividend on convertible preferred series B stock on down round   

(439,999

)   - 
           
Net Loss Available to Common Shareholders  $(1,898,925)  $(793,368)
           
Loss per common share – basic and dilutive  $(0.41)  $(0.50)
           
Weighted average number of common shares outstanding, basic and dilutive   4,622,427    1,576,844 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

2
 

 

CEA Industries Inc.

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Deficit)

For the Three Months Ended March 31, 2022 and 2021

(in US Dollars except share numbers)

(Unaudited)

 

  

Number of

Shares

   Amount  

Paid in

Capital

  

Accumulated

Deficit

  

Shareholders’

Deficit

 
   Common Stock   Additional         
  

Number of

Shares

   Amount  

Paid in

Capital

  

Accumulated

Deficit

  

Shareholders’

Deficit

 
Balance December 31, 2021-  1,600,835   $   16 - $25,211,017   $(28,781,566)  $(3,570,533)
Fair value of vested stock options granted to employees   -    -    32,938    -    32,938 
Fair value of vested stock options granted to directors   -    -    29,656    -    29,656 
Common shares issued in settlement of restricted stock units issued to directors   3,367    0    24,994    -    24,994 
Fair value of restricted stock units issued to directors   -    -    4,928    -    4,928 
Issuance of common shares to round up partial shares following reverse split   6,798    0    0         0 
Common shares and warrants issued for cash   5,811,138    58    21,711,073    -    21,711,131 
Common shares and warrants issued on conversion of series B preferred stock   362,306    4    1,979,996    -    1,980,000 
Dividends on series B preferred stock   -    -    (35,984)   -    (35,984)
Net loss-  -    - -  -    (1,422,942)   (1,422,942)
Balance March 31, 2022-  7,784,444   $78 - $48,958,618   $(30,204,508)  $18,754,188 

 

  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Number of

Shares to

be Issued

   Amount  

Additional

Paid in

Capital

  

Accumulated

Deficit

  

Shareholders’

Deficit

 
  

Series A

Preferred Stock

   Common Stock             
  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Number of

Shares to

be Issued

   Amount  

Additional

Paid in

Capital

  

Accumulated

Deficit

  

Shareholders’

Deficit

 
Balance December 31, 2020   42,030,331   $   420    1,576,844   $    16    -        $26,107,159   $(27,443,643)  $   (1,336,048)
Common shares to be issued in settlement of legal dispute   -    -    -    -    6,667    67,000    -    -    67,000 
Fair value of vested stock options granted to employees   -    -    -    -    -    -    128,434    -    128,434 
Fair value of vested stock options granted to directors   -    -    -    -    -    -    6,342    -    6,342 
Net loss   -    -    -    -    -    -    -    (793,368)   (793,368)
Balance March 1, 2021   42,030,331   $420    1,576,844   $16    6,667   $67,000   $  26,241,935   $(28,237,011)  $(1,927,640)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3
 

 

CEA Industries Inc.

Condensed Consolidated Statements of Cash Flows

(in US Dollars except share numbers)

(Unaudited)

 

   2022   2021 
   For the Three Months Ended March 31, 
   2022   2021 
Cash Flows From Operating Activities:          
Net loss  $(1,422,942)  $(793,368)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation and intangible asset amortization expense   8,556    18,377 
Share-based compensation   92,517    6,342 
Common stock issued for other expense   -    67,000 
Provision for doubtful accounts   (22,168)   - 
Provision for excess and obsolete inventory   3,676    (4,371)
Loss on disposal of assets   5,499    - 
Amortization of ROU asset   25,433    49,051 
           
Changes in operating assets and liabilities:          
Accounts receivable   10,610    6,748 
Inventory   (631,269)   (187,679)
Prepaid expenses and other   (551,261)   (1,026,765)
Accounts payable and accrued liabilities   43,438    5,354 
Deferred revenue   2,645,579    2,362,905 
Accrued interest   -    718 
Lease deposit   -    (8,061)
Operating lease liability, net   (14,811)   (64,672)
Accrued equity compensation   -    52,794 
Net cash (used in)/provided by operating activities   192,857    484,373 
           
Cash Flows From Investing Activities          
Purchases of property and equipment   (13,948)   (12,326)
Net cash used in investing activities   (13,948)   (12,326)
           
Cash Flows From Financing Activities          
Payment of dividends on series B preferred stock   (35,984)   - 
Redemption of series B preferred stock   (1,980,000)   - 
Cash proceeds on sale of common stock and warrants, net of expenses   21,711,131    - 
Proceeds from issuance of note payable   -    514,200 
Net cash provided by financing activities   19,695,147    514,200 
           
Net change in cash and cash equivalents   19,874,056    986,247 
Cash and cash equivalents, beginning of period   2,159,608    2,284,881 
Cash and cash equivalents, end of period  $22,033,664   $3,271,128 
           
Supplemental cash flow information:          
Interest paid  $-   $- 
Income taxes paid  $-   $- 
           
Non-cash investing and financing activities:          
Conversion of series B preferred stock  $1,980,000   $

-

 
Deemed dividend on series B preferred stock arising on down round  $

439,999

   $- 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Note 1 – General

 

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, some producers grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies include: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting and climate control, and (vi) preventive maintenance services for CEA facilities Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.

 

The resulting effects and uncertainties from the COVID-19 pandemic, including the depth and duration of the disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses and reduced operating cash flows in our business. During the three months ended March 31, 2022, the Company experienced significant delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain arising from the long-term effects of the COVID-19 pandemic. Consequently, our revenue recognition of these customer sales has been delayed until future periods when the shipment of these orders can be completed.

 

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued. The Company continues to experience recurring losses since its inception. As a result, in order to continue as a going concern, the Company has been reliant on the ability to obtain additional sources of financing to fund growth. As indicated in Note 9 – Shareholders Equity (Deficit) below, on February 15, 2022, the Company received approximately $22,000,000 in proceeds from completion of an equity offering. Based on management’s evaluation, the proceeds from the Offering will be more than sufficient to fund any deficiencies in working capital or cash flow from operations, and the Company is confident that it will be able to meet its obligations as they come due, and fund operations for at least 12 months after the date the consolidated financial statements are available to be issued. Accordingly, the conditions around liquidity and limited working capital necessary to fund operations have been addressed.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The balance sheet as of December 31, 2021 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2021.

 

5
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding as of December 31, 2021, was reduced from 240,125,224 to 1,600,835.

 

All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

Cash, Cash Equivalents and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of March 31, 2022, the balance in the Company’s account was approximately $22,034,000, consequently $21,784,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

During the three months ended March 31, 2022 and 2021, there were warrants and options outstanding to purchase Company common stock and shares of convertible preferred stock and restricted stock units that were convertible into shares of the Company’s common stock. During the three-month period ended March 31, 2022, the Company incurred a net loss and consequently the common share equivalents of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such inclusion would have been anti-dilutive.

 

6
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

As of March 31, 2022, and 2021, there were respectively, 8,021,057 and 201,662, potentially dilutive equity instruments outstanding in respect of shares of convertible preferred stock and warrants and options outstanding to purchase Company common stock.

 

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

During the three months ended March 31, 2022, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators of impairment. Accordingly, the Company performed an interim impairment analysis at March 31, 2022 and concluded that no impairment relating to goodwill existed at March 31, 2022.

 

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

7
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Revenue Recognition

 

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09 (Topic 606), Revenue from Contracts with Customers and all the related amendments (“ASC 606” or the “revenue standard”) to all contracts and elected the modified retrospective method.

 

The following table sets forth the Company’s revenue by source:

 

   2022   2021 
  

For the Three Months Ended

March 31,

 
   2022   2021 
Equipment and systems sales  $1,642,572   $2,163,468 
Engineering and other services   86,049    181,083 
Shipping and handling   15,806    21,978 
Total revenue  $1,744,427   $2,366,529 

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

8
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2022, and 2021, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to recognize revenue is generally less than one year. As of March 31, 2022, and December 31, 2021, deferred revenue, which was classified as a current liability, was $5,485,416 and $2,839,838, respectively.

 

For the three months ended March 31, 2022, the Company recognized revenue of $1,162,374 related to the deferred revenue at January 1, 2022. For the three months ended March 31, 2021, the Company recognized revenue of $1,880,634 related to the deferred revenue at January 1, 2021.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of March 31, 2022, the Company’s remaining performance obligations, or backlog, was $11,179,000. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2022, includes booked sales orders of $2,217,000 from several customers that the Company does not expect to be realized until 2023, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes that several of its current contracts may be delayed or canceled.

 

9
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

The remaining performance obligations expected to be recognized through 2023 are as follows:

 

   2022   2023   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   8,962,000    2,217,000   11,179,000 
Total remaining performance obligations  $8,962,000   $2,217,000   $11,179,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2022, and December 31, 2021, the Company had an accrued warranty reserve amount of $187,702 and $186,605, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2022, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from 158.21% to 158.70%; expected term in years 10 and risk-free interest rate ranged from 1.52% to 1.98%.

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

10
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021:

 

   2022   2021 
  

For the Three Months Ended

March 31,

 
   2022   2021 
Share-based compensation expense included in:          
Cost of revenue  $791   $14,135 
Advertising and marketing expenses   2,762    6,474 
Product development costs   -    6,694 
Selling, general and administrative expenses   88,964    31,833 
Total share-based compensation expense included in consolidated statement of operations  $92,517   $59,136 

 

Included in the expense for the three months ended March 31, 2021, is an accrual for $52,794 for the 2021 Annual Employee Incentive Compensation Plan.

 

Concentrations

 

One customer accounted for 35% of the Company’s revenue for the three months ended March 31, 2022. Three customers accounted for 38%, 16%, and 11% of the Company’s revenue for the three months March 31, 2021.

 

Three customers accounted for 44%, 19% and 16% of the Company’s accounts receivable as of March 31, 2022. Two customers accounted for 60%, and 31% of the Company’s accounts receivable as of March 31, 2021.

 

Recently Issued Accounting Pronouncements

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

In May 2021, the FASB issued ASU 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. This guidance clarifies and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options due to a lack of explicit guidance in the FASB Codification. The guidance is effective for interim and annual periods beginning after December 15, 2021. Early adoption is permitted. The guidance is to be applied prospectively to modifications or exchanges occurring on or after the effective date. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

11
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

Note 2 – Leases

 

In February 2016 the FASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.

 

The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.

 

12
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

 

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.

 

The lease cost, cash flows and other information related to the Facility Lease were as follows:

 

  

As of March 31,

2022

 
Operating lease right-of-use asset  $540,444 
Operating lease liability, current  $112,072 
Operating lease liability, long-term  $459,482 
      
Remaining lease term   4.8 years 
Discount rate   3.63%

 

  

For the Three

Months Ended

March 31, 2022

 
Operating cash outflow from operating lease  $20,109 

 

13
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Future annual minimum lease payments on the Facility Lease as of March 31, 2022 are as follows:

  

Years ended December 31,    
2022 (excluding the three months ended March 31, 2022)  $91,095 
2023   124,897 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   625,265 
Less imputed interest   (53,710)
Present value of minimum lease payments   $571,555 

 

Note 3 – Inventory

 

Inventory consisted of the following:

 

   March 31,   December 31, 
   2022   2021 
Finished goods  $913,887   $272,199 
Work in progress   971    1,050 
Raw materials   186,115    196,456 
Allowance for excess & obsolete inventory   (95,055)   (91,379)
Inventory, net  $1,005,918   $378,326 

 

Overhead expenses of $16,555 and $13,589 were included in the inventory balance as of March 31, 2022, and December 31, 2021, respectively.

 

The inventory balance at March 31, 2022 includes $692,195 for inventory in transit from one of our suppliers that was delivered to our customer in April of 2022.

 

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $1,579,000 and $1,069,000 in advance payments for inventory for the periods ended March 31, 2022, and December 31, 2021, respectively.

 

14
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Note 4 – Property and Equipment

 

Property and equipment consisted of the following:

 

   March 31,   December 31, 
   2022   2021 
Furniture and equipment  $271,056   $274,472 
Vehicles   15,000    15,000 
Leasehold improvements   -    - 
Property and equipment, gross   286,056    289,472 
Accumulated depreciation   (208,817)   (212,126)
Property and equipment, net  $77,239   $77,346 

 

Depreciation expense was $8,556 for the three months ended March 31, 2022. For the three months ended March 31, 2022, $1,214 was allocated to cost of sales, $304 was allocated to inventory with the remainder recorded as selling, general, and administrative expense.

 

Note 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of the following:

 

   March 31,   December 31, 
   2022   2021 
Accounts payable  $729,040   $616,056 
Sales commissions payable   9,107    27,592 
Accrued payroll liabilities   266,456    322,873 
Product warranty accrual   187,702    186,605 
Other accrued expenses   196,723    192,463 
Total  $1,389,028   $1,345,589 

 

Note 6 – Note Payable and Accrued Interest

 

On February 10, 2021, the Company entered into a note payable with its current bank in the principal amount of $514,200, for working capital purposes.

 

The loan amount bears interest at 1% and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan is also potentially forgivable in full provided proceeds are used for payment of payroll expenses, rent, utilities and mortgage interest and certain other terms and conditions are met. If any portion of the loan is not forgiven, payments will commence 10 months following the end of the 24-week deferral period. The loan has typical default provisions, including for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.

 

On November 30, 2021, the Company received notice from the bank that its loan received on February 10, 2021, in the principal amount of $514,200 and all accrued interest of $2,832, was fully forgiven. This gain on loan forgiveness was recorded as Other Income in the Statement of Operations during the year ended December 31, 2021.

 

15
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Note 7 – Commitments and Contingencies

 

Litigation

 

The Company settled a litigation with a former employee effective March 30, 2021, which included the issuance of 6,667 shares of common stock of the Company, as part of the settlement. These shares were issued on April 8, 2021, as “restricted securities,” subject to a lock-up agreement of six months, without registration rights, and pursuant to a private placement exemption. The settlement agreement also included mutual releases and no admission of liability. The cost to the Company of this settlement, $107,000, in total, has been recognized in full in Other Expenses during the year ended December 31, 2021. The issuance of the 6,667 shares of common stock (valued at $67,000) has been recognized in common stock issued during the year ended December 31, 2021.

 

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

 

Leases

 

The Company has a lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

 

Other Commitments

 

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

 

Note 8 – Temporary Equity

 

On September 28, 2021, the Company sold to an institutional investor (the “Investor”), 3,300 shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”), stated value $1,000 per share, convertible into shares of common stock, for an aggregate purchase price of $3,000,000 (“Consideration”). The Company received net proceeds of approximately $1,260,000 on September 28, 2021, and the balance of approximately $1,365,000 on November 4, 2021.

 

The Series B Preferred Stock had an annual dividend of 8% and an initial common stock conversion price of $8.55. The conversion rate was subject to adjustment in various circumstances, including stock splits, stock dividends, pro rata distributions, fundamental transactions and upon a triggering event and subject to reset if the common stock of the Company sold in any subsequent equity transaction, including a qualified offering, was sold at a price below the then conversion price.

 

The Series B Preferred Stock was mandatorily convertible on the third anniversary of its issuance. All conversions of the Series B Preferred Stock were subject to a blocker provision of 4.99%.

 

16
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Probability of Redemption: As it was considered probable the Series B Preferred stock would become redeemable outside of the Company’s control, the Series B Preferred stock was disclosed as temporary equity and was initially adjusted as of September 30, 2021 to its redemption value of 120% of the stated value of $1,000 per share, or $3,960,000. As a result, the Company recorded a $2,262,847 non-cash redemption value adjustment during 2021. This redemption value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes; accordingly, the redemption value adjustment is therefore added to the “Net Loss” to arrive at “Net Loss Attributable to Common Shareholders on the Company’s Consolidated Statements of Operations. In addition, since the Company did not have a balance of retained earnings, the redemption value adjustment was recorded against additional paid-in capital.

 

On February 16, 2022, the Company redeemed 1,650 shares of its Series B Preferred Stock for payment of $2.016 million in cash, which included both principal and accrued dividends of approximately $36,000.

 

On February 16, 2022, the remaining 1,650 shares of the Company’s Series B Preferred Stock were converted into 362,306 shares of common stock and 703,069 warrants; 170,382 of the warrants vested immediately, have an indefinite term and an exercise price of $0.01 (“pre-funded conversion warrants”), the balance of 532,688 warrants also vested immediately, have a term of 5 years and have an exercise price of $5.00. The initial common stock conversion price for the shares of Series B Preferred Stock was $8.55. However, the terms of the Series B preferred stock were such that the stock conversion price was to be reduced to 75% of the offering price in any subsequent qualified public offering of Company equity instruments, if lower than the common stock conversion price of $8.55. The Company’s public offering that closed on February 15, 2022, was completed at an offering price of $4.13. Accordingly, the initial common stock conversion price for the shares of Series B Preferred Stock was reduced from $8.55 to $3.0975, representing 75% of the offering price of $4.13. As a result, the Company recognized a deemed dividend of $439,999 to Series B Shareholders in respect of the additional shares of common stock and warrants they received on the conversion of their shares of Series B Preferred stock. As the Company does not have a balance of retained earnings, the deemed dividend was recorded against additional paid-in capital.

 

The Company has no remaining Preferred Shares outstanding as of March 31, 2022.

 

Note 9 – Stockholders’ Equity (Deficit)

 

Directors Remuneration

 

On January 3, 2022, the Company issued 3,125 non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $4.80, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.

 

On January 17, 2022, the Company issued an RSU grant of 3,367 shares of common stock 2021 Equity Incentive Plan to each of two new directors, 1,684 shares of common stock vested immediately on grant date and the remaining 1,683 shares of common stock will vest on January 17, 2023, if the recipient remains in service as an independent director. 1,684 shares of common stock were issued to each of the two new directors in settlement of the RSUs that vested immediately.

 

Revised Compensation Plan

 

On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan supersedes the plan adopted on August 20, 2021. The Plan is effective retroactively for the current independent directors and for independent directors elected or appointed after the Effective Date. 3,367 restricted stock units in respect of this plan were issued on January 17, 2022. Cash fees were paid on January 21, 2022.

 

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from 240,125,244 to 1,600,835. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

17
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Change in Authorized Share Capital

 

In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to 200,000,000 shares of common stock and 25,000,000 shares of preferred stock.

 

Equity Raise

 

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $22 million for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

As of March 31, 2022, the Company had 200,000,000 shares authorized at a $.00001 par value. Effective March 31, 2022, 7,784,444 shares of common stock were issued and outstanding. No shares of preferred stock are issued and outstanding.

 

Note 10 – Equity Incentive Plans

 

2017 Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

During the three months ended March 31, 2022, no shares or options were issued and 13,333 options were cancelled under the 2017 Plan.

 

As of March 31,2022, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards related to 148,905 options remain outstanding, and 20,736 shares remain available for future equity awards.

 

2021 Equity Incentive Plan

 

On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.

 

18
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

During the three months ended March 31, 2022, the Company issued 3,367 shares of its common stock to two new independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted in January 2022.

 

During the three months ended March 31, 2022, the Company granted awards for 21,167 non-qualified stock options to employees under the 2021 Equity Incentive Plan as described below.

 

During the three months ended March 31, 2022, the Company granted awards for 6,250 non-qualified stock options to directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted in August of 2021.

 

As of March 31,2022, of the 666,667 shares authorized under the 2021 Equity Plan, 10,170 relate to restricted shares issued, 33,408 relate to outstanding non-qualified stock options, 40,816 relate to outstanding incentive stock options, 3,367 relate to outstanding restricted stock units and 578,906 shares remain available for future equity awards.

 

There was $222,707 in unrecognized compensation expense for unvested non-qualified stock options, incentive stock options and restricted stock units at March 31, 2022 which will be recognized over approximately 3 years.

 

Non-Qualified and Incentive Stock Options

 

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2022, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding, December 31, 2021   158,174   $10.99    7.6   $        - 
Granted   21,167   $3.55    9.8   $

4,650

 
Exercised   -   $-    -   $- 
Forfeited   (13,333)  $9.15    0.0   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2022   166,007   $10.18    8.2   $4,650 
Exercisable, March 31, 2022   118,828   $11.89    7.6   $610 

 

19
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

During the three months ended March 31, 2022, we issued a total of 21,167 stock options to employees as follows:

 

  6,167 stock options were issued to three new employees. The vesting of these options ranges from immediate to three years, have a term of 10 years and an exercise price ranging from $4.80 to $6.90.
  15,000 stock options were issued to our newly appointed Chief Financial Officer. The options vest as follows: 2,000 vested immediately, 3,000 on March 11, 2023, 5,000 on March 11, 2024, and 5,000 on March 11, 2025. The options have a term of 10 years and an exercise price of $2.20.
  During the three months ended March 31, 2022, 1,667 fully vested stock options and 11,667 unvested stock options were forfeited following the departure of one former employee.

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2022, are presented in the table below:

 

 

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant-Date

Fair Value

 
                
Nonvested, December 31, 2021   41,846   $7.65   $        -   $320,122 
Granted   21,167   $3.51   $-   $74,296 
Vested   (4,167)  $4.50   $-   $(18,751)
Forfeited   (11,667)  $9.01   $-   $(105,120)
Expired   -   $-   $-   $- 
Nonvested, March 31, 2022   47,179   $5.73   $-   $270,547 

 

For the three months ended March 31, 2022 and March 31, 2021, the Company recorded $32,939 and $0 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2022, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
                 
Outstanding, December 31, 2021   50,872   $10.02    6.6   $       - 
Granted   6,250   $4.80    9.8   $- 
Exercised   -   $-    -   $- 
Forfeited/Cancelled   -   $-    -   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2022   57,122   $9.44    6.7   $- 
Exerciseable, March 31, 2022   57,122   $9.44    6.7   $- 

 

A summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the three months ended March 31, 2022, are presented in the table below:

 

20
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

 

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant-Date

Fair Value

 
                
Nonvested, December 31, 2021   -   $-   $-   $- 
Granted   6,250   $4.80   $(14,313)  $29,688 
Vested   (6,250)  $4.80   $14,313  $(29,688)
Forfeited   -   $-   $

-

   $- 
Expired   -   $-   $-   $- 
Nonvested, March 31, 2022   -        $-   $- 

 

During the three months ended March 31, 2022 and March 31, 2021, the Company incurred $29,656 and $6,342 respectively, as compensation expense related to 6,250 and 3,333 vested options, respectively, issued to directors.

 

Effective January 3, 2022, the Company issued 6,250 non-qualified stock options under the 2021 Equity Plan to its then current directors. The options vested upon grant. The options have a term of 10 years and an exercise price equal to the closing price of the Company’s common stock on The OTC Markets on the day immediately preceding the grant date.

 

Restricted Stock Units

 

Effective January 17,2022, the Company issued 6,734 restricted stock units (RSUs) under the 2021 Equity Plan to newly appointed directors. 3,367 of these RSUs vested upon grant and the remining 3,367 will vest on January 17, 2023.

 

The Company recorded $29,923 during the three months ended March 31, 2022, as compensation expense related to vested RSUs issued to directors.

 

 

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic Value

 
            
Outstanding, December 31, 2021   -   $-   $      - 
Granted   6,734   $7.42   $- 
Vested and settled with share issuance   (3,367)  $7.42   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, March 31, 2022   3,367   $7.42   $- 

 

 

21
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Note 11 - Warrants

 

The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2022:

 

 

      

Weighted

Average

  

Weighted

Average

Remaining

   Aggregate 
   Number   Exercise   Life   Intrinsic 
   Outstanding   Price   In Months   Value 
                 
Outstanding at December 31, 2021   227,719   $9.59    33   $         0 
                     
Issued   7,566,435   $4.89    58*  $425,955 
                     
Exercised   -    -    -    - 
                     
Expired   -    -    -    - 
                     
Outstanding at March 31, 2022   7,794,154   $5.03    58*  $425,955 

 

*Excludes 170,382 warrants with an indefinite life.

 

The following table summarizes information about warrants outstanding at March 31, 2022:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Months Outstanding 
          
 9.45    192,982    30 
             
 10.40    34,737    31 
             
 5.00    7,105,496    59 
             
 5.16    290,557    59 
             
 0.01    170,382    Indefinite Life 
      7,794,154    58*

 

* Excludes 170,382 warrants with an indefinite life. 

 

22
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Q3 2021 Warrants Issued to Series B Preferred Stockholder

 

On September 28, 2021, the Company entered into a Securities Purchase Agreement with an institutional investor, pursuant to which the investor purchased from the Company 3,300 shares of convertible Series B Preferred Stock with a stated value of $1,000 per share, or $3,300,000 of stated value in the aggregate, and a warrant to purchase up to 192,982 shares of common stock of the Company for an aggregate purchase price of $3,000,000. The warrant is exercisable until September 28, 2024, at an exercise price of $9.45, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights.

 

Q3 2021 Warrants Issued to Series B Preferred Placement Agent

 

In connection with the sale of the shares of convertible Series B Preferred Stock described above, the Company issued 34,737 warrants to the placement agent and its designees. Half of the warrants were issued on September 28, 2021, and the second half were issued on November 3, 2021, and are exercisable commencing February 28, 2022 and May 3, 2022, respectively, until September 28, 2024 and November 3, 2024, respectively. The exercise price per share of the warrants is $10.40, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights.

 

Q1 2022 Investor Warrants

 

On February 15, 2022, the Company issued 5,811,138 investment units for aggregate gross proceeds of $24,000,000, or $4.13 per unit. Each unit consisted of one share of the Company’s common stock and one warrant for the purchase of one share of the Company’s common stock. The warrants vested immediately, had a term of 5 years and an exercise price of $5.00.

 

Q1 2022 Overallotment Warrants

 

Further on February 15, 2022, in connection the Company’s issuance of 5,811,138 investment units for aggregate gross proceeds of $24,000,000, or $4.13 per unit as described above, a further 761,670 warrants were issued in connection with the subscription for substantially all of the available 15% overallotment warrants. The warrants were acquired for consideration of $0.01 per warrant, vested immediately, had a term of 5 years and an exercise price of $5.00.

 

Q1 2022 Underwriter Warrants

 

Further on February 15, 2022, in connection the Company’s issuance of 5,811,138 investment units for aggregate gross proceeds of $24,000,000, or $4.13 per unit described above, the Company also issued representatives of the underwriters 290,557 warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

Q1 2022 Series B Preferred Shares Pre-Funded Conversion Warrants

 

On February 16, 2022, in connection with the conversion of 1,650 shares of Series B Preferred Stock into 362,306 shares of the Company’s common stock, the Series B Preferred Shareholder was issued with 170,382 pre-funded conversion warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $0.01, vested immediately and had an indefinite life.

 

23
 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Q1 2022 Series B Preferred Shares Conversion Warrants

 

Further on February 16, 2022, in connection with the conversion of 1,650 shares of Series B Preferred Stock into 362,306 shares of the Company’s common stock, the Series B Preferred Shareholder was also issued with 532,688 Series B Preferred shares conversion warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $5.00, vested immediately and had a term of 5 years.

 

Note 12 – Income Taxes

 

As of March 31, 2022, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $22,514,000, of which $11,196,000 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%. In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the 80% limitation for NOLs arising in 2018, 2019 and 2020.

 

In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations

 

The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of March 31, 2022 and December 31, 2021. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.

 

Note 13 – Related Party Transactions

 

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant ownership interest in RSX.

 

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless prior notice is given 90 days prior to each annual expiration. During the three months ended March 31, 2022, the Company paid $7,555 in commissions under this agreement.

 

Note 14 – Subsequent Events

 

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No material subsequent events occurred after March 31, 2022, other than as set out below:

 

On April 1, 2022, 31,793 non-qualified stock options were issued to 21 employees in respect of the Company’s 2021 Annual Incentive Awards. The options vested immediately, have a term of 10 years and an exercise price of $2.51. The expense in respect of this issuance had been fully in fully accrued in 2021.

 

24
 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report, which include additional information about our accounting policies, practices, and the transactions underlying our financial results, as well as with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Cautionary Statements” appearing elsewhere herein and the risks and uncertainties described or identified in “Item 1A – Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021, as updated from time to time in the Company’s filings with the SEC, and Part II, Item 1A of this Quarterly Report entitled “Risk Factors.”

 

Non-GAAP Financial Measures

 

To supplement our financial results on U.S. generally accepted accounting principles (“GAAP”) basis, we use non-GAAP measures including net bookings, backlog, as well as adjusted net income (loss) which reflects adjustments for certain non-cash expenses such as stock-based compensation, certain debt-related items and depreciation expense. We believe these non-GAAP measures are helpful in understanding our past performance and are intended to aid in evaluating our potential future results. The presentation of these non-GAAP measures should be considered in addition to our GAAP results and are not intended to be considered in isolation or as a substitute for financial information prepared or presented in accordance with GAAP. We believe these non-GAAP financial measures reflect an additional way to view aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business. For purposes of this Quarterly Report, (i) “adjusted net income (loss)” and “adjusted operating income (loss)” mean GAAP net income (loss) and operating income (loss), respectively, after adjustment for non-cash equity compensation expense, debt-related items and depreciation expense, and (ii) “net bookings” means new sales contracts executed during the quarter for which we received an initial deposit, net of any adjustments including cancellations and change orders during the quarter.

 

Our backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in the backlog or remaining performance obligations will actually generate revenues or when the actual revenues will be generated.

 

Overview

 

CEA Industries is an engineering and design company focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture (“CEA”) industry. The CEA industry uses technology-based methods to grow crops in a way that provides protection from the outdoor elements; these methods have traditionally included indoor agriculture and vertical farming. The CEA industry aims to optimize the use of horticultural resources such as water, energy, space, capital and labor, to create an agriculture business that is more efficient and more productive than traditional farming methods.

 

Headquartered in Colorado, we leverage our experience in the CEA industry to bring our customers a variety of value-added technology solutions that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. We do this by offering our customers a variety of principal service and product offerings that include: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting and climate control, and (vi) preventive maintenance services for CEA facilities.

 

Currently, our revenue stream is derived primarily from supplying our products, services and technologies to commercial indoor facilities operating in the cannabis industry. Our customers include state and provincial-regulated CEA growers located in the U.S., Canada and other international locations. They are focused on building new CEA facilities and expanding or retrofitting existing CEA facilities. Our customers operate CEA facilities that range in size from several thousand square feet to more than 100,000 square feet.

 

25
 

 

CEA growers currently face a challenging business environment that includes high energy costs, water usage and conservation issues, and continuously evolving waste removal regulations. In addition to these issues, our cannabis growing customers face increasingly rigorous quality standards and declining cannabis prices in a growing industry whose standards are constantly evolving. A primary challenge for our customers involves finding innovative ways to reduce energy costs. On average, 50% of our customers’ energy costs are driven by HVACD systems and another 40% by lighting systems.

 

We support our clients by providing integrated mechanical, electrical, and plumbing (“MEP”) engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. In addition, we believe we are among the leading experts in engineering environmental control systems for CEA facilities, which is commonly viewed as the most challenging component of a CEA facility’s technical infrastructure. Over our 16 years in business, we have served over 200 commercial indoor CEA facilities. While a professional engineer (“PE”) license is not required in any other design component of a CEA facility, such a license is required for the design of a CEA facility’s environmental control equipment, and our senior engineers hold PE licenses.

 

We believe our customers partner with us because we have the reputation and experience to help them make cost-conscious and effective decisions on their environmental and climate control systems. Our clients are focused on their crops and rely on us to partner with them on ways to optimize their CEA facility. We are also mindful of the evolving and substantial environmental sustainability standards and concerns raised by governments, consumers and other stakeholders. CEA facilities are resource intensive, and a growing list of states have implemented building code changes that limit energy consumption in cultivation facilities. Energy and resource efficiency is a high priority to us as engineers, and the senior engineers on our team hold the Leadership in Energy and Environmental Design (“LEED”) credential. In addition, our CEO helped build a cleantech company, and is a published author in the energy efficient technologies space. We believe this sustainability-focused technical experience is a unique advantage that our customers value when working with us.

 

While the Company historically focused on HVACD systems, in May of 2021, we announced an initiative to expand our product and service offerings to include most of the technical product and service infrastructure requirements associated with building and retrofitting CEA facilities, as well as post-build recurring maintenance services. Our engineering design services and consulting expertise facilitates early engagement with our customers at the pre-build and construction phases, and this enables us to better understand our customers’ goals at the beginning of a project, and provide the associated infrastructure products and services to reach those goals. Through our prior engagements with customers, we have built long-term relationships with our existing customers, which we plan to leverage and build on in the future.

 

We have three core assets that we believe will support us as we pursue our business strategy. First, we enjoy strong relationships with relevant stakeholders in the CEA industry. Largely focused in the cannabis segment, our partnerships include relationships with new and existing growers, capital providers, consultants, independent contractors, and numerous others. Second, our experience in this industry over time has built up specialized engineering know-how and experience. We have been serving indoor cultivators since 2006 and designing CEA cultivation facilities since 2016. Since then, we have tested and solidified best practices from designing environmental control systems for CEA cultivation facilities. Finally, we have a line of proprietary environmental control products that support the specific growing environments that our customers want. We believe these products offer significant benefits to our customers and we are in the process of expanding our product slate.

 

Shares of our common stock and warrants are traded on the Nasdaq Capital Markets under the ticker symbol “CEAD” and “CEADW”, respectively.

 

26
 

 

Impact of the COVID-19 Pandemic on Our Business

 

The COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in, to implement preventative or protective measures to control its spread. As a result, there have been disruptions in business operations around the world, with an impact on our business.

 

In response to the COVID-19 pandemic and the associated government and business response, the Company took and continues to take measures to adjust its operations as necessary. In early 2020 the Company responded to reduced orders by reducing expenses in an effort to preserve cash. As 2020 progressed and our sales rebounded, and we were able to obtain additional funds through a forgivable bank loan, we restored our workforce increased our operations. Many of the expense reductions were reversed by the end of 2021 when orders picked up and the overall business climate improved. Because the pandemic continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations.

 

We are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant increase in shipments to U.S. ports, compounded by a reduction in cargo being shipped by air, a general shortage of containers, and a shortage of domestic truck driver availability. While these delays have moderately improved in recent months, we, along with many other importers of goods across all industries, continue to experience severe congestion and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed by local, state and federal agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others in our supply chain. We have been working diligently with our network of freight partners and suppliers to expedite delivery dates and provide solutions to reduce further impact and delays. However, we are unable to determine the full impact of these delays and how long they will continue as they are out of our control.

 

While the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full extent of the impact of COVID-19 on our operational and financial performance will depend on future developments, including the duration and spread of the pandemic, the potential uncertainty related to (and proliferation of) new strains, and related actions taken by federal, state, local and international government officials, to prevent and manage the spread of COVID-19. All of these efforts are uncertain, out of our control, and cannot be predicted at this time.

 

Impact of Ukranian Conflict

 

Currently, we believe that the conflict between Ukraine and Russia does not have any direct impact on our operations, financial condition or financial reporting. We believe the conflict will have only a general impact on our operations in the same manner as it is having a general impact on all businesses that have their operations limited to North America resulting from international sanction and embargo regulations, possible shortages of goods and goods incorporating parts that may be supplied from the Ukraine or Russia, supply chain challenges, and the international and US domestic inflationary results of the conflict and government spending for and funding of our country’s response. As our operations are related only to the North American controlled agricultural industry, largely within the cannabis space, we do not believe we will be targeted for cyber-attacks. We have no operations in the countries directly involved in the conflict or are specifically impacted by any of the sanctions and embargoes, as we principally operate in the United States and Canada. We do not believe that the conflict will have any impact on our internal control over financial reporting. Other than general securities market trends, we do not have reason to believe that investors will evaluate the company as having special risks or exposures related to the Ukranian conflict.

 

Our Corporate Strategy

 

Our strategy for growing the Company and increasing shareholder value is informed by two key pillars:

 

Pursue Organic Growth Opportunities Execute on Consolidation Opportunities

 

Pursue aggressive organic growth. According to New Frontier Data and Grandview Research, the legal cannabis market and the global indoor farming markets are forecasted to grow at a 15% annual rate for the foreseeable future. This is largely driven by the cannabis cultivation market we currently focus on, and the rapidly growing popularity of the vertical farming market.

 

We are well positioned to build our business by serving both of these segments, by servicing current and future customers to the CEA industry, and by expanding our customer base to include indoor farming growers. In May of 2021 we announced a series of pivots, to better enable the Company to grow organically:

 

Expansion to New Markets. We expanded our business development plan to include the pursuit of non-cannabis CEA facilities, which includes indoor cultivation farms and other CEA technology users outside of the cannabis industry. This expansion has approximately doubled our potential addressable market without any additional upfront retrofit costs to our Company.

 

Expansion of Product Offering. As previously noted, the Company historically focused on offering HVACD systems to help our existing CEA clients manage their environmental control issues. While significant, this offering represented approximately one third of the total slate of potential products and services required to help a grower build and maintain a CEA facility. We continue to believe that our clients want to focus on growing plants, while leaving the technical infrastructure buildout and maintenance to a more experienced partner. As part of our May 2021 initiative, we expanded our product and service offerings by including almost all of the primary technologies and services required to build and maintain a CEA facility. This expansion includes architectural design, lighting, benching, sensing & control systems, and CO2 dosing and control. It also includes maintenance services and other post-build products and services that create more recurring revenue streams than the product set we traditionally offered.

 

27
 

 

For example, by offering Facility Selection & Design services, we plan to establish ‘pre-build’ customer relationships with prospects at the earliest opportunity in the lifecycle of the CEA facility. From there, we plan to offer nearly every piece of the technical infrastructure required in a facility, engaging with our customers at the earliest possible moment to provide all products and services required for the buildout of their CEA facility. Once a CEA facility is built, our Preventive Maintenance Services will provide recurring revenue, as we maintain the productivity of the facility for the facility’s full life.

 

We believe that we are uniquely positioned to engineer all of the complex components of a CEA facility into a more integrated and coordinated system, because of our dedicated engineering staff and our experience in over 800 projects including over 200 commercial facilities. We have built a wide network of technology vendors from which we curate a selection of the best products. We are the leading experts in applying the most challenging component of the technical infrastructure, the environmental controls. As a result, we have the knowledge required to engineer the interactions among the required components. The reputation we have built and the relationships we have established as experts in the complex environmental control space positions us to engineer the interactions among the other key components. We believe this effort will grow revenues from our existing platform in the future.

 

Corporate Name Rebrand. In November of 2021 we changed the name of our parent company from Surna Inc. to CEA Industries Inc. We believe this name better demonstrates the breadth of both our newly expanded product offering and our ability to serve the broader CEA industry in segments beyond traditional cannabis cultivation. We believe this name will more clearly identify our business to prospects and make us easier to find on various social media and search engine platforms. In January 2022, we moved our environmental controls operations to Surna Cultivation Technologies LLC, a newly formed subsidiary of CEA Industries Inc., in order to separate our environmental controls business from other businesses we plan to pursue as we expand our product and service offerings.

 

Seek strategic relationships, mergers, and acquisitions to add to our existing business. We have been involved in over 800 cultivation projects over 16 years. This experience has exposed us to almost all of the ancillary and primary product and service components within a CEA facility, including lighting, irrigation, HVACD, fertigation, sensors, controls, CO2 dosing, monitoring, facility power availability, and energy consumption. Exposure to these primary components has built a uniquely well-informed view of the value contribution from various primary services and components on offer in the marketplace.

 

We believe that this knowledge will help us identify opportunities to acquire products and services for strategic relationships and potential acquisitions. As we evaluate the state of the CEA industry and the various industry participants, we see significant opportunity for the industry to create value through consolidation. As a growing industry, CEA has a significant need for capital and a recognition that not all companies can be funded for growth. We believe this positions us well as we identify partners whose business platforms are complementary to our business platform.

 

Finally, members of our team have extensive experience in identifying, evaluating and acquisitions that are accretive and create long-term value for our shareholders. We believe that assets on our platform can benefit our shareholders via synergies and scale economics. For certain component providers, we believe that our public stock and strong existing platform of products, expertise, and marketing reach will make us an attractive partner for a potentially accretive, value creating partnership.

 

Our Bookings, Backlog and Revenue

 

During the three months ended March 31, 2022, we executed new sales contracts with a total contract value of $2,347,000. During this same period, we had positive change orders of $159,000 and cancellations of $401,000. The cancellations were based on discussions with customers who have abandoned their projects. After adjustments for these change orders and cancellations, our net bookings in the three months ended March 31, 2022 were $2,105,000, representing a decrease of $1,888,000 (or 47%) from net bookings of $3,993,000 in the fourth quarter of 2021.

 

28
 

 

 

Our backlog at March 31, 2022 was $11,179,000, an increase of $361,000, or 3%, from December 31, 2021. The increase in backlog is the result of lower revenue in the first quarter. Our backlog at March 31, 2022 includes booked sales orders of $2,217,000 (20% of the total backlog) from several customers that we do not expect to be realized until 2023. We believe the sales orders in this portion of our backlog have an elevated level of risk and may, ultimately, be delayed or cancelled by our customers. Therefore, investors should not view backlog as earned revenue.

 

The following table sets forth: (i) our beginning backlog (the remaining contract value of outstanding sales contracts for which we have received an initial deposit as of the previous period), (ii) our net bookings for the period (new sales contracts executed during the period for which we received an initial deposit, net of any adjustments including cancelations and change orders during the period), (iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning backlog and net bookings, less recognized revenue).

 

   For the quarter ended 
  

March 31,

2021

  

June 30,

2021

  

September 30,

2021

  

December 31,

2021

  

March 31,

2022

 
Backlog, beginning balance  $8,448,000   $11,578,000   $7,987,000   $9,881,000   $10,818,000 
Net bookings, current period  $5,497,000   $919,000   $5,600,000   $3,993,000   $2,105,000 
Recognized revenue, current period  $2,367,000   $4,510,000   $3,706,000   $3,056,000   $1,744,000 
Backlog, ending balance  $11,578,000   $7,987,000   $9,881,000   $10,818,000   $11,179,000 

 

The completion of a customer’s new build facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for these customers to complete a new build project, which corresponds to when we are able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project.

 

As has historically been the case for the Company at each quarter-end, there remains significant uncertainty regarding the timing of revenue recognition of our backlog as of March 31, 2022.

 

We have provided an estimate in our condensed consolidated financial statements for when we expect to recognize revenue on our remaining performance obligations (i.e., our Q1 2022 backlog), using separate time bands, with respect to engineering only paid contracts and partial equipment paid contracts. There continues to be significant uncertainty regarding the timing of our recognition of revenue on our Q1 2022 backlog. Refer to the Revenue Recognition section of Note 1 in our condensed consolidated financial statements, included as part of this Quarterly Report for additional information on our estimate of future revenue recognition on our remaining performance obligations.

 

Our backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in backlog or remaining performance obligations will generate revenues or when the revenues will be generated. Net bookings and backlog are considered non-GAAP financial measures, and therefore, they should be considered in addition to, rather than as a substitute for, our GAAP measures for recognized revenue, deferred revenue and remaining performance obligations. Further, we can provide no assurance as to the profitability of our contracts reflected in remaining performance obligations, backlog and net bookings.

 

29
 

 

Results of Operations

 

Comparison of Three Months Ended March 31, 2022 and March 31, 2021

 

Revenues and Cost of Goods Sold

 

Revenue for the three months ended March 31, 2022 was $1,744,000, compared to $2,367,000 for the three months ended March 31, 2021, representing a decrease of $622,000, or 26%. The decrease was primarily due to delays with our international supply of products and shipments from vendors which delayed contract fulfillment and revenue recognition on existing contracts. As a result, even though our bookings were down, our ending backlog increased. The supply chain impact was largely due to delays at U.S. ports, compounded by a reduction in cargo shipped by air, a shortage of containers, and a shortage of domestic truck delivery availability.

 

Cost of revenue decreased by $368,000, or 18%, from $2,022,000 for the three months ended March 31, 2021 to $1,654,000 for the three months ended March 31, 2022. The decrease was primarily due to a decrease in revenue and an increase in fixed costs as a percent of revenue as discussed below.

 

The gross profit for the three months ended March 31, 2022 was $91,000 compared to $345,000 for the three months ended March 31, 2021, a decrease of 74%. Gross profit margin decreased by 9.4 percentage points from 14.6% for the three months ended March 31, 2022 to 5.2% for the three months ended March 31, 2021 primarily due to an increase in fixed costs as a percent of revenue, as described below.

 

Our fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead) totaled $359,000, or 21% of total revenue, for the three months ended March 31, 2022 as compared to $337,000, or 14% of total revenue, for the three months ended March 31, 2021. The increase of $22,000 was primarily due to an increase in salaries and benefits (including stock-based compensation) of $33,000, offset by a decrease in overhead of $11,000.

 

Our variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs) totaled $1,295,000, or 74% of total revenue, in the three months ended March 31, 2022 as compared to $1,685,000, or 71% of total revenue, in the three months ended March 31, 2021. The decrease in variable costs was primarily due to: (i) a decrease in equipment costs of $376,000 driven by lower revenue, (ii) a decrease in warranty expense of $64,000, offset by (iii) an increase in travel expenses of $45,000.

 

We continue to focus on gross margin improvement through a combination of efforts, including more disciplined pricing, better absorption of our fixed costs as we convert our bookings into revenue, and the implementation over time of lower-cost supplier alternatives.

 

Operating Expenses

 

Operating expenses increased to $1,702,000 for the three months ended March 31, 2022, from $1,030,000 for the three months ended March 31, 2021, an increase of $671,000, or 65%. The operating expense increase consisted of: (i) an increase in selling, general and administrative expenses (“SG&A expenses”) of $571,000, (ii) an increase in advertising and marketing expenses of $74,000, and (iii) an increase in product development expenses of $26,000.

 

The increase in SG&A expenses for the three months ended March 31, 2022 compared to the three months ended March 31, 2021, was primarily due to: (i) an increase of $384,000 in salaries and benefits (including stock-based compensation) and other employee related costs, (ii) an increase of $87,000 for accounting and other professional fees, (iii) an increase in insurance costs of $44,000, and (iv) an increase of $50,000 for board fees and investor relations expenses.

 

30
 

 

The increase in marketing expenses was primarily due to (i) an increase in salaries and benefits (including stock-based compensation) of $51,000, and (ii) an increase in other promotional marketing expenses of $23,000.

 

The increase in product development costs was due to an increase in salaries and benefits (including stock-based compensation) of $26,000.

 

Operating Income (Loss)

 

We recognized an operating loss of $1,611,000 for the three months ended March 31, 2022, as compared to an operating loss of $686,000 for the three months ended March 31, 2021, an increase of $926,000, or 135%. The operating loss for the three months ended March 31, 2022 included $93,000 of non-cash, stock-based compensation and $7,000 of depreciation and amortization expense, compared to $59,000 of non-cash, stock-based compensation and $17,000 of depreciation and amortization expense for the three months ended March 31, 2021. Excluding these non-cash items, our operating loss increased by $902,000, or 148%.

 

Other Income (Expense)

 

We recognized other income (net) of $188,000 for the three months ended March 31, 2022, compared to other expense (net) of $108,000 for the three months ended March 31, 2021. Other income for the three months ended March 31, 2022 primarily consisted of income from an insurance settlement of $185,000. Other expense for the three months ended March 31, 2021 consisted of $107,000 related to the settlement of litigation with a former employee.

 

Net Income (Loss)

 

Overall, we recognized a net loss of $1,423,000 for the three months ended March 31, 2022, as compared to a net loss of $793,000 for the three months ended March 31, 2021, an increase of $630,000, or 79%. The net loss for the three months ended March 31, 2022 included $93,000 of non-cash, stock-based compensation and $7,000 of depreciation and amortization expense, compared to $126,000 of non-cash, stock-based compensation and $17,000 of depreciation and amortization expense for the three months ended March 31, 2021. Excluding these non-cash items, our net loss increased by $673,000, or 104%.

 

Financial Condition, Liquidity and Capital Resources

 

Cash, Cash Equivalents

 

As of March 31, 2022, we had cash and cash equivalents of $22,034,000, compared to cash and cash equivalents of $2,160,000 as of December 31, 2021. The $19,874,000 increase in cash and cash equivalents during the three months ended March 31, 2022, was primarily the result of cash proceeds from the sale of common stock and warrants of $21,711,000, offset by the redemption of series B preferred stock and interest of $2,016,000. Our cash is held in bank depository accounts in certain financial institutions. During the three months ended March 31, 2022, we held deposits in financial institutions that exceeded the federally insured amount.

 

As of March 31, 2022, we had accounts receivable (net of allowance for doubtful accounts) of $191,000, inventory (net of excess and obsolete allowance) of $1,006,000 (including $692,000 of inventory in transit), and prepaid expenses of $1,774,000 (including $1,579,000 in advance payments on inventory purchases). While we typically require advance payment before we commence engineering services or ship equipment to our customers, we have made exceptions requiring us to record accounts receivable, which carry a risk of non-collectability especially since most of our customers are funded on an as-needed basis to complete facility construction. We expect our exposure to accounts receivable risk to increase as we continue to pursue larger projects.

 

31
 

 

As of March 31, 2022, we had total accounts payable and accrued expenses of $1,389,000, deferred revenue of $5,485,000, accrued equity compensation of $84,000, other current liabilities of $37,000 and the current portion of operating lease liability of $112,000. As of March 31, 2022, we had working capital of $17,948,000, compared to a working capital deficit of $415,000 as of December 31, 2021. The increase in our working capital was primarily related to (i) an increase in cash of $19,874,000, (ii) an increase in inventory of $628,000, (iii) an increase in prepaid expenses and other assets of $551,000, offset by (iv) an increase in deferred revenue of $2,646,000.

 

We have never declared or paid any cash dividends on our common stock. We currently intend to retain all available funds and any future earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future.

 

Summary of Cash Flows

 

The following summarizes our approximate cash flows for the three months ended March 31, 2022 and 2021:

 

  

For the Three Months Ended

March 31,

 
   2022   2021 
Net cash provided by operating activities  $193,000   $484,000 
Net cash used in investing activities   (14,000)   (12,000)
Net cash provided by financing activities   19,695,000    514,000 
Net increase in cash  $19,874,000   $986,000 

 

Operating Activities

 

We incurred a net loss for the three months ended March 31, 2022 of $1,423,000 and have an accumulated deficit of $30,205,000 as of March 31, 2022.

 

Cash provided by operations for the nine months ended March 31, 2022 was $193,000 compared to $484,000 for the three months ended March 31, 2021, a decrease of $291,000.

 

The decrease in cash provided by operating activities during the three months ended March 31, 2022 as compared to the three months ended March 31, 2021, was primarily attributable to: (i) an increase in net loss of $630,000, (ii) an increase in cash used to fund working capital of $361,000, and (iii) a decrease in non-cash operating charges of $22,000.

 

The increase in working capital was related to: (i) an increase in cash of $19,874,000, (ii) an increase in inventory of $628,000, (iii) an increase in prepaid expenses and other assets of $551,000, offset by (iv) an increase in deferred revenue of $2,646,000.

 

The decrease in non-cash operating charges was due to (i) a decrease in amortization of ROU asset of $24,000, (ii) a decrease in the allowance for doubtful accounts of $22,000, and (iii) an increase in other share-based compensation of $19,000.

 

Investing Activities

 

The $14,000 cash used in investing activities during the three months ended March 31, 2022 was related to the purchase of property and equipment. Cash used in investing activities during the three months ended March 31, 2021 was related to the purchase of property and equipment of $12,000.

 

Financing Activities

 

Cash flows from financing activities during the three months ended March 31, 2022, was the result of cash proceeds from the sale of common stock and warrants (net of issuance costs) of $21,711,000, offset by a cash payment of $2,016,000 for the redemption of series B preferred stock, including related interest.

 

32
 

 

Common Stock Equity Offering

 

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $21,711,000 for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.16, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

The net proceeds from the offering will be used to advance the Company’s organic growth and new product initiatives, to pursue select acquisitions, and for general corporate and working capital purposes. In connection with this offering, we received approval to list our common stock on the Nasdaq Capital Market under the symbol “CEAD” and our warrants under the symbol “CEADW”. As a result, effective February 10, 2022, trading of both shares of the Company’s common stock and certain of the Company’s warrants commenced on the Nasdaq.

 

Inflation

 

To date, we have experienced and are likely to continue to face inflationary increases on the cost of products, which may adversely affect our margins and financial results, and the pricing of our service and product supply contracts. The inflationary pressures are in both the larger economy and in the industries related to building renovations, retrofitting and new build facilities in which we operate. This inflation is reflected in higher wages, increased pricing of equipment and other products that we have contracted to provide to our customers, and generally higher prices across all sectors of the economy. As we move forward, we plan to continuously monitor our various contract terms and may decide to add clauses that will permit us to adjust pricing if inflation and price increase pressures on us will impact our ability to perform our contracts and maintain our margins.

 

Contractual Payment Obligations

 

As of March 31, 2022, our contractual payment obligations consisted of a building lease. Refer to Note 2Leases of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of building lease.

 

Commitments and Contingencies

 

Refer to Note 7 – Commitments and Contingencies of the notes to the condensed consolidated financial statements, included as part of this Quarterly Report for a discussion of commitments and contingencies.

 

Off-Balance Sheet Arrangements

 

We are required to disclose any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. As of March 31, 2022, we had no off-balance sheet arrangements. During the three months ended March 31, 2022, we did not engage in any off-balance sheet financing activities other than those included in the “Contractual Payment Obligations” discussed above and those reflected in Note 7 of our condensed consolidated financial statements.

 

Recent Developments

 

Refer to Note 12 - Subsequent Events of the notes to condensed consolidated financial statements, included as part of this Quarterly Report for certain significant events occurring since March 31, 2022.

 

Critical Accounting Estimates

 

This discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting policies are particularly important to the understanding of our financial position and results of operations and require the application of significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, management uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, observance of trends in the industry, information provided by our customers, and information available from other outside sources, as appropriate. Actual results could materially differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

33
 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, therefore are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and our Principal Financial and Accounting Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Principal Financial and Accounting Officer concluded that as a result of material weakness in our internal control over financial reporting as described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC, our disclosure controls and procedures were not effective as of March 31, 2022.

 

We did not maintain effective controls over certain aspects of the financial reporting process because: (i) we lack a sufficient complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements, (ii) there is inadequate segregation of duties due to our limited number of accounting personnel, and (iii) we have insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets that we use for a variety of purposes including revenue, taxes, stock-based compensation and other areas, and place significant reliance on, for our financial reporting.

 

We intend to take appropriate and reasonable steps to make the necessary improvements to remediate these deficiencies. We are committed to continuing to improve our financial organization including, without limitation, expanding our accounting staff and improving our systems and controls to reduce our reliance on the manual nature of our existing systems. However, due to our size and our financial resources, remediating the several identified weaknesses has not been possible and may not be economically feasible now or in the future.

 

Changes in Internal Control over Financial Reporting

 

There were no changes identified in connection with our internal control over financial reporting during the three months ended March 31, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

34
 

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are not currently a party to any material legal proceedings, nor are we aware of any pending or threatened litigation that would have a material adverse effect on our business, operating results, cash flows, or financial condition should such litigation be resolved unfavorably. We have and will continue to have commercial disputes arising in the ordinary course of our business.

 

Item 1A. Risk Factors

 

In addition to the information set forth in this Form 10-Q, you should also carefully review and consider the risk factors contained in our other reports and periodic filings with the SEC, including, without limitation, the risk factors and uncertainties contained under the caption “Item 1A—Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 that could materially and adversely affect our business, financial condition, and results of operations. The risk factors discussed in that Form 10-K do not identify all risks that we face because our business operations could also be affected by additional factors that are not known to us or that we currently consider to be immaterial to our operations.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On February 16, 2022, the Company agreed to convert 1,650 shares of the Series B Preferred Stock into 362,306 shares of common stock and 703,069 warrants. Of the warrants, 170,382 are pre-funded warrants that vested immediately, have an indefinite term and an exercise price of $0.01, and the balance of 532,688 warrants also vested immediately, have a term of 5 years and have an exercise price of $5.00. Each warrant entitles the holder to purchase one share of common stock. The issuances were to an accredited investor pursuant to an exemption from registration of the Securities Act under Section 4(a)(2).

 

Item 3. Defaults upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

The documents listed in the Exhibit Index of this Form 10-Q are incorporated by reference or are filed with this Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

 

35
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CEA INDUSTRIES INC.
  (the “Registrant”)
     
Dated: May 12, 2022 By: /s/ Anthony K. McDonald
    Anthony K. McDonald
    Chief Executive Officer and President
    (Principal Executive Officer)
     
Dated: May 12, 2022 By: /s/ Ian K. Patel
    Ian K. Patel
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

36
 

 

EXHIBIT INDEX

 

Exhibit    
Number   Description of Exhibit
     
31.1 *   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2 *   Certification of Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1**   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2**   Certification of Principal Financial and Accounting, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
 101.INS*   Inline XBRL Instance Document
     
101.SCH*   Inline XBRL Taxonomy Schema
     
101.CAL*   Inline XBRL Taxonomy Calculation Linkbase
     
101.DEF*   Inline XBRL Taxonomy Definition Linkbase
     
101.LAB*   Inline XBRL Taxonomy Label Linkbase
     
101.PRE*   Inline XBRL Taxonomy Presentation Linkbase
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.
** Furnished herewith.

 

37

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Anthony K. McDonald, the Chief Executive Officer of CEA Industries Inc. certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of CEA Industries Inc. for the quarterly period ended March 31, 2022;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated May 12, 2022.

 

By: /s/ Anthony K. McDonald  
 

Anthony K. McDonald

Chief Executive Officer

 

 

 

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Ian K. Patel, the Principal Financial and Accounting Officer of CEA Industries Inc. certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of CEA Industries Inc. for the quarterly period ended March 31, 2022;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated May 12, 2022.

 

By: /s/ Ian K. Patel  
 

Ian K. Patel

Chief Financial Officer

 

 

 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES

CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 (the “Report”) of CEA Industries Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    /s/ Anthony K. McDonald
  Name: Anthony K. McDonald,
    Chief Executive Officer
  Date: May 12, 2022

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES

CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 (the “Report”) of CEA Industries Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Ian K. Patel, the Principal Financial and Accounting Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

    /s/ Ian K. Patel
  Name: Ian K. Patel,
    Chief Financial Officer
  Date: May 12, 2022

 

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

 

EX-101.SCH 6 cead-20220331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholder's Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Note Payable and Accrued Interest link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Temporary Equity link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Stockholders’ Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Equity Incentive Plans link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - General (Policies) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - General (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Equity Incentive Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Schedule of Revenue by Source (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Schedule of Share-based Compensation Costs (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - General (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Schedule of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Inventory (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Note Payable and Accrued Interest (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Temporary Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Stockholders’ Equity (Deficit) (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Schedule of Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Equity Incentive Plans (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Schedule of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Warrants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cead-20220331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cead-20220331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cead-20220331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.00001 Par Value [Member] Warrants to Purchase Common Stock [Member] Equity Components [Axis] Preferred Stock [Member] Series A Preferred Stock [Member] Common Stock [Member] Common Shares To Be Issued [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Award Date [Axis] 2023 [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Plan Name [Axis] 2021 Annual Employee Incentive Compensation Plan [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Customer [Axis] Customer One [Member] Customer Two [Member] Customer Three [Member] Accounts Receivable [Member] Product and Service [Axis] Equipment And Systems Sales [Member] Engineering and Other Services [Member] Shipping and Handling [Member] 2022 [Member] Income Statement Location [Axis] Cost of Sales [Member] Advertising and Marketing Expenses [Member] Product Development Costs [Member] Selling, General and Administrative Expenses [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] New Facility Lease [Member] Long-Lived Tangible Asset [Axis] Furniture and Fixtures [Member] Vehicles [Member] Leasehold Improvements [Member] Property, Plant and Equipment [Member] Inventory [Member] Other Expense [Member] Series B Redeemable Convertible Preferred Stock [Member] Convertible Preferred Stock [Member] Series B Preferred Stock [Member] Warrant [Member] Warrant One [Member] Award Type [Axis] Indefinite Term [Member] Decrease In Common Stock Conversion Price [Member] 2021 Equity Incentive Plan [Member] Restricted Stock Units (RSUs) [Member] January 17, 2022 [Member] January 17, 2023 [Member] Title of Individual [Axis] Two Directors [Member] Board of Directors Chairman [Member] Underwriters [Member] 2017 Equity Incentive Plan [Member] 2021 Equity Plan [Member] 2021 Equity Plan [Member] Employees [Member] Directors [Member] Derivative Instrument [Axis] Restricted Shares Issued [Member] Non Qualified Stock Option [Member] Incentive Stock Option [Member] Three New Employees [Member] Cheif Financial Officer [Member] One Former Employee [Member] Non-Qualified Stock Options [Member] Related Party [Axis] Employees And Consultants [Member] Director [Member] 2021 Plan [Member] Vested [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Employees, Directors and Consultants [Member] Exercise Price Range [Axis] Warrants Range [Member] Warrants Range One [Member] Warrants Range Two [Member] Warrants Range Three [Member] Warrants Range Four [Member] Securities Purchase Agreement [Member] Sale of Stock [Axis] Private Placement [Member] Placement Agent Warrants [Member] 2022 Investor Warrants [Member] 2022 OverAllotment Warrants [Member] 2022 UnderwriterWarrants [Member] Series B Preferred Shares Pre Funded Conversion Warrants [Member] Series B Preferred Shares Conversion Warrants [Member] Consulting Agreement [Member] Subsequent Event Type [Axis] Subsequent Event [Member] 21 Employees [Member] Employment Agreement [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Accounts receivable (net of allowance for doubtful accounts of $159,744 and $181,942, respectively) Other receivables Inventory, net Prepaid expenses and other Total Current Assets Noncurrent Assets Property and equipment, net Goodwill Intangible assets, net Deposits Operating lease right-of-use asset Total Noncurrent Assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) CURRENT LIABILITIES Accounts payable and accrued liabilities Deferred revenue Accrued equity compensation Other liabilities Current portion of operating lease liability Total Current Liabilities NONCURRENT LIABILITIES Operating lease liability, net of current portion Total Noncurrent Liabilities TOTAL LIABILITIES Commitments and Contingencies (Note 7) TEMPORARY EQUITY Series B Redeemable Convertible Preferred Stock, $0.00001 par value; 0 and 3,300 issued and outstanding, respectively Total Temporary Equity SHAREHOLDERS’ EQUITY (DEFICIT) Preferred stock; 25,000,000 and 150,000,000 shares authorized, respectively Common stock, $0.00001 par value; 200,000,000 and 850,000,000 shares authorized, respectively; 7,784,444 and 1,600,835 shares issued and outstanding, respectively Additional paid in capital Accumulated deficit Total Shareholders’ Equity (Deficit) TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) Allowance for doubtful accounts, net Temporary equity, par value Temporary equity, shares issued Temporary equity, shares outstanding Preferred stock, shares authorized Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue, net Cost of revenue Gross profit Operating expenses: Advertising and marketing expenses Product development costs Selling, general and administrative expenses Total operating expenses Operating loss Other income (expense): Other income (expense), net Interest income (expense),net Total other income (expense) Loss before provision for income taxes Income taxes Net loss Convertible preferred series B stock dividends Deemed dividend on convertible preferred series B stock on down round Net Loss Available to Common Shareholders Loss per common share – basic and dilutive Weighted average number of common shares outstanding, basic and dilutive Balance Balance, shares Fair value of vested stock options granted to employees Fair value of vested stock options granted to directors Common shares issued in settlement of restricted stock units issued to directors Common shares issued in settlement of restricted stock units issued to directors, shares Fair value of restricted stock units issued to directors Issuance of common shares to round up partial shares following reverse split Issuance of common shares to round up partial shares following reverse split, shares Common shares and warrants issued for cash Common shares and warrants issued for cash, shares Common shares and warrants issued on conversion of series B preferred stock Common shares and warrants issued on conversion of series B preferred stock, shares Dividends on series B preferred stock Net loss Common shares to be issued in settlement of legal dispute Common shares to be issued in settlement of legal dispute, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash Flows From Operating Activities: Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation and intangible asset amortization expense Share-based compensation Common stock issued for other expense Provision for doubtful accounts Provision for excess and obsolete inventory Loss on disposal of assets Amortization of ROU asset Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other Accounts payable and accrued liabilities Deferred revenue Accrued interest Lease deposit Operating lease liability, net Accrued equity compensation Net cash (used in)/provided by operating activities Cash Flows From Investing Activities Purchases of property and equipment Net cash used in investing activities Cash Flows From Financing Activities Payment of dividends on series B preferred stock Redemption of series B preferred stock Cash proceeds on sale of common stock and warrants, net of expenses Proceeds from issuance of note payable Net cash provided by financing activities Net change in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental cash flow information: Interest paid Income taxes paid Non-cash investing and financing activities: Conversion of series B preferred stock Deemed dividend on series B preferred stock arising on down round Accounting Policies [Abstract] General Leases Leases Inventory Disclosure [Abstract] Inventory Property, Plant and Equipment [Abstract] Property and Equipment Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Debt Disclosure [Abstract] Note Payable and Accrued Interest Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Temporary Equity Temporary Equity Equity [Abstract] Stockholders’ Equity (Deficit) Share-Based Payment Arrangement [Abstract] Equity Incentive Plans Warrants Warrants Income Tax Disclosure [Abstract] Income Taxes Related Party Transactions [Abstract] Related Party Transactions Subsequent Events [Abstract] Subsequent Events Description of Business Impact of the COVID-19 Pandemic on Our Business Financial Statement Presentation Principles Reverse Stock Split Use of Estimates Cash, Cash Equivalents and Restricted Cash Income (Loss) Per Common Share Goodwill Temporary Equity Revenue Recognition Accounting for Share-Based Compensation Concentrations Recently Issued Accounting Pronouncements Schedule of Revenue by Source Schedule of Remaining Performance Obligations Expected to be Recognized Schedule of Share-based Compensation Costs Schedule of Lease Cost Schedule of Future Annual Minimum Lease Payments Schedule of Inventory Schedule of Property and Equipment Schedule of Accounts Payable and Accrued Liabilities Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Schedule of Stock Option Activity Summary of Non-vested Non-qualified Stock Option Activity Schedule of Restricted Stock Units Activity Schedule of Outstanding Warrants to Purchase Common Stock Schedule of Warrants Outstanding Schedule of Product Information [Table] Product Information [Line Items] Total revenue Remaining performance obligations related to engineering only paid contracts Remaining performance obligations related to partial equipment paid contracts Total remaining performance obligations Total share-based compensation expense included in consolidated statement of operations Proceeds from issuance of common stock Reverse stock split description Common stock issued Common stock outstanding Federal insured amount Cash balance, amount Federal deposit insurance corporation premium expense Potentially dilutive equity instruments that are convertible into common stock Contract with Customer, Liability, Current Revenue recognized Revenue remaining performance obligation Product Warranty Accrual, Current Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Share-Based Payment Arrangement, Expense Concentration risk percentage Schedule Of Lease Cost Operating lease liability, current Operating lease liability, long-term Remaning lease term Discount rate Operating cash outflow from operating lease Schedule Of Future Annual Minimum Lease Payments 2022 (excluding the three months ended March 31, 2022) 2023 2024 2025 2026 Thereafter Total minimum lease payments Less imputed interest Present value of minimum lease payments Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Area of land Operating lease term description Lease rental expense Increase in rent percent Security deposit Finished goods Work in progress Raw materials Allowance for excess & obsolete inventory Inventory, net Overhead expenses Inventory in transit Prepaid inventory expenses Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Accumulated depreciation Property and equipment, net Impaired Assets to be Disposed of by Method Other than Sale [Table] Impaired Assets to be Disposed of by Method Other than Sale [Line Items] Depreciation expenses Accounts payable Sales commissions payable Accrued payroll liabilities Product warranty accrual Other accrued expenses Total Note payable principal amount Loan interest rate Loan due date Debt Instrument, Increase, Accrued Interest Loss Contingencies [Table] Loss Contingencies [Line Items] Common shares issued in settlement of legal dispute, shares Cost of settelement Common shares issued in settlement of legal dispute, value Temporary Equity, Shares Authorized Temporary Equity, Par or Stated Value Per Share Temporary Equity, Aggregate Amount of Redemption Requirement Proceeds from Issuance of Redeemable Convertible Preferred Stock Dividend rate percentage Conversion price Dividend rate percentage Debt Instrument, Redemption Price, Percentage Debt Instrument, Convertible, Liquidation Preference, Per Share Debt Instrument, Convertible, Liquidation Preference, Value Temporary equity noncash redemption value adjustment Stock Redeemed or Called During Period, Shares Stock Redeemed or Called During Period, Value Dividends Stock Issued During Period, Shares, Conversion of Units Conversion of Stock, Shares Converted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Exercise price, per share Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Preferred Stock, Convertible, Conversion Price Conversion price reduced offering price, percentage Deemed dividend on series B preferred stock on down round Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of stock options issued Exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Shares, granted Shares, vested Number of shares issued during the period Net proceeds from sale of common stock Number of shares sold Warrant term Exercise price Stock issued during period, shares, issued for services Warrants maturity date Par value Preferred stock, shares issued Preferred stock, shares outstanding Number of Options, Outstanding Beginning Weighted Average Exercise Price, Outstanding Beginning Aggregate Intrinsic Value, Outstanding Beginning Number of Options, Granted Weighted Average Exercise Price, Granted Weighted Average Remaining Contractual Term, Granted Aggregate Intrinsic Value, Exercised Number of Options, Exercised Weighted Average Exercise Price, Exercised Weighted Average Remaining Contractual Term,Exercised Number of Options, Forfeited Weighted Average Exercise Price, Forfeited/Cancelled Weighted Average Remaining Contractual Term,Forfeited Number of Options, Expired Weighted Average Exercise Price, Expired Weighted Average Remaining Contractual Term,Expired Number of Options, Outstanding Ending Weighted Average Exercise Price, Outstanding Ending Weighted Average Remaining Contractual Term, Outstanding Ending Aggregate Intrinsic Value, Outstanding Ending Number of Options, Exercisable Ending Weighted Average Exercise Price, Exercisable Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate Intrinsic Value, Exercisable Ending Number of Options, Forfeited/Cancelled Number of Options Nonvested, Beginning Weighted Average Grant-Date Fair Value, Beginning Aggregated Intrinsic Value, Nonvested Beginning Grant Date Fair Value Nonvested, Beginning Number of Options Nonvested, Beginning Weighted Average Grant-Date Fair Value, Beginning Grant Date Fair Value Nonvested, Granted Number of Options Nonvested, Beginning Weighted Average Grant-Date Fair Value, Beginning Grant Date Fair Value Nonvested, Vested Number of Options Nonvested, Forfeited Weighted Average Grant-Date Fair Value, Beginning Grant Date Fair Value Nonvested, Forfeited Number of Options Nonvested, Beginning Weighted Average Grant-Date Fair Value, Beginning Grant Date Fair Value Nonvested, Expired Number of Options Nonvested, Beginning Weighted Average Grant-Date Fair Value, Ending Aggregated Intrinsic Value, Nonvested Ending Grant Date Fair Value Nonvested, Ending Grant Date Fair Value Nonvested, Beginning Aggregated Intrinsic Value, Nonvested Granted Aggregated Intrinsic Value, Nonvested Vested Number of Options Nonvested, Beginning Number of Units, beginning Weighted Average Grant-Date Fair Value, Beginning Aggregate Intrinsic Value Nonvested, Beginning Number of Units, Granted Weighted Average Grant-Date Fair Value, Granted Number of Units, Vested and settled with share issuance Weighted Average Grant-Date Fair Value, Vested Number of Units, Forfeited/canceled Weighted Average Grant-Date Fair Value, Forfeited/Canceled Number of Units, ending Weighted Average Grant-Date Fair Value,ending Aggregate Intrinsic Value Nonvested, ending Number of options to purchase shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Number of shares authorized for equity awards Number of shares issued Number of option remain outstanding Shares available for future equity awards Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Issuance of shares Issuance of shares Number of shares authorized Unrecognized compensation expense Expected term years Expected term years Exercise price, lower Exercise price, upper Description,shares Number of options to purchase shares Issuance of stock, unvested Share based compensation Issuance of stock Issuance of shares Schedule Of Outstanding Warrants To Purchase Common Stock Warrants Outstanding, Beginning Balance Weighted Average Exercise Price, Beginning Balance Weighted Average Life of Outstanding Warrants in Months, Beginning Balance Aggregate Intrinsic Value, Beginning Balance Warrants, issued Weighted Average Exercise Price, Issued Weighted Average Life of Outstanding Warrants in Months, Issued Aggregate Intrinsic Value, Issued Warrants, Exercised Weighted Average Exercise Price, Exercised Aggregate Intrinsic Value, Exercised Warrants, Expired Weighted Average Exercise Price, Expired Aggregate Intrinsic Value, Expired Warrants Outstanding, Ending Balance Weighted Average Exercise Price, Ending Balance Weighted Average Life of Outstanding Warrants in Months, Ending Balance Aggregate Intrinsic Value, Ending Balance Schedule Of Outstanding Warrants To Purchase Common Stock Details Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Warrants Outstanding Weighted Average Life of Outstanding Warrants in Months Weighted Average Life of Outstanding Warrants in Months Per share Issuance of Value Issuance of warrants Purchase price Issuance of warrants Proceeds from warrants issuance Issuance of per unit Warrants term Warrants percent Warrant price per share Issuance of shares Operating Loss Carryforwards Net operating loss carryforward expected to expire amount NOLs usage against taxable income percentage Equity Method Investment, Ownership Percentage Nols carryforwards term description Payments for commissions Subsequent Event [Table] Subsequent Event [Line Items] Non qualified stock options Stock options vesting, period Exercise price per share Warrants to Purchase Common Stock [Member] Common Stock, $0.00001 Par Value [Member] Series B Redeemable Convertible Preferred Stock [Member] Warrants to purchase common stock, shares. Percentage of preferred stock conversion provision. Temporary equity noncash redemption value adjustment. Convertible Preferred Series B Stock Dividends. Gain on conversion of series B preferred stock Common shares to be issued in settlement of legal dispute Fair value of vested stock options granted to employees Fair value of vested stock options granted to employees Fair value of restricted stock units issued to directors 2021 Equity Incentive Plan [Member] Dividends on series B preferred stock January 17, 2023 [Member] Common shares issued in settlement of restricted stock units issued to directors. Two Directors [Member] Common shares issued in settlement of restricted stock units issued to directors Issuance of common shares to round up partial shares following reverse split Common shares to be issued in settlement of legal dispute Underwriters [Member] Common stock issued for other expense. Increase decrease in lease deposit. Increase decrease in deferred compensation accrued equity compensation. Cash proceeds from sale of preferred stock and warrants, net of issuance costs. Exercise price, per share Payment of interest on series B preferred stock Conversion of series B preferred stock. January 17, 2022 [Member] 2017 Equity Incentive Plan [Member] 2021 Equity Plan [Member] Net operating loss carry forward expected to expire amount. NOLs usage against taxable income percentage. Nols carryforwards term description. Consulting Agreement [Member] Description Of Business [Policy Text Block] Impact Of Covid19 Pandemic On Our Business [Policy Text Block] Share-based compensation arrangement by share-based payment award, number of shares authorized. 2021 Equity Plan [Member] Restricted Shares Issued [Member] Non Qualified Stock Option [Member] Incentive Stock Option [Member] Employees [Member] Directors [Member] Non-qualified Stock Options [Member] 2017 Equity Plan and 2021 Equity Plan [Member] Weighted average remaining contractual term, granted. Weighted Average Remaining Contractual Term, Ending. Weighted Average Remaining Contractual Term,Forfeited. Weighted Average Remaining Contractual Term,Expired. Employees And Consultants [Member] Number of Options, Expired. Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Customer Two [Member] Customer Three [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired New Facility Lease [Member] Grant Date Fair Value Nonvested, Beginning. Therafter Prepaid inventory expenses 2021 Plan [Member] Employees, Directors and Consultants [Member] Inventory [Member] Class of Warrant or Right Issued. Class of Warrant or Right Exercised Class of Warrant or Right Expired. Weighted average exercise price of warrants issued. Weighted average exercise price of warrants exercised. Weighted average exercise price of warrants expired. Weighted average life of outstanding warrants in months, beginning balance. Weighted Average Life of Outstanding Warrants in Months, Issued. Weighted average life of outstanding warrants in months, ending balance. Aggregate intrinsic value of outstanding warrants. Aggregate intrinsic value of warrants issued. Aggregate intrinsic value of warrants exercised. Aggregate intrinsic value of warrants expired. Warrants Range [Member] Warrants Range One [Member] Warrants Range Three [Member] Securities Purchase Agreement [Member] Placement Agent Warrants [Member] Weighted Average Life of Outstanding Warrants in Months. Temporary Equity [Text Block] Warrant One [Member] Indefinite Term [Member] Employment Agreement [Member] ReverseStockSplit [Policy Text Block] Temporary Equity [Policy Text Block] Weighted Average Remaining Contractual Term,Exercised. 2023 [Member] 2022 [Member] Remaining performance obligations related to engineering only paid contracts. Remaining performance obligations related to partial equipment paid contracts. Engineering and Other Services [Member] Three New Employees [Member] Cheif Financial Officer [Member] Advertising and Marketing Expenses [Member] Product Development Costs [Member] 2021 Annual Employee Incentive Compensation Plan [Member] One Former Employee [Member] Customer One [Member] Common shares issued in settlement of legal dispute, value. Number of Options, price per share Increase in rent percent. Vested [Member] Warrants Disclosure [Text Block] Schedule of Outstanding Warrants to Purchase Common Stock [Table Text Block] Warrants Range Two [Member] Warrants Range Four [Member] 2022 Investor Warrants [Member] 2022 OverAllotment Warrants [Member] 2022 UnderwriterWarrants [Member] Series B Preferred Shares Pre Funded Conversion Warrants [Member] Series B Preferred Shares Conversion Warrants [Member] Common shares issued in settlement of legal dispute, shares. Warrants percent. 21 Employees [Member] Common Shares To Be Issued [Member] Deemed dividend on series B preferred stock on down round. Deemed dividend on series B preferred stock arising on down round. Conversion price reduced offering price, percentage Share based compensation arrangement by share based payment award options exercised in period aggregate intrinsic value. Redemption of series B preferred stock 2021 Equity Plan [Member] [Default Label] Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Redeemable Noncontrolling Interest, Equity, Carrying Amount Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ConvertiblePreferredStockConvertedToSecurities Net Income (Loss) Available to Common Stockholders, Basic Shares, Outstanding Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Increase (Decrease) in Accounts and Notes Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expenses, Other Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability IncreaseDecreaseInDeferredCompensationAccruedEquityCompensation Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Payments of Ordinary Dividends, Preferred Stock and Preference Stock Redemption of series B preferred stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Lessee, Operating Leases [Text Block] Temporary Equity [Text Block] WarrantsDisclosureTextBlock Goodwill and Intangible Assets, Policy [Policy Text Block] TemporaryEquityPolicyTextBlock Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Inventory Valuation Reserves Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Percentage of preferred stock conversion provision Class of Warrant or Right, Exercise Price of Warrants or Rights Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Aggregated Intrinsic Value, Nonvested Beginning Aggregated Intrinsic Value, Nonvested Beginning [Default Label] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Aggregate intrinsic value of outstanding warrants Weighted Average Exercise Price, Exercised [Default Label] Aggregate Intrinsic Value, Exercised [Default Label] ClassOfWarrantOrRightExpired Weighted Average Exercise Price, Expired [Default Label] EX-101.PRE 10 cead-20220331_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover - shares
3 Months Ended
Mar. 31, 2022
May 12, 2022
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2022  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 000-54286  
Entity Registrant Name CEA INDUSTRIES INC.  
Entity Central Index Key 0001482541  
Entity Tax Identification Number 27-3911608  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 385 South Pierce Avenue  
Entity Address, Address Line Two Suite C  
Entity Address, City or Town Louisville  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80027  
City Area Code (303)  
Local Phone Number 993-5271  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   7,784,444
Common Stock, $0.00001 Par Value [Member]    
Title of 12(b) Security Common Stock, $0.00001 par value  
Trading Symbol CEAD  
Security Exchange Name NASDAQ  
Warrants to Purchase Common Stock [Member]    
Title of 12(b) Security Warrants to purchase common stock  
Trading Symbol CEADW  
Security Exchange Name NASDAQ  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 22,033,664 $ 2,159,608
Accounts receivable (net of allowance for doubtful accounts of $159,744 and $181,942, respectively) 191,002 179,444
Other receivables 50,762
Inventory, net 1,005,918 378,326
Prepaid expenses and other 1,774,219 1,273,720
Total Current Assets 25,055,565 3,991,098
Noncurrent Assets    
Property and equipment, net 77,239 77,346
Goodwill 631,064 631,064
Intangible assets, net 1,830 1,830
Deposits 14,747 14,747
Operating lease right-of-use asset 540,444 565,877
Total Noncurrent Assets 1,265,324 1,290,864
TOTAL ASSETS 26,320,889 5,281,962
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 1,389,028 1,345,589
Deferred revenue 5,485,416 2,839,838
Accrued equity compensation 83,625 83,625
Other liabilities 37,078 37,078
Current portion of operating lease liability 112,072 100,139
Total Current Liabilities 7,107,219 4,406,269
NONCURRENT LIABILITIES    
Operating lease liability, net of current portion 459,482 486,226
Total Noncurrent Liabilities 459,482 486,226
TOTAL LIABILITIES 7,566,701 4,892,495
Commitments and Contingencies (Note 7)
TEMPORARY EQUITY    
Series B Redeemable Convertible Preferred Stock, $0.00001 par value; 0 and 3,300 issued and outstanding, respectively 3,960,000
Total Temporary Equity 3,960,000
SHAREHOLDERS’ EQUITY (DEFICIT)    
Preferred stock; 25,000,000 and 150,000,000 shares authorized, respectively
Common stock, $0.00001 par value; 200,000,000 and 850,000,000 shares authorized, respectively; 7,784,444 and 1,600,835 shares issued and outstanding, respectively 78 16
Additional paid in capital 48,958,618 25,211,017
Accumulated deficit (30,204,508) (28,781,566)
Total Shareholders’ Equity (Deficit) 18,754,188 (3,570,533)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) $ 26,320,889 $ 5,281,962
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts, net $ 159,744 $ 181,942
Temporary equity, par value $ 0.00001 $ 0.00001
Temporary equity, shares issued 0 3,300
Temporary equity, shares outstanding 0 3,300
Preferred stock, shares authorized 25,000,000 150,000,000
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 200,000,000 850,000,000
Common stock, shares issued 7,784,444 1,600,835
Common stock, shares outstanding 7,784,444 1,600,835
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue, net $ 1,744,427 $ 2,366,529
Cost of revenue 1,653,919 2,021,923
Gross profit 90,508 344,606
Operating expenses:    
Advertising and marketing expenses 251,015 177,145
Product development costs 138,918 112,638
Selling, general and administrative expenses 1,311,777 740,473
Total operating expenses 1,701,710 1,030,256
Operating loss (1,611,202) (685,650)
Other income (expense):    
Other income (expense), net 185,000 (107,000)
Interest income (expense),net 3,260 (718)
Total other income (expense) 188,260 (107,718)
Loss before provision for income taxes (1,422,942) (793,368)
Income taxes
Net loss (1,422,942) (793,368)
Convertible preferred series B stock dividends (35,984)
Deemed dividend on convertible preferred series B stock on down round (439,999)
Net Loss Available to Common Shareholders $ (1,898,925) $ (793,368)
Loss per common share – basic and dilutive $ (0.41) $ (0.50)
Weighted average number of common shares outstanding, basic and dilutive 4,622,427 1,576,844
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Shareholder's Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Common Shares To Be Issued [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2020 $ 420 $ 16   $ 26,107,159 $ (27,443,643) $ (1,336,048)
Balance, shares at Dec. 31, 2020 42,030,331 1,576,844      
Fair value of vested stock options granted to employees 128,434 128,434
Fair value of vested stock options granted to directors 6,342 6,342
Net loss (793,368) (793,368)
Common shares to be issued in settlement of legal dispute $ 67,000 67,000
Common shares to be issued in settlement of legal dispute, shares     6,667      
Balance at Mar. 31, 2021 $ 420 $ 16 $ 67,000 26,241,935 (28,237,011) (1,927,640)
Balance, shares at Mar. 31, 2021 42,030,331 1,576,844 6,667      
Balance at Dec. 31, 2021 $ 16 25,211,017 (28,781,566) (3,570,533)
Balance, shares at Dec. 31, 2021   1,600,835        
Fair value of vested stock options granted to employees     32,938 32,938
Fair value of vested stock options granted to directors     29,656 29,656
Common shares issued in settlement of restricted stock units issued to directors   $ 0   24,994 24,994
Common shares issued in settlement of restricted stock units issued to directors, shares   3,367        
Fair value of restricted stock units issued to directors     4,928 4,928
Issuance of common shares to round up partial shares following reverse split   $ 0   0   0
Issuance of common shares to round up partial shares following reverse split, shares   6,798        
Common shares and warrants issued for cash   $ 58   21,711,073 21,711,131
Common shares and warrants issued for cash, shares   5,811,138        
Common shares and warrants issued on conversion of series B preferred stock   $ 4   1,979,996 1,980,000
Common shares and warrants issued on conversion of series B preferred stock, shares   362,306        
Dividends on series B preferred stock     (35,984) (35,984)
Net loss (1,422,942) (1,422,942)
Balance at Mar. 31, 2022 $ 78 $ 48,958,618 $ (30,204,508) $ 18,754,188
Balance, shares at Mar. 31, 2022   7,784,444        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows From Operating Activities:    
Net loss $ (1,422,942) $ (793,368)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and intangible asset amortization expense 8,556 18,377
Share-based compensation 92,517 6,342
Common stock issued for other expense 67,000
Provision for doubtful accounts (22,168)
Provision for excess and obsolete inventory 3,676 (4,371)
Loss on disposal of assets 5,499
Amortization of ROU asset 25,433 49,051
Changes in operating assets and liabilities:    
Accounts receivable 10,610 6,748
Inventory (631,269) (187,679)
Prepaid expenses and other (551,261) (1,026,765)
Accounts payable and accrued liabilities 43,438 5,354
Deferred revenue 2,645,579 2,362,905
Accrued interest 718
Lease deposit (8,061)
Operating lease liability, net (14,811) (64,672)
Accrued equity compensation 52,794
Net cash (used in)/provided by operating activities 192,857 484,373
Cash Flows From Investing Activities    
Purchases of property and equipment (13,948) (12,326)
Net cash used in investing activities (13,948) (12,326)
Cash Flows From Financing Activities    
Payment of dividends on series B preferred stock (35,984)
Redemption of series B preferred stock (1,980,000)
Cash proceeds on sale of common stock and warrants, net of expenses 21,711,131
Proceeds from issuance of note payable 514,200
Net cash provided by financing activities 19,695,147 514,200
Net change in cash and cash equivalents 19,874,056 986,247
Cash and cash equivalents, beginning of period 2,159,608 2,284,881
Cash and cash equivalents, end of period 22,033,664 3,271,128
Supplemental cash flow information:    
Interest paid
Income taxes paid
Non-cash investing and financing activities:    
Conversion of series B preferred stock 1,980,000
Deemed dividend on series B preferred stock arising on down round $ 439,999
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
General
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
General

Note 1 – General

 

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, some producers grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies include: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting and climate control, and (vi) preventive maintenance services for CEA facilities Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.

 

The resulting effects and uncertainties from the COVID-19 pandemic, including the depth and duration of the disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses and reduced operating cash flows in our business. During the three months ended March 31, 2022, the Company experienced significant delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain arising from the long-term effects of the COVID-19 pandemic. Consequently, our revenue recognition of these customer sales has been delayed until future periods when the shipment of these orders can be completed.

 

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued. The Company continues to experience recurring losses since its inception. As a result, in order to continue as a going concern, the Company has been reliant on the ability to obtain additional sources of financing to fund growth. As indicated in Note 9 – Shareholders Equity (Deficit) below, on February 15, 2022, the Company received approximately $22,000,000 in proceeds from completion of an equity offering. Based on management’s evaluation, the proceeds from the Offering will be more than sufficient to fund any deficiencies in working capital or cash flow from operations, and the Company is confident that it will be able to meet its obligations as they come due, and fund operations for at least 12 months after the date the consolidated financial statements are available to be issued. Accordingly, the conditions around liquidity and limited working capital necessary to fund operations have been addressed.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The balance sheet as of December 31, 2021 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2021.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding as of December 31, 2021, was reduced from 240,125,224 to 1,600,835.

 

All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

Cash, Cash Equivalents and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of March 31, 2022, the balance in the Company’s account was approximately $22,034,000, consequently $21,784,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

During the three months ended March 31, 2022 and 2021, there were warrants and options outstanding to purchase Company common stock and shares of convertible preferred stock and restricted stock units that were convertible into shares of the Company’s common stock. During the three-month period ended March 31, 2022, the Company incurred a net loss and consequently the common share equivalents of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such inclusion would have been anti-dilutive.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

As of March 31, 2022, and 2021, there were respectively, 8,021,057 and 201,662, potentially dilutive equity instruments outstanding in respect of shares of convertible preferred stock and warrants and options outstanding to purchase Company common stock.

 

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

During the three months ended March 31, 2022, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators of impairment. Accordingly, the Company performed an interim impairment analysis at March 31, 2022 and concluded that no impairment relating to goodwill existed at March 31, 2022.

 

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Revenue Recognition

 

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09 (Topic 606), Revenue from Contracts with Customers and all the related amendments (“ASC 606” or the “revenue standard”) to all contracts and elected the modified retrospective method.

 

The following table sets forth the Company’s revenue by source:

 

   2022   2021 
  

For the Three Months Ended

March 31,

 
   2022   2021 
Equipment and systems sales  $1,642,572   $2,163,468 
Engineering and other services   86,049    181,083 
Shipping and handling   15,806    21,978 
Total revenue  $1,744,427   $2,366,529 

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2022, and 2021, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to recognize revenue is generally less than one year. As of March 31, 2022, and December 31, 2021, deferred revenue, which was classified as a current liability, was $5,485,416 and $2,839,838, respectively.

 

For the three months ended March 31, 2022, the Company recognized revenue of $1,162,374 related to the deferred revenue at January 1, 2022. For the three months ended March 31, 2021, the Company recognized revenue of $1,880,634 related to the deferred revenue at January 1, 2021.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of March 31, 2022, the Company’s remaining performance obligations, or backlog, was $11,179,000. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2022, includes booked sales orders of $2,217,000 from several customers that the Company does not expect to be realized until 2023, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes that several of its current contracts may be delayed or canceled.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

The remaining performance obligations expected to be recognized through 2023 are as follows:

 

   2022   2023   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   8,962,000    2,217,000   11,179,000 
Total remaining performance obligations  $8,962,000   $2,217,000   $11,179,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2022, and December 31, 2021, the Company had an accrued warranty reserve amount of $187,702 and $186,605, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2022, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from 158.21% to 158.70%; expected term in years 10 and risk-free interest rate ranged from 1.52% to 1.98%.

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021:

 

   2022   2021 
  

For the Three Months Ended

March 31,

 
   2022   2021 
Share-based compensation expense included in:          
Cost of revenue  $791   $14,135 
Advertising and marketing expenses   2,762    6,474 
Product development costs   -    6,694 
Selling, general and administrative expenses   88,964    31,833 
Total share-based compensation expense included in consolidated statement of operations  $92,517   $59,136 

 

Included in the expense for the three months ended March 31, 2021, is an accrual for $52,794 for the 2021 Annual Employee Incentive Compensation Plan.

 

Concentrations

 

One customer accounted for 35% of the Company’s revenue for the three months ended March 31, 2022. Three customers accounted for 38%, 16%, and 11% of the Company’s revenue for the three months March 31, 2021.

 

Three customers accounted for 44%, 19% and 16% of the Company’s accounts receivable as of March 31, 2022. Two customers accounted for 60%, and 31% of the Company’s accounts receivable as of March 31, 2021.

 

Recently Issued Accounting Pronouncements

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

In May 2021, the FASB issued ASU 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. This guidance clarifies and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options due to a lack of explicit guidance in the FASB Codification. The guidance is effective for interim and annual periods beginning after December 15, 2021. Early adoption is permitted. The guidance is to be applied prospectively to modifications or exchanges occurring on or after the effective date. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Leases
3 Months Ended
Mar. 31, 2022
Leases  
Leases

Note 2 – Leases

 

In February 2016 the FASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.

 

The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

On July 28, 2021, the Company entered into an agreement to lease 11,491 square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $10,055 and will increase by 3% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $14,747. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.

 

Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $582,838. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.

 

The lease cost, cash flows and other information related to the Facility Lease were as follows:

 

  

As of March 31,

2022

 
Operating lease right-of-use asset  $540,444 
Operating lease liability, current  $112,072 
Operating lease liability, long-term  $459,482 
      
Remaining lease term   4.8 years 
Discount rate   3.63%

 

  

For the Three

Months Ended

March 31, 2022

 
Operating cash outflow from operating lease  $20,109 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Future annual minimum lease payments on the Facility Lease as of March 31, 2022 are as follows:

  

Years ended December 31,    
2022 (excluding the three months ended March 31, 2022)  $91,095 
2023   124,897 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   625,265 
Less imputed interest   (53,710)
Present value of minimum lease payments   $571,555 

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Inventory
3 Months Ended
Mar. 31, 2022
Inventory Disclosure [Abstract]  
Inventory

Note 3 – Inventory

 

Inventory consisted of the following:

 

   March 31,   December 31, 
   2022   2021 
Finished goods  $913,887   $272,199 
Work in progress   971    1,050 
Raw materials   186,115    196,456 
Allowance for excess & obsolete inventory   (95,055)   (91,379)
Inventory, net  $1,005,918   $378,326 

 

Overhead expenses of $16,555 and $13,589 were included in the inventory balance as of March 31, 2022, and December 31, 2021, respectively.

 

The inventory balance at March 31, 2022 includes $692,195 for inventory in transit from one of our suppliers that was delivered to our customer in April of 2022.

 

Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $1,579,000 and $1,069,000 in advance payments for inventory for the periods ended March 31, 2022, and December 31, 2021, respectively.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment
3 Months Ended
Mar. 31, 2022
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 4 – Property and Equipment

 

Property and equipment consisted of the following:

 

   March 31,   December 31, 
   2022   2021 
Furniture and equipment  $271,056   $274,472 
Vehicles   15,000    15,000 
Leasehold improvements   -    - 
Property and equipment, gross   286,056    289,472 
Accumulated depreciation   (208,817)   (212,126)
Property and equipment, net  $77,239   $77,346 

 

Depreciation expense was $8,556 for the three months ended March 31, 2022. For the three months ended March 31, 2022, $1,214 was allocated to cost of sales, $304 was allocated to inventory with the remainder recorded as selling, general, and administrative expense.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.1
Accounts Payable and Accrued Liabilities
3 Months Ended
Mar. 31, 2022
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities

Note 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of the following:

 

   March 31,   December 31, 
   2022   2021 
Accounts payable  $729,040   $616,056 
Sales commissions payable   9,107    27,592 
Accrued payroll liabilities   266,456    322,873 
Product warranty accrual   187,702    186,605 
Other accrued expenses   196,723    192,463 
Total  $1,389,028   $1,345,589 

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Note Payable and Accrued Interest
3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]  
Note Payable and Accrued Interest

Note 6 – Note Payable and Accrued Interest

 

On February 10, 2021, the Company entered into a note payable with its current bank in the principal amount of $514,200, for working capital purposes.

 

The loan amount bears interest at 1% and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan is also potentially forgivable in full provided proceeds are used for payment of payroll expenses, rent, utilities and mortgage interest and certain other terms and conditions are met. If any portion of the loan is not forgiven, payments will commence 10 months following the end of the 24-week deferral period. The loan has typical default provisions, including for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.

 

On November 30, 2021, the Company received notice from the bank that its loan received on February 10, 2021, in the principal amount of $514,200 and all accrued interest of $2,832, was fully forgiven. This gain on loan forgiveness was recorded as Other Income in the Statement of Operations during the year ended December 31, 2021.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 7 – Commitments and Contingencies

 

Litigation

 

The Company settled a litigation with a former employee effective March 30, 2021, which included the issuance of 6,667 shares of common stock of the Company, as part of the settlement. These shares were issued on April 8, 2021, as “restricted securities,” subject to a lock-up agreement of six months, without registration rights, and pursuant to a private placement exemption. The settlement agreement also included mutual releases and no admission of liability. The cost to the Company of this settlement, $107,000, in total, has been recognized in full in Other Expenses during the year ended December 31, 2021. The issuance of the 6,667 shares of common stock (valued at $67,000) has been recognized in common stock issued during the year ended December 31, 2021.

 

From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.

 

Leases

 

The Company has a lease agreement for its manufacturing and office space. Refer to Note 2 Leases above.

 

Other Commitments

 

In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Temporary Equity
3 Months Ended
Mar. 31, 2022
Temporary Equity  
Temporary Equity

Note 8 – Temporary Equity

 

On September 28, 2021, the Company sold to an institutional investor (the “Investor”), 3,300 shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”), stated value $1,000 per share, convertible into shares of common stock, for an aggregate purchase price of $3,000,000 (“Consideration”). The Company received net proceeds of approximately $1,260,000 on September 28, 2021, and the balance of approximately $1,365,000 on November 4, 2021.

 

The Series B Preferred Stock had an annual dividend of 8% and an initial common stock conversion price of $8.55. The conversion rate was subject to adjustment in various circumstances, including stock splits, stock dividends, pro rata distributions, fundamental transactions and upon a triggering event and subject to reset if the common stock of the Company sold in any subsequent equity transaction, including a qualified offering, was sold at a price below the then conversion price.

 

The Series B Preferred Stock was mandatorily convertible on the third anniversary of its issuance. All conversions of the Series B Preferred Stock were subject to a blocker provision of 4.99%.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Probability of Redemption: As it was considered probable the Series B Preferred stock would become redeemable outside of the Company’s control, the Series B Preferred stock was disclosed as temporary equity and was initially adjusted as of September 30, 2021 to its redemption value of 120% of the stated value of $1,000 per share, or $3,960,000. As a result, the Company recorded a $2,262,847 non-cash redemption value adjustment during 2021. This redemption value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes; accordingly, the redemption value adjustment is therefore added to the “Net Loss” to arrive at “Net Loss Attributable to Common Shareholders on the Company’s Consolidated Statements of Operations. In addition, since the Company did not have a balance of retained earnings, the redemption value adjustment was recorded against additional paid-in capital.

 

On February 16, 2022, the Company redeemed 1,650 shares of its Series B Preferred Stock for payment of $2.016 million in cash, which included both principal and accrued dividends of approximately $36,000.

 

On February 16, 2022, the remaining 1,650 shares of the Company’s Series B Preferred Stock were converted into 362,306 shares of common stock and 703,069 warrants; 170,382 of the warrants vested immediately, have an indefinite term and an exercise price of $0.01 (“pre-funded conversion warrants”), the balance of 532,688 warrants also vested immediately, have a term of 5 years and have an exercise price of $5.00. The initial common stock conversion price for the shares of Series B Preferred Stock was $8.55. However, the terms of the Series B preferred stock were such that the stock conversion price was to be reduced to 75% of the offering price in any subsequent qualified public offering of Company equity instruments, if lower than the common stock conversion price of $8.55. The Company’s public offering that closed on February 15, 2022, was completed at an offering price of $4.13. Accordingly, the initial common stock conversion price for the shares of Series B Preferred Stock was reduced from $8.55 to $3.0975, representing 75% of the offering price of $4.13. As a result, the Company recognized a deemed dividend of $439,999 to Series B Shareholders in respect of the additional shares of common stock and warrants they received on the conversion of their shares of Series B Preferred stock. As the Company does not have a balance of retained earnings, the deemed dividend was recorded against additional paid-in capital.

 

The Company has no remaining Preferred Shares outstanding as of March 31, 2022.

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Deficit)
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Stockholders’ Equity (Deficit)

Note 9 – Stockholders’ Equity (Deficit)

 

Directors Remuneration

 

On January 3, 2022, the Company issued 3,125 non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $4.80, vested immediately and had a term ending at the earlier of five years after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.

 

On January 17, 2022, the Company issued an RSU grant of 3,367 shares of common stock 2021 Equity Incentive Plan to each of two new directors, 1,684 shares of common stock vested immediately on grant date and the remaining 1,683 shares of common stock will vest on January 17, 2023, if the recipient remains in service as an independent director. 1,684 shares of common stock were issued to each of the two new directors in settlement of the RSUs that vested immediately.

 

Revised Compensation Plan

 

On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan supersedes the plan adopted on August 20, 2021. The Plan is effective retroactively for the current independent directors and for independent directors elected or appointed after the Effective Date. 3,367 restricted stock units in respect of this plan were issued on January 17, 2022. Cash fees were paid on January 21, 2022.

 

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from 240,125,244 to 1,600,835. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Change in Authorized Share Capital

 

In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to 200,000,000 shares of common stock and 25,000,000 shares of preferred stock.

 

Equity Raise

 

On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $22 million for the sale of 5,811,138 shares of common stock and 6,572,808 warrants, each warrant to purchase one share of common stock for five years, exercisable immediately, at an exercise price of $5.00. The Company also issued to the representative of the underwriters 290,557 warrants, each warrant to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

As of March 31, 2022, the Company had 200,000,000 shares authorized at a $.00001 par value. Effective March 31, 2022, 7,784,444 shares of common stock were issued and outstanding. No shares of preferred stock are issued and outstanding.

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Incentive Plans
3 Months Ended
Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans

Note 10 – Equity Incentive Plans

 

2017 Equity Incentive Plan

 

Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 333,333 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.

 

During the three months ended March 31, 2022, no shares or options were issued and 13,333 options were cancelled under the 2017 Plan.

 

As of March 31,2022, of the 333,333 shares authorized under the 2017 Plan for equity awards, 163,692 shares have been issued, awards related to 148,905 options remain outstanding, and 20,736 shares remain available for future equity awards.

 

2021 Equity Incentive Plan

 

On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 666,667 shares of common stock. The 2021 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

During the three months ended March 31, 2022, the Company issued 3,367 shares of its common stock to two new independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted in January 2022.

 

During the three months ended March 31, 2022, the Company granted awards for 21,167 non-qualified stock options to employees under the 2021 Equity Incentive Plan as described below.

 

During the three months ended March 31, 2022, the Company granted awards for 6,250 non-qualified stock options to directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted in August of 2021.

 

As of March 31,2022, of the 666,667 shares authorized under the 2021 Equity Plan, 10,170 relate to restricted shares issued, 33,408 relate to outstanding non-qualified stock options, 40,816 relate to outstanding incentive stock options, 3,367 relate to outstanding restricted stock units and 578,906 shares remain available for future equity awards.

 

There was $222,707 in unrecognized compensation expense for unvested non-qualified stock options, incentive stock options and restricted stock units at March 31, 2022 which will be recognized over approximately 3 years.

 

Non-Qualified and Incentive Stock Options

 

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2022, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding, December 31, 2021   158,174   $10.99    7.6   $        - 
Granted   21,167   $3.55    9.8   $

4,650

 
Exercised   -   $-    -   $- 
Forfeited   (13,333)  $9.15    0.0   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2022   166,007   $10.18    8.2   $4,650 
Exercisable, March 31, 2022   118,828   $11.89    7.6   $610 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

During the three months ended March 31, 2022, we issued a total of 21,167 stock options to employees as follows:

 

  6,167 stock options were issued to three new employees. The vesting of these options ranges from immediate to three years, have a term of 10 years and an exercise price ranging from $4.80 to $6.90.
  15,000 stock options were issued to our newly appointed Chief Financial Officer. The options vest as follows: 2,000 vested immediately, 3,000 on March 11, 2023, 5,000 on March 11, 2024, and 5,000 on March 11, 2025. The options have a term of 10 years and an exercise price of $2.20.
  During the three months ended March 31, 2022, 1,667 fully vested stock options and 11,667 unvested stock options were forfeited following the departure of one former employee.

 

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2022, are presented in the table below:

 

 

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant-Date

Fair Value

 
                
Nonvested, December 31, 2021   41,846   $7.65   $        -   $320,122 
Granted   21,167   $3.51   $-   $74,296 
Vested   (4,167)  $4.50   $-   $(18,751)
Forfeited   (11,667)  $9.01   $-   $(105,120)
Expired   -   $-   $-   $- 
Nonvested, March 31, 2022   47,179   $5.73   $-   $270,547 

 

For the three months ended March 31, 2022 and March 31, 2021, the Company recorded $32,939 and $0 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.

 

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2022, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
                 
Outstanding, December 31, 2021   50,872   $10.02    6.6   $       - 
Granted   6,250   $4.80    9.8   $- 
Exercised   -   $-    -   $- 
Forfeited/Cancelled   -   $-    -   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2022   57,122   $9.44    6.7   $- 
Exerciseable, March 31, 2022   57,122   $9.44    6.7   $- 

 

A summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the three months ended March 31, 2022, are presented in the table below:

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

 

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant-Date

Fair Value

 
                
Nonvested, December 31, 2021   -   $-   $-   $- 
Granted   6,250   $4.80   $(14,313)  $29,688 
Vested   (6,250)  $4.80   $14,313  $(29,688)
Forfeited   -   $-   $

-

   $- 
Expired   -   $-   $-   $- 
Nonvested, March 31, 2022   -        $-   $- 

 

During the three months ended March 31, 2022 and March 31, 2021, the Company incurred $29,656 and $6,342 respectively, as compensation expense related to 6,250 and 3,333 vested options, respectively, issued to directors.

 

Effective January 3, 2022, the Company issued 6,250 non-qualified stock options under the 2021 Equity Plan to its then current directors. The options vested upon grant. The options have a term of 10 years and an exercise price equal to the closing price of the Company’s common stock on The OTC Markets on the day immediately preceding the grant date.

 

Restricted Stock Units

 

Effective January 17,2022, the Company issued 6,734 restricted stock units (RSUs) under the 2021 Equity Plan to newly appointed directors. 3,367 of these RSUs vested upon grant and the remining 3,367 will vest on January 17, 2023.

 

The Company recorded $29,923 during the three months ended March 31, 2022, as compensation expense related to vested RSUs issued to directors.

 

 

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic Value

 
            
Outstanding, December 31, 2021   -   $-   $      - 
Granted   6,734   $7.42   $- 
Vested and settled with share issuance   (3,367)  $7.42   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, March 31, 2022   3,367   $7.42   $- 

 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.1
Warrants
3 Months Ended
Mar. 31, 2022
Warrants  
Warrants

Note 11 - Warrants

 

The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2022:

 

 

      

Weighted

Average

  

Weighted

Average

Remaining

   Aggregate 
   Number   Exercise   Life   Intrinsic 
   Outstanding   Price   In Months   Value 
                 
Outstanding at December 31, 2021   227,719   $9.59    33   $         0 
                     
Issued   7,566,435   $4.89    58*  $425,955 
                     
Exercised   -    -    -    - 
                     
Expired   -    -    -    - 
                     
Outstanding at March 31, 2022   7,794,154   $5.03    58*  $425,955 

 

*Excludes 170,382 warrants with an indefinite life.

 

The following table summarizes information about warrants outstanding at March 31, 2022:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Months Outstanding 
          
 9.45    192,982    30 
             
 10.40    34,737    31 
             
 5.00    7,105,496    59 
             
 5.16    290,557    59 
             
 0.01    170,382    Indefinite Life 
      7,794,154    58*

 

* Excludes 170,382 warrants with an indefinite life. 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Q3 2021 Warrants Issued to Series B Preferred Stockholder

 

On September 28, 2021, the Company entered into a Securities Purchase Agreement with an institutional investor, pursuant to which the investor purchased from the Company 3,300 shares of convertible Series B Preferred Stock with a stated value of $1,000 per share, or $3,300,000 of stated value in the aggregate, and a warrant to purchase up to 192,982 shares of common stock of the Company for an aggregate purchase price of $3,000,000. The warrant is exercisable until September 28, 2024, at an exercise price of $9.45, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights.

 

Q3 2021 Warrants Issued to Series B Preferred Placement Agent

 

In connection with the sale of the shares of convertible Series B Preferred Stock described above, the Company issued 34,737 warrants to the placement agent and its designees. Half of the warrants were issued on September 28, 2021, and the second half were issued on November 3, 2021, and are exercisable commencing February 28, 2022 and May 3, 2022, respectively, until September 28, 2024 and November 3, 2024, respectively. The exercise price per share of the warrants is $10.40, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights.

 

Q1 2022 Investor Warrants

 

On February 15, 2022, the Company issued 5,811,138 investment units for aggregate gross proceeds of $24,000,000, or $4.13 per unit. Each unit consisted of one share of the Company’s common stock and one warrant for the purchase of one share of the Company’s common stock. The warrants vested immediately, had a term of 5 years and an exercise price of $5.00.

 

Q1 2022 Overallotment Warrants

 

Further on February 15, 2022, in connection the Company’s issuance of 5,811,138 investment units for aggregate gross proceeds of $24,000,000, or $4.13 per unit as described above, a further 761,670 warrants were issued in connection with the subscription for substantially all of the available 15% overallotment warrants. The warrants were acquired for consideration of $0.01 per warrant, vested immediately, had a term of 5 years and an exercise price of $5.00.

 

Q1 2022 Underwriter Warrants

 

Further on February 15, 2022, in connection the Company’s issuance of 5,811,138 investment units for aggregate gross proceeds of $24,000,000, or $4.13 per unit described above, the Company also issued representatives of the underwriters 290,557 warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027.

 

Q1 2022 Series B Preferred Shares Pre-Funded Conversion Warrants

 

On February 16, 2022, in connection with the conversion of 1,650 shares of Series B Preferred Stock into 362,306 shares of the Company’s common stock, the Series B Preferred Shareholder was issued with 170,382 pre-funded conversion warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $0.01, vested immediately and had an indefinite life.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Q1 2022 Series B Preferred Shares Conversion Warrants

 

Further on February 16, 2022, in connection with the conversion of 1,650 shares of Series B Preferred Stock into 362,306 shares of the Company’s common stock, the Series B Preferred Shareholder was also issued with 532,688 Series B Preferred shares conversion warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $5.00, vested immediately and had a term of 5 years.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes
3 Months Ended
Mar. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes

Note 12 – Income Taxes

 

As of March 31, 2022, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $22,514,000, of which $11,196,000 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to 80%. In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the 80% limitation for NOLs arising in 2018, 2019 and 2020.

 

In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations

 

The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of March 31, 2022 and December 31, 2021. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transactions
3 Months Ended
Mar. 31, 2022
Related Party Transactions [Abstract]  
Related Party Transactions

Note 13 – Related Party Transactions

 

The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant ownership interest in RSX.

 

Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless prior notice is given 90 days prior to each annual expiration. During the three months ended March 31, 2022, the Company paid $7,555 in commissions under this agreement.

 

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events
3 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

Note 14 – Subsequent Events

 

In accordance with ASC 855, Subsequent Events, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No material subsequent events occurred after March 31, 2022, other than as set out below:

 

On April 1, 2022, 31,793 non-qualified stock options were issued to 21 employees in respect of the Company’s 2021 Annual Incentive Awards. The options vested immediately, have a term of 10 years and an exercise price of $2.51. The expense in respect of this issuance had been fully in fully accrued in 2021.

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.1
General (Policies)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Description of Business

Description of Business

 

CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, some producers grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies include: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting and climate control, and (vi) preventive maintenance services for CEA facilities Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis or its related products.

 

Impact of the COVID-19 Pandemic on Our Business

Impact of the COVID-19 Pandemic on Our Business

 

The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.

 

The resulting effects and uncertainties from the COVID-19 pandemic, including the depth and duration of the disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses and reduced operating cash flows in our business. During the three months ended March 31, 2022, the Company experienced significant delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain arising from the long-term effects of the COVID-19 pandemic. Consequently, our revenue recognition of these customer sales has been delayed until future periods when the shipment of these orders can be completed.

 

Financial Statement Presentation

Financial Statement Presentation

 

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued. The Company continues to experience recurring losses since its inception. As a result, in order to continue as a going concern, the Company has been reliant on the ability to obtain additional sources of financing to fund growth. As indicated in Note 9 – Shareholders Equity (Deficit) below, on February 15, 2022, the Company received approximately $22,000,000 in proceeds from completion of an equity offering. Based on management’s evaluation, the proceeds from the Offering will be more than sufficient to fund any deficiencies in working capital or cash flow from operations, and the Company is confident that it will be able to meet its obligations as they come due, and fund operations for at least 12 months after the date the consolidated financial statements are available to be issued. Accordingly, the conditions around liquidity and limited working capital necessary to fund operations have been addressed.

 

Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The balance sheet as of December 31, 2021 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2021.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Principles

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.

 

Reverse Stock Split

Reverse Stock Split

 

On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.

 

As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding as of December 31, 2021, was reduced from 240,125,224 to 1,600,835.

 

All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.

 

Use of Estimates

Use of Estimates

 

Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.

 

Cash, Cash Equivalents and Restricted Cash

Cash, Cash Equivalents and Restricted Cash

 

All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $250,000. As of March 31, 2022, the balance in the Company’s account was approximately $22,034,000, consequently $21,784,000 of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.

 

Income (Loss) Per Common Share

Income (Loss) Per Common Share

 

Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.

 

During the three months ended March 31, 2022 and 2021, there were warrants and options outstanding to purchase Company common stock and shares of convertible preferred stock and restricted stock units that were convertible into shares of the Company’s common stock. During the three-month period ended March 31, 2022, the Company incurred a net loss and consequently the common share equivalents of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such inclusion would have been anti-dilutive.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

As of March 31, 2022, and 2021, there were respectively, 8,021,057 and 201,662, potentially dilutive equity instruments outstanding in respect of shares of convertible preferred stock and warrants and options outstanding to purchase Company common stock.

 

Goodwill

Goodwill

 

The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.

 

During the three months ended March 31, 2022, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators of impairment. Accordingly, the Company performed an interim impairment analysis at March 31, 2022 and concluded that no impairment relating to goodwill existed at March 31, 2022.

 

Temporary Equity

Temporary Equity

 

Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Revenue Recognition

Revenue Recognition

 

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09 (Topic 606), Revenue from Contracts with Customers and all the related amendments (“ASC 606” or the “revenue standard”) to all contracts and elected the modified retrospective method.

 

The following table sets forth the Company’s revenue by source:

 

   2022   2021 
  

For the Three Months Ended

March 31,

 
   2022   2021 
Equipment and systems sales  $1,642,572   $2,163,468 
Engineering and other services   86,049    181,083 
Shipping and handling   15,806    21,978 
Total revenue  $1,744,427   $2,366,529 

 

Revenue Recognition Accounting Policy Summary

 

The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.

 

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.

 

Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.

 

The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.

 

The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.

 

Other Judgments and Assumptions

 

The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.

 

Contract Assets and Contract Liabilities

 

Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on the terms established in its contracts.

 

Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2022, and 2021, the Company had no contract assets.

 

Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to recognize revenue is generally less than one year. As of March 31, 2022, and December 31, 2021, deferred revenue, which was classified as a current liability, was $5,485,416 and $2,839,838, respectively.

 

For the three months ended March 31, 2022, the Company recognized revenue of $1,162,374 related to the deferred revenue at January 1, 2022. For the three months ended March 31, 2021, the Company recognized revenue of $1,880,634 related to the deferred revenue at January 1, 2021.

 

Remaining Performance Obligations

 

Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.

 

Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.

 

As of March 31, 2022, the Company’s remaining performance obligations, or backlog, was $11,179,000. There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2022, includes booked sales orders of $2,217,000 from several customers that the Company does not expect to be realized until 2023, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes that several of its current contracts may be delayed or canceled.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

The remaining performance obligations expected to be recognized through 2023 are as follows:

 

   2022   2023   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   8,962,000    2,217,000   11,179,000 
Total remaining performance obligations  $8,962,000   $2,217,000   $11,179,000 

 

Product Warranty

 

The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.

 

The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2022, and December 31, 2021, the Company had an accrued warranty reserve amount of $187,702 and $186,605, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.

 

Accounting for Share-Based Compensation

Accounting for Share-Based Compensation

 

The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.

 

The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2022, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from 158.21% to 158.70%; expected term in years 10 and risk-free interest rate ranged from 1.52% to 1.98%.

 

The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.

 

The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021:

 

   2022   2021 
  

For the Three Months Ended

March 31,

 
   2022   2021 
Share-based compensation expense included in:          
Cost of revenue  $791   $14,135 
Advertising and marketing expenses   2,762    6,474 
Product development costs   -    6,694 
Selling, general and administrative expenses   88,964    31,833 
Total share-based compensation expense included in consolidated statement of operations  $92,517   $59,136 

 

Included in the expense for the three months ended March 31, 2021, is an accrual for $52,794 for the 2021 Annual Employee Incentive Compensation Plan.

 

Concentrations

Concentrations

 

One customer accounted for 35% of the Company’s revenue for the three months ended March 31, 2022. Three customers accounted for 38%, 16%, and 11% of the Company’s revenue for the three months March 31, 2021.

 

Three customers accounted for 44%, 19% and 16% of the Company’s accounts receivable as of March 31, 2022. Two customers accounted for 60%, and 31% of the Company’s accounts receivable as of March 31, 2021.

 

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.

 

In May 2021, the FASB issued ASU 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. This guidance clarifies and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options due to a lack of explicit guidance in the FASB Codification. The guidance is effective for interim and annual periods beginning after December 15, 2021. Early adoption is permitted. The guidance is to be applied prospectively to modifications or exchanges occurring on or after the effective date. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

March 31, 2022

(in US Dollars except share numbers)

(Unaudited)

 

In March 2020, the FAS issued ASU No. 2020-04 “Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.1
General (Tables)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Schedule of Revenue by Source

The following table sets forth the Company’s revenue by source:

 

   2022   2021 
  

For the Three Months Ended

March 31,

 
   2022   2021 
Equipment and systems sales  $1,642,572   $2,163,468 
Engineering and other services   86,049    181,083 
Shipping and handling   15,806    21,978 
Total revenue  $1,744,427   $2,366,529 

Schedule of Remaining Performance Obligations Expected to be Recognized

The remaining performance obligations expected to be recognized through 2023 are as follows:

 

   2022   2023   Total 
Remaining performance obligations related to engineering only paid contracts  $-   $-   $- 
Remaining performance obligations related to partial equipment paid contracts   8,962,000    2,217,000   11,179,000 
Total remaining performance obligations  $8,962,000   $2,217,000   $11,179,000 
Schedule of Share-based Compensation Costs

The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021:

 

   2022   2021 
  

For the Three Months Ended

March 31,

 
   2022   2021 
Share-based compensation expense included in:          
Cost of revenue  $791   $14,135 
Advertising and marketing expenses   2,762    6,474 
Product development costs   -    6,694 
Selling, general and administrative expenses   88,964    31,833 
Total share-based compensation expense included in consolidated statement of operations  $92,517   $59,136 

 

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Leases (Tables)
3 Months Ended
Mar. 31, 2022
Leases  
Schedule of Lease Cost

The lease cost, cash flows and other information related to the Facility Lease were as follows:

 

  

As of March 31,

2022

 
Operating lease right-of-use asset  $540,444 
Operating lease liability, current  $112,072 
Operating lease liability, long-term  $459,482 
      
Remaining lease term   4.8 years 
Discount rate   3.63%

 

  

For the Three

Months Ended

March 31, 2022

 
Operating cash outflow from operating lease  $20,109 
Schedule of Future Annual Minimum Lease Payments

Future annual minimum lease payments on the Facility Lease as of March 31, 2022 are as follows:

  

Years ended December 31,    
2022 (excluding the three months ended March 31, 2022)  $91,095 
2023   124,897 
2024   128,643 
2025   132,503 
2026   136,473 
Thereafter   11,654 
Total minimum lease payments   625,265 
Less imputed interest   (53,710)
Present value of minimum lease payments   $571,555 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Inventory (Tables)
3 Months Ended
Mar. 31, 2022
Inventory Disclosure [Abstract]  
Schedule of Inventory

Inventory consisted of the following:

 

   March 31,   December 31, 
   2022   2021 
Finished goods  $913,887   $272,199 
Work in progress   971    1,050 
Raw materials   186,115    196,456 
Allowance for excess & obsolete inventory   (95,055)   (91,379)
Inventory, net  $1,005,918   $378,326 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment (Tables)
3 Months Ended
Mar. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment consisted of the following:

 

   March 31,   December 31, 
   2022   2021 
Furniture and equipment  $271,056   $274,472 
Vehicles   15,000    15,000 
Leasehold improvements   -    - 
Property and equipment, gross   286,056    289,472 
Accumulated depreciation   (208,817)   (212,126)
Property and equipment, net  $77,239   $77,346 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Accounts Payable and Accrued Liabilities (Tables)
3 Months Ended
Mar. 31, 2022
Payables and Accruals [Abstract]  
Schedule of Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following:

 

   March 31,   December 31, 
   2022   2021 
Accounts payable  $729,040   $616,056 
Sales commissions payable   9,107    27,592 
Accrued payroll liabilities   266,456    322,873 
Product warranty accrual   187,702    186,605 
Other accrued expenses   196,723    192,463 
Total  $1,389,028   $1,345,589 

 

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2022, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding, December 31, 2021   158,174   $10.99    7.6   $        - 
Granted   21,167   $3.55    9.8   $

4,650

 
Exercised   -   $-    -   $- 
Forfeited   (13,333)  $9.15    0.0   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2022   166,007   $10.18    8.2   $4,650 
Exercisable, March 31, 2022   118,828   $11.89    7.6   $610 
Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2022, are presented in the table below:

 

 

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant-Date

Fair Value

 
                
Nonvested, December 31, 2021   41,846   $7.65   $        -   $320,122 
Granted   21,167   $3.51   $-   $74,296 
Vested   (4,167)  $4.50   $-   $(18,751)
Forfeited   (11,667)  $9.01   $-   $(105,120)
Expired   -   $-   $-   $- 
Nonvested, March 31, 2022   47,179   $5.73   $-   $270,547 
Schedule of Restricted Stock Units Activity

 

 

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic Value

 
            
Outstanding, December 31, 2021   -   $-   $      - 
Granted   6,734   $7.42   $- 
Vested and settled with share issuance   (3,367)  $7.42   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, March 31, 2022   3,367   $7.42   $- 

 

2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2022, are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
                 
Outstanding, December 31, 2021   50,872   $10.02    6.6   $       - 
Granted   6,250   $4.80    9.8   $- 
Exercised   -   $-    -   $- 
Forfeited/Cancelled   -   $-    -   $- 
Expired   -   $-    -   $- 
Outstanding, March 31, 2022   57,122   $9.44    6.7   $- 
Exerciseable, March 31, 2022   57,122   $9.44    6.7   $- 
Summary of Non-vested Non-qualified Stock Option Activity

 

 

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant-Date

Fair Value

 
                
Nonvested, December 31, 2021   -   $-   $-   $- 
Granted   6,250   $4.80   $(14,313)  $29,688 
Vested   (6,250)  $4.80   $14,313  $(29,688)
Forfeited   -   $-   $

-

   $- 
Expired   -   $-   $-   $- 
Nonvested, March 31, 2022   -        $-   $- 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Warrants (Tables)
3 Months Ended
Mar. 31, 2022
Warrants  
Schedule of Outstanding Warrants to Purchase Common Stock

The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2022:

 

 

      

Weighted

Average

  

Weighted

Average

Remaining

   Aggregate 
   Number   Exercise   Life   Intrinsic 
   Outstanding   Price   In Months   Value 
                 
Outstanding at December 31, 2021   227,719   $9.59    33   $         0 
                     
Issued   7,566,435   $4.89    58*  $425,955 
                     
Exercised   -    -    -    - 
                     
Expired   -    -    -    - 
                     
Outstanding at March 31, 2022   7,794,154   $5.03    58*  $425,955 

 

*Excludes 170,382 warrants with an indefinite life.
Schedule of Warrants Outstanding

The following table summarizes information about warrants outstanding at March 31, 2022:

 

    Warrants   Weighted Average 
Exercise price   Outstanding   Months Outstanding 
          
 9.45    192,982    30 
             
 10.40    34,737    31 
             
 5.00    7,105,496    59 
             
 5.16    290,557    59 
             
 0.01    170,382    Indefinite Life 
      7,794,154    58*

 

* Excludes 170,382 warrants with an indefinite life. 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Revenue by Source (Details) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Product Information [Line Items]    
Total revenue $ 1,744,427 $ 2,366,529
Equipment And Systems Sales [Member]    
Product Information [Line Items]    
Total revenue 1,642,572 2,163,468
Engineering and Other Services [Member]    
Product Information [Line Items]    
Total revenue 86,049 181,083
Shipping and Handling [Member]    
Product Information [Line Items]    
Total revenue $ 15,806 $ 21,978
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Remaining Performance Obligations Expected to be Recognized (Details)
Mar. 31, 2022
USD ($)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts
Remaining performance obligations related to partial equipment paid contracts 11,179,000
Total remaining performance obligations 11,179,000
2022 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts
Remaining performance obligations related to partial equipment paid contracts 8,962,000
Total remaining performance obligations 8,962,000
2023 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Remaining performance obligations related to engineering only paid contracts
Remaining performance obligations related to partial equipment paid contracts 2,217,000
Total remaining performance obligations $ 2,217,000
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Share-based Compensation Costs (Details) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Total share-based compensation expense included in consolidated statement of operations $ 92,517 $ 59,136
Cost of Sales [Member]    
Total share-based compensation expense included in consolidated statement of operations 791 14,135
Advertising and Marketing Expenses [Member]    
Total share-based compensation expense included in consolidated statement of operations 2,762 6,474
Product Development Costs [Member]    
Total share-based compensation expense included in consolidated statement of operations 6,694
Selling, General and Administrative Expenses [Member]    
Total share-based compensation expense included in consolidated statement of operations $ 88,964 $ 31,833
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.1
General (Details Narrative) - USD ($)
3 Months Ended
Feb. 15, 2022
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 30, 2021
Dec. 29, 2021
Product Information [Line Items]            
Proceeds from issuance of common stock $ 22,000,000          
Reverse stock split description   On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022        
Common stock issued   7,784,444   1,600,835 240,125,224 240,125,244
Common stock outstanding   7,784,444   1,600,835 240,125,224 240,125,244
Federal insured amount   $ 250,000        
Cash balance, amount   22,034,000        
Federal deposit insurance corporation premium expense   $ 21,784,000        
Potentially dilutive equity instruments that are convertible into common stock   8,021,057 201,662      
Contract with Customer, Liability, Current   $ 5,485,416   $ 2,839,838    
Revenue recognized   1,162,374 $ 1,880,634      
Revenue remaining performance obligation   11,179,000        
Product Warranty Accrual, Current   187,702   $ 186,605    
Share-Based Payment Arrangement, Expense   $ 92,517 $ 59,136      
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage   35.00% 38.00%      
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage     16.00%      
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]            
Product Information [Line Items]            
Concentration risk percentage     11.00%      
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage   44.00% 60.00%      
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage   19.00% 31.00%      
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]            
Product Information [Line Items]            
Concentration risk percentage   16.00%        
2021 Annual Employee Incentive Compensation Plan [Member]            
Product Information [Line Items]            
Share-Based Payment Arrangement, Expense   $ 52,794        
Minimum [Member]            
Product Information [Line Items]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate   158.21%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   1.52%        
Maximum [Member]            
Product Information [Line Items]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate   158.70%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   1.98%        
2023 [Member]            
Product Information [Line Items]            
Revenue remaining performance obligation   $ 2,217,000        
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Lease Cost (Details) - USD ($)
3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Leases    
Operating lease right-of-use asset $ 540,444 $ 565,877
Operating lease liability, current 112,072 100,139
Operating lease liability, long-term $ 459,482 $ 486,226
Remaning lease term 4 years 9 months 18 days  
Discount rate 3.63%  
Operating cash outflow from operating lease $ 20,109  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Future Annual Minimum Lease Payments (Details)
Mar. 31, 2022
USD ($)
Leases  
2022 (excluding the three months ended March 31, 2022) $ 91,095
2023 124,897
2024 128,643
2025 132,503
2026 136,473
Thereafter 11,654
Total minimum lease payments 625,265
Less imputed interest (53,710)
Present value of minimum lease payments $ 571,555
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Leases (Details Narrative)
Jul. 28, 2021
USD ($)
ft²
Mar. 31, 2022
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Present value of minimum lease payments   $ 571,555
New Facility Lease [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Area of land | ft² 11,491  
Operating lease term description The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027  
Lease rental expense $ 10,055  
Increase in rent percent 3.00%  
Security deposit $ 14,747  
Present value of minimum lease payments $ 582,838  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Inventory (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Finished goods $ 913,887 $ 272,199
Work in progress 971 1,050
Raw materials 186,115 196,456
Allowance for excess & obsolete inventory (95,055) (91,379)
Inventory, net $ 1,005,918 $ 378,326
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Inventory (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Overhead expenses $ 16,555 $ 13,589
Inventory in transit 692,195  
Prepaid inventory expenses $ 1,579,000 $ 1,069,000
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Property and Equipment (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 286,056 $ 289,472
Accumulated depreciation (208,817) (212,126)
Property and equipment, net 77,239 77,346
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 271,056 274,472
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 15,000 15,000
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment (Details Narrative)
3 Months Ended
Mar. 31, 2022
USD ($)
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]  
Depreciation expenses $ 8,556
Cost of Sales [Member] | Property, Plant and Equipment [Member]  
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]  
Depreciation expenses 1,214
Inventory [Member] | Property, Plant and Equipment [Member]  
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]  
Depreciation expenses $ 304
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Accounts payable $ 729,040 $ 616,056
Sales commissions payable 9,107 27,592
Accrued payroll liabilities 266,456 322,873
Product warranty accrual 187,702 186,605
Other accrued expenses 196,723 192,463
Total $ 1,389,028 $ 1,345,589
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Note Payable and Accrued Interest (Details Narrative) - USD ($)
Nov. 30, 2021
Feb. 10, 2021
Debt Disclosure [Abstract]    
Note payable principal amount $ 514,200 $ 514,200
Loan interest rate   1.00%
Loan due date   Feb. 05, 2026
Debt Instrument, Increase, Accrued Interest $ 2,832  
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Commitments and Contingencies (Details Narrative)
3 Months Ended
Mar. 31, 2022
USD ($)
shares
Loss Contingencies [Line Items]  
Common shares issued in settlement of legal dispute, value $ 67,000
Other Expense [Member]  
Loss Contingencies [Line Items]  
Cost of settelement $ 107,000
Common Stock [Member]  
Loss Contingencies [Line Items]  
Common shares issued in settlement of legal dispute, shares | shares 6,667
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.1
Temporary Equity (Details Narrative) - USD ($)
3 Months Ended
Feb. 16, 2022
Nov. 04, 2021
Sep. 30, 2021
Sep. 28, 2021
Mar. 31, 2022
Mar. 31, 2021
Feb. 15, 2022
Dec. 31, 2021
Temporary Equity, Par or Stated Value Per Share         $ 0.00001     $ 0.00001
Proceeds from Issuance of Redeemable Convertible Preferred Stock   $ 1,365,000   $ 1,260,000        
Dividends $ 36,000              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period         3 years      
Deemed dividend on series B preferred stock on down round         $ 439,999    
Warrant [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period 532,688              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 5 years              
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price $ 5.00              
Series B Redeemable Convertible Preferred Stock [Member]                
Temporary Equity, Shares Authorized       3,300        
Temporary Equity, Par or Stated Value Per Share       $ 1,000        
Convertible Preferred Stock [Member]                
Temporary Equity, Aggregate Amount of Redemption Requirement       $ 3,000,000        
Series B Preferred Stock [Member]                
Dividend rate percentage         8.00%      
Conversion price         $ 8.55      
Dividend rate percentage         4.99%      
Debt Instrument, Redemption Price, Percentage     120.00%          
Debt Instrument, Convertible, Liquidation Preference, Per Share     $ 1,000          
Debt Instrument, Convertible, Liquidation Preference, Value     $ 3,960,000          
Temporary equity noncash redemption value adjustment         $ 2,262,847      
Stock Redeemed or Called During Period, Shares 1,650              
Stock Redeemed or Called During Period, Value $ 2,016,000.000              
Stock Issued During Period, Shares, Conversion of Units 1,650              
Preferred Stock, Convertible, Conversion Price $ 8.55           $ 4.13  
Conversion price reduced offering price, percentage 75.00%              
Series B Preferred Stock [Member] | Decrease In Common Stock Conversion Price [Member]                
Preferred Stock, Convertible, Conversion Price $ 3.0975              
Series B Preferred Stock [Member] | Common Stock [Member]                
Conversion of Stock, Shares Converted 362,306              
Series B Preferred Stock [Member] | Warrant [Member]                
Conversion of Stock, Shares Converted 703,069              
Series B Preferred Stock [Member] | Warrant One [Member] | Indefinite Term [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period 170,382              
Exercise price, per share $ 0.01              
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
3 Months Ended
Feb. 15, 2022
Jan. 17, 2022
Jan. 03, 2022
Mar. 31, 2022
Dec. 31, 2021
Dec. 30, 2021
Dec. 29, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of stock options issued       163,692      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term       3 years      
Common stock, shares issued       7,784,444 1,600,835 240,125,224 240,125,244
Common stock, shares outstanding       7,784,444 1,600,835 240,125,224 240,125,244
Common stock, shares authorized       200,000,000 850,000,000    
Preferred stock, shares authorized       25,000,000 150,000,000    
Net proceeds from sale of common stock $ 22,000,000            
Number of shares sold 6,572,808            
Exercise price       $ 5.03 $ 9.59    
Par value       $ 0.00001 $ 0.00001    
Preferred stock, shares issued       0      
Preferred stock, shares outstanding       0      
Common Stock [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of shares issued during the period       5,811,138      
Number of shares sold 5,811,138            
Warrant [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Warrant term 5 years            
Exercise price $ 5.00            
Board of Directors Chairman [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Common stock, shares authorized         200,000,000    
Preferred stock, shares authorized         25,000,000    
Underwriters [Member] | Warrant [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Exercise price $ 5.1625            
Stock issued during period, shares, issued for services 290,557            
Warrants maturity date Feb. 10, 2027            
2021 Equity Incentive Plan [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of stock options issued     3,125        
Exercise price     $ 4.80        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term     5 years        
Number of shares issued during the period       3,367      
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Shares, granted   3,367          
Number of shares issued during the period   3,367          
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Two Directors [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Shares, vested   1,684          
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | January 17, 2022 [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Shares, granted   1,684          
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | January 17, 2023 [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Shares, granted   1,683          
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Stock Option Activity (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 3 years  
Number of Options, Forfeited (13,333)  
Number of Options, Outstanding Ending 148,905  
Number of Options, Forfeited/Cancelled 13,333  
Employees And Consultants [Member] | 2017 Equity Plan and 2021 Equity Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Granted 21,167  
Employees And Consultants [Member] | Non-Qualified Stock Options [Member] | 2017 Equity Plan and 2021 Equity Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding Beginning 158,174  
Weighted Average Exercise Price, Outstanding Beginning $ 10.99  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 7 years 7 months 6 days  
Aggregate Intrinsic Value, Outstanding Beginning  
Number of Options, Granted 21,167  
Weighted Average Exercise Price, Granted $ 3.55  
Weighted Average Remaining Contractual Term, Granted 9 years 9 months 18 days  
Aggregate Intrinsic Value, Exercised $ 4,650  
Number of Options, Exercised  
Weighted Average Exercise Price, Exercised  
Weighted Average Remaining Contractual Term,Exercised  
Number of Options, Forfeited (13,333)  
Weighted Average Exercise Price, Forfeited/Cancelled $ 9.15  
Weighted Average Remaining Contractual Term,Forfeited 0 years  
Number of Options, Expired  
Weighted Average Exercise Price, Expired  
Weighted Average Remaining Contractual Term,Expired  
Number of Options, Outstanding Ending 166,007  
Weighted Average Exercise Price, Outstanding Ending $ 10.18  
Weighted Average Remaining Contractual Term, Outstanding Ending 8 years 2 months 12 days  
Aggregate Intrinsic Value, Outstanding Ending $ 4,650  
Number of Options, Exercisable Ending 118,828  
Weighted Average Exercise Price, Exercisable Ending $ 11.89  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 7 years 7 months 6 days  
Aggregate Intrinsic Value, Exercisable Ending $ 610  
Number of Options, Forfeited/Cancelled 13,333  
Directors [Member] | 2017 Equity Plan and 2021 Equity Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Granted 6,250  
Directors [Member] | Non-Qualified Stock Options [Member] | 2017 Equity Plan and 2021 Equity Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding Beginning 50,872  
Weighted Average Exercise Price, Outstanding Beginning $ 10.02  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 6 years 7 months 6 days  
Aggregate Intrinsic Value, Outstanding Beginning  
Number of Options, Granted 6,250  
Weighted Average Exercise Price, Granted $ 4.80  
Weighted Average Remaining Contractual Term, Granted 9 years 9 months 18 days  
Number of Options, Exercised  
Weighted Average Exercise Price, Exercised  
Number of Options, Forfeited  
Weighted Average Exercise Price, Forfeited/Cancelled  
Number of Options, Expired  
Weighted Average Exercise Price, Expired  
Number of Options, Outstanding Ending 57,122  
Weighted Average Exercise Price, Outstanding Ending $ 9.44  
Weighted Average Remaining Contractual Term, Outstanding Ending 6 years 8 months 12 days  
Aggregate Intrinsic Value, Outstanding Ending  
Number of Options, Exercisable Ending 57,122  
Weighted Average Exercise Price, Exercisable Ending $ 9.44  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 6 years 8 months 12 days  
Aggregate Intrinsic Value, Exercisable Ending  
Number of Options, Forfeited/Cancelled  
Directors [Member] | Non-Qualified Stock Options [Member] | 2017 Equity Incentive Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted Average Remaining Contractual Term,Expired  
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Non-vested Non-qualified Stock Option Activity (Details)
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Aggregated Intrinsic Value, Nonvested Granted | $ / shares $ (14,313)
2017 Equity Plan and 2021 Equity Plan [Member] | Employees And Consultants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options Nonvested, Beginning | shares 41,846
Weighted Average Grant-Date Fair Value, Beginning | $ / shares $ 7.65
Aggregated Intrinsic Value, Nonvested Beginning
Grant Date Fair Value Nonvested, Beginning $ 320,122
Number of Options Nonvested, Beginning | shares 21,167
Weighted Average Grant-Date Fair Value, Beginning | $ / shares $ 3.51
Grant Date Fair Value Nonvested, Granted $ 74,296
Number of Options Nonvested, Beginning | shares (4,167)
Weighted Average Grant-Date Fair Value, Beginning | $ / shares $ 4.50
Grant Date Fair Value Nonvested, Vested $ (18,751)
Number of Options Nonvested, Forfeited | shares (11,667)
Weighted Average Grant-Date Fair Value, Beginning | $ / shares $ 9.01
Grant Date Fair Value Nonvested, Forfeited $ (105,120)
Number of Options Nonvested, Beginning | shares
Weighted Average Grant-Date Fair Value, Beginning | $ / shares
Grant Date Fair Value Nonvested, Expired
Number of Options Nonvested, Beginning | shares 47,179
Weighted Average Grant-Date Fair Value, Ending | $ / shares $ 5.73
Aggregated Intrinsic Value, Nonvested Ending
Grant Date Fair Value Nonvested, Ending $ 270,547
Number of Options Nonvested, Beginning | shares 11,667
2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options Nonvested, Beginning | shares
Weighted Average Grant-Date Fair Value, Beginning | $ / shares
Aggregated Intrinsic Value, Nonvested Beginning
Number of Options Nonvested, Beginning | shares 6,250
Weighted Average Grant-Date Fair Value, Beginning | $ / shares $ 4.80
Grant Date Fair Value Nonvested, Granted $ 29,688
Number of Options Nonvested, Beginning | shares (6,250)
Weighted Average Grant-Date Fair Value, Beginning | $ / shares $ 4.80
Grant Date Fair Value Nonvested, Vested $ (29,688)
Number of Options Nonvested, Forfeited | shares
Weighted Average Grant-Date Fair Value, Beginning | $ / shares
Number of Options Nonvested, Beginning | shares
Weighted Average Grant-Date Fair Value, Beginning | $ / shares
Number of Options Nonvested, Beginning | shares
Aggregated Intrinsic Value, Nonvested Ending
Grant Date Fair Value Nonvested, Ending
Grant Date Fair Value Nonvested, Beginning
Aggregated Intrinsic Value, Nonvested Vested $ 14,313
Number of Options Nonvested, Beginning | shares
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Restricted Stock Units Activity (Details) - 2017 Equity Incentive Plan [Member] - Employees, Directors and Consultants [Member] - Restricted Stock Units (RSUs) [Member]
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Units, beginning | shares
Weighted Average Grant-Date Fair Value, Beginning | $ / shares
Aggregate Intrinsic Value Nonvested, Beginning | $
Number of Units, Granted | shares 6,734
Weighted Average Grant-Date Fair Value, Granted | $ / shares $ 7.42
Number of Units, Vested and settled with share issuance | shares (3,367)
Weighted Average Grant-Date Fair Value, Vested | $ / shares $ 7.42
Number of Units, Forfeited/canceled | shares
Weighted Average Grant-Date Fair Value, Forfeited/Canceled | $ / shares
Number of Units, ending | shares 3,367
Weighted Average Grant-Date Fair Value,ending | $ / shares $ 7.42
Aggregate Intrinsic Value Nonvested, ending | $
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Incentive Plans (Details Narrative) - USD ($)
3 Months Ended
Jan. 17, 2022
Jan. 17, 2022
Jan. 03, 2022
Jan. 03, 2022
Mar. 31, 2022
Mar. 30, 2022
Mar. 31, 2021
Mar. 22, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period         13,333      
Number of shares authorized for equity awards         333,333      
Number of shares issued         163,692      
Number of option remain outstanding         148,905      
Shares available for future equity awards         20,736      
Unrecognized compensation expense         $ 222,707      
Expected term years         3 years      
Expected term years         3 years      
Share based compensation         $ 92,517   $ 6,342  
Employees [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Issuance of shares         21,167      
Three New Employees [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Issuance of shares         6,167      
Expected term years         10 years      
Exercise price, lower         $ 4.80      
Exercise price, upper         $ 6.90      
Cheif Financial Officer [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Issuance of shares           15,000    
Expected term years           10 years    
Description,shares           The options vest as follows: 2,000 vested immediately, 3,000 on March 11, 2023, 5,000 on March 11, 2024, and 5,000 on March 11, 2025    
Exercise price           $ 2.20    
One Former Employee [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of options to purchase shares         1,667      
Issuance of stock, unvested         11,667      
2021 Equity Plan [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant               666,667
2017 Equity Incentive Plan [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of options to purchase shares         333,333      
2017 Equity Incentive Plan [Member] | Director [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of options to purchase shares         6,250   3,333  
Share based compensation         $ 29,656   $ 6,342  
2017 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member] | Employees And Consultants [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share based compensation         $ 32,939   $ 0  
2021 Equity Incentive Plan [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of shares issued     3,125          
Issuance of shares         3,367      
Expected term years     5 years          
Exercise price     $ 4.80          
2021 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 3,367 3,367            
Issuance of shares 3,367              
2021 Equity Plan [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Shares available for future equity awards         578,906      
Number of shares authorized         666,667      
2021 Equity Plan [Member] | Restricted Shares Issued [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of shares issued         10,170      
2021 Equity Plan [Member] | Non Qualified Stock Option [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of option remain outstanding         33,408      
2021 Equity Plan [Member] | Incentive Stock Option [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of option remain outstanding         40,816      
2021 Equity Plan [Member] | Employees [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Issuance of shares         21,167      
2021 Equity Plan [Member] | Directors [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Issuance of shares         6,250      
2021 Equity Plan [Member] | Restricted Stock Units (RSUs) [Member] | Incentive Stock Option [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of option remain outstanding         3,367      
2021 Equity Plan [Member] | Restricted Stock Units (RSUs) [Member] | Directors [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Issuance of shares   3,367            
Share based compensation         $ 29,923      
Issuance of stock   $ 6,734            
2021 Equity Plan [Member] | Vested [Member] | Directors [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Issuance of shares         3,367      
2021 Plan [Member] | Non-Qualified Stock Options [Member] | Director [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of options to purchase shares       6,250        
2021 Equity Plan [Member] | Non-Qualified Stock Options [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Expected term years       10 years        
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Outstanding Warrants to Purchase Common Stock (Details)
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Warrants  
Warrants Outstanding, Beginning Balance | shares 227,719
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 9.59
Weighted Average Life of Outstanding Warrants in Months, Beginning Balance 33 months
Aggregate Intrinsic Value, Beginning Balance | $ $ 0
Warrants, issued | shares 7,566,435
Weighted Average Exercise Price, Issued | $ / shares $ 4.89
Weighted Average Life of Outstanding Warrants in Months, Issued 58 months [1]
Aggregate Intrinsic Value, Issued | $ $ 425,955
Warrants, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Aggregate Intrinsic Value, Exercised | $
Warrants, Expired | shares
Weighted Average Exercise Price, Expired | $ / shares
Aggregate Intrinsic Value, Expired | $
Warrants Outstanding, Ending Balance | shares 7,794,154
Weighted Average Exercise Price, Ending Balance | $ / shares $ 5.03
Weighted Average Life of Outstanding Warrants in Months, Ending Balance 58 months [1],[2]
Aggregate Intrinsic Value, Ending Balance | $ $ 425,955
[1] Excludes 170,382 warrants with an indefinite life.
[2] Excludes 170,382 warrants with an indefinite life. 
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Outstanding Warrants to Purchase Common Stock (Details) (Parenthetical)
Mar. 31, 2022
shares
Warrants  
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 170,382
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Warrants Outstanding (Details) - $ / shares
3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.03 $ 9.59
Warrants Outstanding 7,794,154 227,719
Weighted Average Life of Outstanding Warrants in Months [1],[2] 58 months  
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 170,382  
Warrants Range [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 9.45  
Warrants Outstanding 192,982  
Weighted Average Life of Outstanding Warrants in Months 30 months  
Warrants Range One [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 10.40  
Warrants Outstanding 34,737  
Weighted Average Life of Outstanding Warrants in Months 31 months  
Warrants Range Two [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.00  
Warrants Outstanding 7,105,496  
Weighted Average Life of Outstanding Warrants in Months 59 months  
Warrants Range Three [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 5.16  
Warrants Outstanding 290,557  
Weighted Average Life of Outstanding Warrants in Months 59 months  
Warrants Range Four [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise price $ 0.01  
Warrants Outstanding 170,382  
Weighted Average Life of Outstanding Warrants in Months Indefinite Life  
[1] Excludes 170,382 warrants with an indefinite life.
[2] Excludes 170,382 warrants with an indefinite life. 
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.1
Warrants (Details Narrative) - USD ($)
3 Months Ended
Feb. 16, 2022
Feb. 15, 2022
Feb. 15, 2022
Sep. 28, 2021
Sep. 28, 2021
Mar. 31, 2022
Dec. 31, 2021
Issuance of Value           $ 21,711,131  
Exercise price           $ 5.03 $ 9.59
Issuance of warrants           7,794,154 227,719
2022 Investor Warrants [Member]              
Issuance of warrants   5,811,138 5,811,138        
Exercise price   $ 5.00 $ 5.00        
Proceeds from warrants issuance   $ 24,000,000          
Issuance of per unit   $ 4.13 $ 4.13        
Warrants term   5 years 5 years        
2022 OverAllotment Warrants [Member]              
Issuance of shares     761,670        
Issuance of warrants   5,811,138 5,811,138        
Exercise price   $ 5.00 $ 5.00        
Proceeds from warrants issuance   $ 24,000,000          
Issuance of per unit   $ 4.13 $ 4.13        
Warrants term   5 years 5 years        
Warrants percent   1500.00% 1500.00%        
Warrant price per share   $ 0.01 $ 0.01        
2022 UnderwriterWarrants [Member]              
Issuance of shares   290,557          
Issuance of warrants   5,811,138 5,811,138        
Exercise price   $ 5.1625 $ 5.1625        
Proceeds from warrants issuance   $ 24,000,000          
Issuance of per unit   $ 4.13 $ 4.13        
Common Stock [Member]              
Issuance of shares           5,811,138  
Issuance of Value           $ 58  
Issuance of shares 362,306         362,306  
Series B Preferred Shares Pre Funded Conversion Warrants [Member]              
Exercise price $ 0.01            
Issuance of shares 170,382            
Series B Preferred Shares Conversion Warrants [Member]              
Exercise price $ 5.00            
Warrants term   5 years 5 years        
Issuance of shares 532,688            
Private Placement [Member] | Placement Agent Warrants [Member]              
Exercise price       $ 10.40 $ 10.40    
Issuance of warrants       34,737 34,737    
Series B Preferred Stock [Member]              
Issuance of shares 1,650            
Series B Preferred Stock [Member] | Securities Purchase Agreement [Member]              
Issuance of shares         3,300    
Per share       $ 1,000 $ 1,000    
Issuance of Value         $ 3,300,000    
Purchase price       $ 3,000,000      
Exercise price       $ 9.45 $ 9.45    
Series B Preferred Stock [Member] | Securities Purchase Agreement [Member] | Maximum [Member]              
Issuance of warrants       192,982 192,982    
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Details Narrative)
3 Months Ended
Mar. 31, 2022
USD ($)
Income Tax Disclosure [Abstract]  
Operating Loss Carryforwards $ 22,514,000
Net operating loss carryforward expected to expire amount $ 11,196,000
NOLs usage against taxable income percentage 80.00%
Equity Method Investment, Ownership Percentage 50.00%
Nols carryforwards term description three-year period
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Transactions (Details Narrative)
3 Months Ended
Mar. 31, 2022
USD ($)
Consulting Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Payments for commissions $ 7,555
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events (Details Narrative) - $ / shares
3 Months Ended
Apr. 01, 2022
Mar. 31, 2022
Subsequent Event [Line Items]    
Stock options vesting, period   3 years
Subsequent Event [Member] | Employment Agreement [Member]    
Subsequent Event [Line Items]    
Stock options vesting, period 10 years  
Exercise price per share $ 2.51  
Subsequent Event [Member] | 21 Employees [Member] | Employment Agreement [Member]    
Subsequent Event [Line Items]    
Non qualified stock options 31,793  
XML 66 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001482541 2022-01-01 2022-03-31 0001482541 CEAD:CommonStock0.00001ParValueMember 2022-01-01 2022-03-31 0001482541 CEAD:WarrantsToPurchaseCommonStockMember 2022-01-01 2022-03-31 0001482541 2022-05-12 0001482541 2022-03-31 0001482541 2021-12-31 0001482541 2021-01-01 2021-03-31 0001482541 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001482541 us-gaap:CommonStockMember 2021-12-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2021-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001482541 us-gaap:RetainedEarningsMember 2021-12-31 0001482541 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001482541 us-gaap:CommonStockMember 2020-12-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2020-12-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001482541 us-gaap:RetainedEarningsMember 2020-12-31 0001482541 2020-12-31 0001482541 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001482541 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2022-01-01 2022-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001482541 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001482541 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2021-01-01 2021-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001482541 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001482541 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001482541 us-gaap:CommonStockMember 2022-03-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2022-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001482541 us-gaap:RetainedEarningsMember 2022-03-31 0001482541 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0001482541 us-gaap:CommonStockMember 2021-03-31 0001482541 CEAD:CommonSharesToBeIssuedMember 2021-03-31 0001482541 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001482541 us-gaap:RetainedEarningsMember 2021-03-31 0001482541 2021-03-31 0001482541 2022-02-14 2022-02-15 0001482541 2021-12-30 0001482541 CEAD:TwoThousandAndTwentyThreeMember 2022-03-31 0001482541 srt:MinimumMember 2022-01-01 2022-03-31 0001482541 srt:MaximumMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001482541 CEAD:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001482541 CEAD:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001482541 CEAD:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001482541 CEAD:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001482541 CEAD:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001482541 CEAD:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001482541 CEAD:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001482541 CEAD:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2022-01-01 2022-03-31 0001482541 CEAD:EquipmentAndSystemsSalesMember 2021-01-01 2021-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2022-01-01 2022-03-31 0001482541 CEAD:EngineeringAndOtherServicesMember 2021-01-01 2021-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-03-31 0001482541 us-gaap:ShippingAndHandlingMember 2021-01-01 2021-03-31 0001482541 CEAD:TwoThousandAndTwentyTwoMember 2022-03-31 0001482541 us-gaap:CostOfSalesMember 2022-01-01 2022-03-31 0001482541 us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2022-01-01 2022-03-31 0001482541 CEAD:AdvertisingAndMarketingExpensesMember 2021-01-01 2021-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2022-01-01 2022-03-31 0001482541 CEAD:ProductDevelopmentCostsMember 2021-01-01 2021-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-03-31 0001482541 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-03-31 0001482541 CEAD:NewFacilityLeaseMember 2021-07-28 0001482541 CEAD:NewFacilityLeaseMember 2021-07-24 2021-07-28 0001482541 2021-01-01 2021-12-31 0001482541 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001482541 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001482541 us-gaap:VehiclesMember 2022-03-31 0001482541 us-gaap:VehiclesMember 2021-12-31 0001482541 us-gaap:LeaseholdImprovementsMember 2022-03-31 0001482541 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001482541 us-gaap:CostOfSalesMember us-gaap:PropertyPlantAndEquipmentMember 2022-01-01 2022-03-31 0001482541 CEAD:InventoryMember us-gaap:PropertyPlantAndEquipmentMember 2022-01-01 2022-03-31 0001482541 2021-02-10 0001482541 2021-02-09 2021-02-10 0001482541 2021-11-30 0001482541 2021-11-29 2021-11-30 0001482541 us-gaap:OtherExpenseMember 2022-01-01 2022-03-31 0001482541 CEAD:SeriesBRedeemableConvertiblePreferredStockMember 2021-09-28 0001482541 us-gaap:ConvertiblePreferredStockMember 2021-09-28 0001482541 2021-09-26 2021-09-28 0001482541 2021-11-01 2021-11-04 0001482541 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001482541 us-gaap:SeriesBPreferredStockMember 2021-09-27 2021-09-30 0001482541 us-gaap:SeriesBPreferredStockMember 2021-09-30 0001482541 us-gaap:SeriesBPreferredStockMember 2022-02-14 2022-02-16 0001482541 2022-02-14 2022-02-16 0001482541 us-gaap:SeriesBPreferredStockMember us-gaap:CommonStockMember 2022-02-14 2022-02-16 0001482541 us-gaap:SeriesBPreferredStockMember us-gaap:WarrantMember 2022-02-14 2022-02-16 0001482541 CEAD:IndefiniteTermMember us-gaap:SeriesBPreferredStockMember CEAD:WarrantOneMember 2022-02-14 2022-02-16 0001482541 CEAD:IndefiniteTermMember us-gaap:SeriesBPreferredStockMember CEAD:WarrantOneMember 2022-02-16 0001482541 us-gaap:WarrantMember 2022-02-14 2022-02-16 0001482541 us-gaap:WarrantMember 2022-02-16 0001482541 us-gaap:SeriesBPreferredStockMember 2022-02-16 0001482541 us-gaap:SeriesBPreferredStockMember 2022-02-15 0001482541 us-gaap:SeriesBPreferredStockMember CEAD:DecreaseInCommonStockConversionPriceMember 2022-02-16 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-01-03 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyTwoMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:JanuarySeventeernTwoThousandTwentyThreeMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-17 0001482541 CEAD:TwoDirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-12 2022-01-17 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-12 2022-01-17 0001482541 2021-12-29 0001482541 srt:BoardOfDirectorsChairmanMember 2021-12-31 0001482541 us-gaap:CommonStockMember 2022-02-14 2022-02-15 0001482541 us-gaap:WarrantMember 2022-02-15 0001482541 CEAD:UnderwritersMember us-gaap:WarrantMember 2022-02-14 2022-02-15 0001482541 CEAD:UnderwritersMember us-gaap:WarrantMember 2022-02-15 0001482541 CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandAndTwentyOneEquityPlanMember 2021-03-22 0001482541 CEAD:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001482541 CEAD:EmployeesMember CEAD:TwoThousandTwentyOneEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:DirectorsMember CEAD:TwoThousandTwentyOneEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:TwoThousandTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:RestrictedSharesIssuedMember CEAD:TwoThousandTwentyOneEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:NonQualifiedStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:IncentiveStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2022-03-31 0001482541 us-gaap:RestrictedStockUnitsRSUMember CEAD:IncentiveStockOptionMember CEAD:TwoThousandTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:EmployeesMember 2022-01-01 2022-03-31 0001482541 CEAD:ThreeNewEmployeesMember 2022-01-01 2022-03-31 0001482541 CEAD:CheifFinancialOfficerMember 2022-01-02 2022-03-30 0001482541 CEAD:OneFormerEmployeeMember 2022-01-01 2022-03-31 0001482541 CEAD:OneFormerEmployeeMember 2022-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesAndConsultantsMember 2022-01-01 2022-03-31 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanMember CEAD:EmployeesAndConsultantsMember 2021-01-01 2021-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-03-31 0001482541 srt:DirectorMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2021-01-01 2021-03-31 0001482541 srt:DirectorMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndTwentyOnePlanMember 2022-01-02 2022-01-03 0001482541 CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndTwentyOneEquityPlanMember 2022-01-02 2022-01-03 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityPlanMember 2022-01-16 2022-01-17 0001482541 CEAD:DirectorsMember CEAD:VestedMember CEAD:TwoThousandTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:DirectorsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandTwentyOneEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:DirectorsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2021-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2021-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2020-01-01 2020-12-31 0001482541 CEAD:DirectorsMember CEAD:NonQualifiedStockOptionsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2021-12-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:EmployeesAndConsultantsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:DirectorsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2021-12-31 0001482541 CEAD:DirectorsMember CEAD:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember 2022-03-31 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2021-12-31 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-01-01 2022-03-31 0001482541 CEAD:EmployeesDirectorsandConsultantsMember us-gaap:RestrictedStockUnitsRSUMember CEAD:TwoThousandAndSeventeenEquityPlanMember 2022-03-31 0001482541 CEAD:WarrantsRangeMember 2022-03-31 0001482541 CEAD:WarrantsRangeMember 2022-01-01 2022-03-31 0001482541 CEAD:WarrantsRangeOneMember 2022-03-31 0001482541 CEAD:WarrantsRangeOneMember 2022-01-01 2022-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2022-03-31 0001482541 CEAD:WarrantsRangeTwoMember 2022-01-01 2022-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2022-03-31 0001482541 CEAD:WarrantsRangeThreeMember 2022-01-01 2022-03-31 0001482541 CEAD:WarrantsRangeFourMember 2022-03-31 0001482541 CEAD:WarrantsRangeFourMember 2022-01-01 2022-03-31 0001482541 us-gaap:SeriesBPreferredStockMember CEAD:SecuritiesPurchaseAgreementMember 2021-09-26 2021-09-28 0001482541 us-gaap:SeriesBPreferredStockMember CEAD:SecuritiesPurchaseAgreementMember 2021-09-28 0001482541 srt:MaximumMember us-gaap:SeriesBPreferredStockMember CEAD:SecuritiesPurchaseAgreementMember 2021-09-28 0001482541 us-gaap:SeriesBPreferredStockMember CEAD:SecuritiesPurchaseAgreementMember 2021-09-27 2021-09-28 0001482541 CEAD:PlacementAgentWarrantsMember us-gaap:PrivatePlacementMember 2021-09-28 0001482541 CEAD:TwoThousandTwentyTwoInvestorWarrantsMember 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoInvestorWarrantsMember 2022-02-13 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoOverAllotmentWarrantsMember 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoOverAllotmentWarrantsMember 2022-02-13 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoOverAllotmentWarrantsMember 2022-02-10 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoUnderwriterWarrantsMember 2022-02-15 0001482541 CEAD:TwoThousandTwentyTwoUnderwriterWarrantsMember 2022-02-13 2022-02-15 0001482541 us-gaap:SeriesBPreferredStockMember 2022-02-12 2022-02-16 0001482541 us-gaap:CommonStockMember 2022-02-12 2022-02-16 0001482541 CEAD:SeriesBPreferredSharesPreFundedConversionWarrantsMember 2022-02-12 2022-02-16 0001482541 CEAD:SeriesBPreferredSharesPreFundedConversionWarrantsMember 2022-02-16 0001482541 CEAD:SeriesBPreferredSharesConversionWarrantsMember 2022-02-12 2022-02-16 0001482541 CEAD:SeriesBPreferredSharesConversionWarrantsMember 2022-02-16 0001482541 CEAD:SeriesBPreferredSharesConversionWarrantsMember 2022-02-15 0001482541 CEAD:ConsultingAgreementMember 2022-01-01 2022-03-31 0001482541 CEAD:TwentyOneEmployeesMember CEAD:EmploymentAgreementMember us-gaap:SubsequentEventMember 2022-03-29 2022-04-01 0001482541 CEAD:EmploymentAgreementMember us-gaap:SubsequentEventMember 2022-03-29 2022-04-01 0001482541 CEAD:EmploymentAgreementMember us-gaap:SubsequentEventMember 2022-04-01 iso4217:USD shares iso4217:USD shares utr:sqft pure 0001482541 false Q1 2022 --12-31 Yes Yes 10-Q true 2022-03-31 false 000-54286 CEA INDUSTRIES INC. NV 27-3911608 385 South Pierce Avenue Suite C Louisville CO 80027 80027 (303) 993-5271 Common Stock, $0.00001 par value CEAD NASDAQ Warrants to purchase common stock CEADW NASDAQ Non-accelerated Filer true false false 7784444 22033664 2159608 159744 181942 191002 179444 50762 1005918 378326 1774219 1273720 25055565 3991098 77239 77346 631064 631064 1830 1830 14747 14747 540444 565877 1265324 1290864 26320889 5281962 1389028 1345589 5485416 2839838 83625 83625 37078 37078 112072 100139 7107219 4406269 459482 486226 459482 486226 7566701 4892495 0.00001 0.00001 0 0 3300 3300 3960000 3960000 25000000 150000000 0.00001 0.00001 200000000 850000000 7784444 7784444 1600835 1600835 78 16 48958618 25211017 -30204508 -28781566 18754188 -3570533 26320889 5281962 1744427 2366529 1653919 2021923 90508 344606 251015 177145 138918 112638 1311777 740473 1701710 1030256 -1611202 -685650 185000 -107000 3260 -718 188260 -107718 -1422942 -793368 -1422942 -793368 35984 439999 -1898925 -793368 -0.41 -0.50 4622427 1576844 1600835 16 25211017 -28781566 -3570533 32938 32938 29656 29656 3367 0 24994 24994 4928 4928 6798 0 0 0 5811138 58 21711073 21711131 362306 4 1979996 1980000 -35984 -35984 -1422942 -1422942 7784444 78 48958618 -30204508 18754188 42030331 420 1576844 16 26107159 -27443643 -1336048 42030331 420 1576844 16 26107159 -27443643 -1336048 6667 67000 67000 128434 128434 6342 6342 -793368 -793368 42030331 420 1576844 16 6667 67000 26241935 -28237011 -1927640 42030331 420 1576844 16 6667 67000 26241935 -28237011 -1927640 -1422942 -793368 8556 18377 92517 6342 67000 -22168 3676 -4371 -5499 25433 49051 -10610 -6748 631269 187679 551261 1026765 43438 5354 2645579 2362905 718 -8061 -14811 -64672 52794 192857 484373 13948 12326 -13948 -12326 35984 1980000 21711131 514200 19695147 514200 19874056 986247 2159608 2284881 22033664 3271128 1980000 439999 <p id="xdx_80D_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_z21hrvtWHb7c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_827_zz5K4gUz7x1j">General</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--DescriptionOfBusinessPolicyTextBlock_z261SdR7Tj31" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Description of Business</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, some producers grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies include: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting and climate control, and (vi) preventive maintenance services for CEA facilities Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis or its related products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zrrkmnJ5vzsb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_z69NFWGbS7ki">Impact of the COVID-19 Pandemic on Our Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The resulting effects and uncertainties from the COVID-19 pandemic, including the depth and duration of the disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses and reduced operating cash flows in our business. During the three months ended March 31, 2022, the Company experienced significant delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain arising from the long-term effects of the COVID-19 pandemic. Consequently, our revenue recognition of these customer sales has been delayed until future periods when the shipment of these orders can be completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zlNsSZhJO7rc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zgOPtJw5XpF1">Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued. The Company continues to experience recurring losses since its inception. As a result, in order to continue as a going concern, the Company has been reliant on the ability to obtain additional sources of financing to fund growth. As indicated in Note 9 – Shareholders Equity (Deficit) below, on February 15, 2022, the Company received approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220214__20220215_zS8KW5LnPDO2" title="Proceeds from issuance of common stock">22,000,000</span> in proceeds from completion of an equity offering. Based on management’s evaluation, the proceeds from the Offering will be more than sufficient to fund any deficiencies in working capital or cash flow from operations, and the Company is confident that it will be able to meet its obligations as they come due, and fund operations for at least 12 months after the date the consolidated financial statements are available to be issued. Accordingly, the conditions around liquidity and limited working capital necessary to fund operations have been addressed.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><b><i>Interim Financial Statements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The balance sheet as of December 31, 2021 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_846_eus-gaap--ConsolidationPolicyTextBlock_zR90NWmBRT9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span id="xdx_866_zcbr8lfdxK41" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principles </i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>of Consolidation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--ReverseStockSplitPolicyTextBlock_zjIJ9IcczZyd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zvg66sTdG80l">Reverse Stock Split</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220331_zvS06s5sbqk4" title="Reverse stock split description">On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022</span>. The par value for the Common Stock was not affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding as of December 31, 2021, was reduced from <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20211230_zhzSF9Q2Aeyl"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20211230_zUGOp1kgZ46g">240,125,224</span></span> to <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20211231_zNqMSHikJ19l" title="Common stock issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zRQiHUFNJNB" title="Common stock outstanding">1,600,835</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--UseOfEstimates_z4f4GRr4yvYb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_znhGmXL6KQP6">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z160uEzNcpl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zPk4jWZCzDqf">Cash, Cash Equivalents and Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20220331_zfzhGB6EmMjc" title="Federal insured amount">250,000</span>. As of March 31, 2022, the balance in the Company’s account was approximately $<span id="xdx_90E_eus-gaap--Cash_iI_pp0p0_c20220331_z2QFkbQToiHi" title="Cash balance, amount">22,034,000</span>, consequently $<span id="xdx_906_eus-gaap--FederalDepositInsuranceCorporationPremiumExpense_pp0p0_c20220101__20220331_zpjLi8rHYsQ7" title="Federal deposit insurance corporation premium expense">21,784,000</span> of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zWjYro4WmwF7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zQimNyV2dUH9">Income (Loss) Per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022 and 2021, there were warrants and options outstanding to purchase Company common stock and shares of convertible preferred stock and restricted stock units that were convertible into shares of the Company’s common stock. During the three-month period ended March 31, 2022, the Company incurred a net loss and consequently the common share equivalents of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such inclusion would have been anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2022, and 2021, there were respectively, <span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_c20220101__20220331_zGvIOvbR0iu5" title="Potentially dilutive equity instruments that are convertible into common stock">8,021,057</span> and <span id="xdx_90D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_c20210101__20210331_zX79rwpAjVL9" title="Potentially dilutive equity instruments that are convertible into common stock">201,662</span>, potentially dilutive equity instruments outstanding in respect of shares of convertible preferred stock and warrants and options outstanding to purchase Company common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zQMQVjq8EEbl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zUnVsJ9mOurb">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators of impairment. Accordingly, the Company performed an interim impairment analysis at March 31, 2022 and concluded that no impairment relating to goodwill existed at March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--TemporaryEquityPolicyTextBlock_zVx6xbU2U4h1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zcOpwBYjbjgj">Temporary Equity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zDQ0YOqw5Yoa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zvYn05FcJOR2">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09 (Topic 606), <i>Revenue from Contracts with Customers</i> and all the related amendments (“ASC 606” or the “revenue standard”) to all contracts and elected the modified retrospective method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_zcNxO1Fke2e8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth the Company’s revenue by source:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zqABdPrXh2ml" style="display: none">Schedule of Revenue by Source</span></span></p> <table cellpadding="0" cellspacing="0" style="margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_498_20220101__20220331_z1CZsKBcQNPg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_492_20210101__20210331_zmQunTAvdIl7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zxgblojxKagg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Equipment and systems sales</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,642,572</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">2,163,468</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zq1msl7zcWM" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Engineering and other services</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">86,049</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">181,083</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zyKWbTVoxjmc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shipping and handling</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,806</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">21,978</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zS3sZfDod9Z1" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total revenue</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,744,427</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,366,529</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_8A2_zbBWOyHfPSn" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="text-decoration: underline">Revenue Recognition Accounting Policy Summary</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="text-decoration: underline">Other Judgments and Assumptions</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="text-decoration: underline">Contract Assets and Contract Liabilities</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company </span>receives payments from customers based on the terms established in its contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2022, and 2021, the Company had no contract assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to recognize revenue is generally less than one year. As of March 31, 2022, and December 31, 2021, deferred revenue, which was classified as a current liability, was $<span id="xdx_909_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20220331_zUFqgmDgK6V7">5,485,416</span> and $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20211231_z2Maiatpm2h6">2,839,838</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2022, the Company recognized revenue of $<span id="xdx_908_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220101__20220331_z9pSkYNco8ul" title="Revenue recognized">1,162,374</span> related to the deferred revenue at January 1, 2022. For the three months ended March 31, 2021, the Company recognized revenue of $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210331_zjRjycZo7bze" title="Revenue recognized">1,880,634</span> related to the deferred revenue at January 1, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2022, the Company’s remaining performance obligations, or backlog, was $<span id="xdx_90B_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20220331_zLHfuAFUeN8b" title="Revenue remaining performance obligation">11,179,000</span>.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2022, includes booked sales orders of $<span id="xdx_906_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20220331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zvB24X3PBiW9">2,217,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from several customers that the Company does not expect to be realized until 2023, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes that several of its current contracts may be delayed or canceled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zO5yBjE8iYz6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zcWqKVqfa9i9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zOnw2oJ0mB3e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zlUcQrCGz3d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220331_zBOYqZHi1T32" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_zr8ltAE3Jbg7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0617">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0618">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0619">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_z3TwSWiaxQ0a" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">8,962,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">2,217,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"/><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">11,179,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueRemainingPerformanceObligation_iI_zyFvgyTbBhfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,962,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,217,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,179,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zXdW8tW9RJ13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Product Warranty</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2022, and December 31, 2021, the Company had an accrued warranty reserve amount of $<span id="xdx_90B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20220331_zvzvo0G3GcW9">187,702</span> and $<span id="xdx_90D_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20211231_zzDl5b6jbch7">186,605</span>, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"/> <p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zhJVdbm0SHea" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zKltg7YYAhW6">Accounting for Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2022, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20220331__srt--RangeAxis__srt--MinimumMember_zr8u50FLrtje">158.21</span>% to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20220331__srt--RangeAxis__srt--MaximumMember_zULFB8WdTxjk">158.70</span>%; expected term in years 10 and risk-free interest rate ranged from <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20220331__srt--RangeAxis__srt--MinimumMember_zmmFbBcaJm9j">1.52</span>% to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20220331__srt--RangeAxis__srt--MaximumMember_zckd1COI5n3k">1.98</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zoUkYdabdR9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zHTAfvY2qhV" style="display: none">Schedule of Share-based Compensation Costs</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20220331_zT36mjwgzjW1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20210331_zjrMvXXglzWb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zRg1TeQXHhf5" style="vertical-align: bottom; background-color: White"> <td style="width: 60%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">791</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,135</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zgmAUyqCCCs7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,762</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,474</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zIloMxAWbzHa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0645"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,694</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zUEddlzGZPi6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">88,964</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,833</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zYn8e5imaZ3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">92,517</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">59,136</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_8A1_z74wOWQwLHk4" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in the expense for the three months ended March 31, 2021, is an accrual for $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zC9yRPDJEtE7">52,794</span> for the 2021 Annual Employee Incentive Compensation Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zoT13O9Izs6l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zrmdcDsgbyQa">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One customer accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zptBUS3tNZx5" title="Concentration risk percentage">35</span>% of the Company’s revenue for the three months ended March 31, 2022. Three customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zHcQPdCi4qRa" title="Concentration risk percentage">38</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zpfxu14rEP01" title="Concentration risk percentage">16</span>%, and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zLt61dwwoZEi" title="Concentration risk percentage">11</span>% of the Company’s revenue for the three months March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zrQcu5UiZfLj">44</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zNaG6bYcyCnc">19</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z7wfRvKTZvqb">16</span>% of the Company’s accounts receivable as of March 31, 2022. Two customers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zWRWUiB7QuZj" title="Concentration risk percentage">60</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zvPnjGUbcXKj" title="Concentration risk percentage">31</span>% of the Company’s accounts receivable as of March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zDZNWhLNTF3b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_ziMXSQHvCKI">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the FASB issued ASU 2021-04, <i>Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. </i>This guidance clarifies and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options due to a lack of explicit guidance in the FASB Codification. The guidance is effective for interim and annual periods beginning after December 15, 2021. Early adoption is permitted. The guidance is to be applied prospectively to modifications or exchanges occurring on or after the effective date. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FAS issued ASU No. 2020-04 “<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”).</i> ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--DescriptionOfBusinessPolicyTextBlock_z261SdR7Tj31" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Description of Business</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA Industries Inc., formerly Surna Inc. (the “Company”), was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (“CEA”) industry. The CEA industry is one of the fastest-growing sectors of the United States’ economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals, and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, some producers grow crops indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies include: (i) architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting and climate control, and (vi) preventive maintenance services for CEA facilities Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Louisville, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis or its related products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zrrkmnJ5vzsb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_z69NFWGbS7ki">Impact of the COVID-19 Pandemic on Our Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation, supply chain infrastructure, operating margins, and working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The resulting effects and uncertainties from the COVID-19 pandemic, including the depth and duration of the disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs in order to mitigate the impact of the COVID-19 pandemic to the best of our ability. However, these actions may not be sufficient in the long run to avoid reduced sales, increased losses and reduced operating cash flows in our business. During the three months ended March 31, 2022, the Company experienced significant delays in the receipt of equipment it had ordered to meet its customer orders due to disruption and delays in its supply chain arising from the long-term effects of the COVID-19 pandemic. Consequently, our revenue recognition of these customer sales has been delayed until future periods when the shipment of these orders can be completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zlNsSZhJO7rc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zgOPtJw5XpF1">Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are available to be issued. The Company continues to experience recurring losses since its inception. As a result, in order to continue as a going concern, the Company has been reliant on the ability to obtain additional sources of financing to fund growth. As indicated in Note 9 – Shareholders Equity (Deficit) below, on February 15, 2022, the Company received approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220214__20220215_zS8KW5LnPDO2" title="Proceeds from issuance of common stock">22,000,000</span> in proceeds from completion of an equity offering. Based on management’s evaluation, the proceeds from the Offering will be more than sufficient to fund any deficiencies in working capital or cash flow from operations, and the Company is confident that it will be able to meet its obligations as they come due, and fund operations for at least 12 months after the date the consolidated financial statements are available to be issued. Accordingly, the conditions around liquidity and limited working capital necessary to fund operations have been addressed.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><b><i>Interim Financial Statements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The balance sheet as of December 31, 2021 has been derived from the audited financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 22000000 <p id="xdx_846_eus-gaap--ConsolidationPolicyTextBlock_zR90NWmBRT9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span id="xdx_866_zcbr8lfdxK41" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Principles </i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>of Consolidation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiaries, Hydro Innovations, LLC (“Hydro”) and Surna Cultivation Technologies LLC (“SCT”). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--ReverseStockSplitPolicyTextBlock_zjIJ9IcczZyd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zvg66sTdG80l">Reverse Stock Split</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220331_zvS06s5sbqk4" title="Reverse stock split description">On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022</span>. The par value for the Common Stock was not affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding as of December 31, 2021, was reduced from <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20211230_zhzSF9Q2Aeyl"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20211230_zUGOp1kgZ46g">240,125,224</span></span> to <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20211231_zNqMSHikJ19l" title="Common stock issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zRQiHUFNJNB" title="Common stock outstanding">1,600,835</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. Such reverse stock split was implemented effective January 27, 2022 240125224 240125224 1600835 1600835 <p id="xdx_843_eus-gaap--UseOfEstimates_z4f4GRr4yvYb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_znhGmXL6KQP6">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z160uEzNcpl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zPk4jWZCzDqf">Cash, Cash Equivalents and Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount of $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20220331_zfzhGB6EmMjc" title="Federal insured amount">250,000</span>. As of March 31, 2022, the balance in the Company’s account was approximately $<span id="xdx_90E_eus-gaap--Cash_iI_pp0p0_c20220331_z2QFkbQToiHi" title="Cash balance, amount">22,034,000</span>, consequently $<span id="xdx_906_eus-gaap--FederalDepositInsuranceCorporationPremiumExpense_pp0p0_c20220101__20220331_zpjLi8rHYsQ7" title="Federal deposit insurance corporation premium expense">21,784,000</span> of this balance was not insured by the FDIC. The Company has not experienced any losses to date on depository accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 22034000 21784000 <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zWjYro4WmwF7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zQimNyV2dUH9">Income (Loss) Per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022 and 2021, there were warrants and options outstanding to purchase Company common stock and shares of convertible preferred stock and restricted stock units that were convertible into shares of the Company’s common stock. During the three-month period ended March 31, 2022, the Company incurred a net loss and consequently the common share equivalents of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such inclusion would have been anti-dilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2022, and 2021, there were respectively, <span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_c20220101__20220331_zGvIOvbR0iu5" title="Potentially dilutive equity instruments that are convertible into common stock">8,021,057</span> and <span id="xdx_90D_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_c20210101__20210331_zX79rwpAjVL9" title="Potentially dilutive equity instruments that are convertible into common stock">201,662</span>, potentially dilutive equity instruments outstanding in respect of shares of convertible preferred stock and warrants and options outstanding to purchase Company common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8021057 201662 <p id="xdx_847_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zQMQVjq8EEbl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zUnVsJ9mOurb">Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determined that it has one reporting unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators of impairment. Accordingly, the Company performed an interim impairment analysis at March 31, 2022 and concluded that no impairment relating to goodwill existed at March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--TemporaryEquityPolicyTextBlock_zVx6xbU2U4h1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zcOpwBYjbjgj">Temporary Equity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument will become redeemable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zDQ0YOqw5Yoa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zvYn05FcJOR2">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) 2014-09 (Topic 606), <i>Revenue from Contracts with Customers</i> and all the related amendments (“ASC 606” or the “revenue standard”) to all contracts and elected the modified retrospective method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_zcNxO1Fke2e8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth the Company’s revenue by source:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zqABdPrXh2ml" style="display: none">Schedule of Revenue by Source</span></span></p> <table cellpadding="0" cellspacing="0" style="margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_498_20220101__20220331_z1CZsKBcQNPg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_492_20210101__20210331_zmQunTAvdIl7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zxgblojxKagg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Equipment and systems sales</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,642,572</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">2,163,468</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zq1msl7zcWM" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Engineering and other services</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">86,049</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">181,083</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zyKWbTVoxjmc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shipping and handling</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,806</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">21,978</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zS3sZfDod9Z1" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total revenue</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,744,427</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,366,529</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_8A2_zbBWOyHfPSn" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="text-decoration: underline">Revenue Recognition Accounting Policy Summary</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the Company’s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer’s project life cycle from facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some of the Company’s contracts with customers contain a single performance obligation, typically engineering only services contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable input is the Company’s actual selling price for the same good or service, however, this input is generally not available for the Company’s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for consideration in an amount for which the Company expects to be entitled.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> The Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company’s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on historical warranty costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="text-decoration: underline">Other Judgments and Assumptions</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">The Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been collected and earned by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="text-decoration: underline">Contract Assets and Contract Liabilities</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. The Company </span>receives payments from customers based on the terms established in its contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject to completing a milestone, such as a phase of a project. The Company typically</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> does not have material amounts of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of March 31, 2022, and 2021, the Company had no contract assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of advance payments in excess of revenue recognized. The Company’s contract liabilities are recorded as a current liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to recognize revenue is generally less than one year. As of March 31, 2022, and December 31, 2021, deferred revenue, which was classified as a current liability, was $<span id="xdx_909_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20220331_zUFqgmDgK6V7">5,485,416</span> and $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20211231_z2Maiatpm2h6">2,839,838</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2022, the Company recognized revenue of $<span id="xdx_908_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20220101__20220331_z9pSkYNco8ul" title="Revenue recognized">1,162,374</span> related to the deferred revenue at January 1, 2022. For the three months ended March 31, 2021, the Company recognized revenue of $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210331_zjRjycZo7bze" title="Revenue recognized">1,880,634</span> related to the deferred revenue at January 1, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Remaining Performance Obligations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company’s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer’s cultivation facility project is dependent upon the customer’s ability to secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer’s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company’s recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2022, the Company’s remaining performance obligations, or backlog, was $<span id="xdx_90B_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20220331_zLHfuAFUeN8b" title="Revenue remaining performance obligation">11,179,000</span>.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> There is significant uncertainty regarding the timing of the Company’s recognition of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2022, includes booked sales orders of $<span id="xdx_906_eus-gaap--RevenueRemainingPerformanceObligation_iI_c20220331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zvB24X3PBiW9">2,217,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from several customers that the Company does not expect to be realized until 2023, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes that several of its current contracts may be delayed or canceled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zO5yBjE8iYz6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zcWqKVqfa9i9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zOnw2oJ0mB3e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zlUcQrCGz3d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220331_zBOYqZHi1T32" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_zr8ltAE3Jbg7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0617">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0618">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0619">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_z3TwSWiaxQ0a" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">8,962,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">2,217,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"/><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">11,179,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueRemainingPerformanceObligation_iI_zyFvgyTbBhfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,962,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,217,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,179,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zXdW8tW9RJ13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Product Warranty</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment. The Company’s warranty provides for the repair, rework, or replacement of products (at the Company’s option) that fail to perform within stated specification. The Company’s third-party suppliers also warrant their products under similar terms, which are passed through to the Company’s customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of March 31, 2022, and December 31, 2021, the Company had an accrued warranty reserve amount of $<span id="xdx_90B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20220331_zvzvo0G3GcW9">187,702</span> and $<span id="xdx_90D_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_c20211231_zzDl5b6jbch7">186,605</span>, respectively, which are included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"/> <p id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_zcNxO1Fke2e8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth the Company’s revenue by source:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zqABdPrXh2ml" style="display: none">Schedule of Revenue by Source</span></span></p> <table cellpadding="0" cellspacing="0" style="margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_498_20220101__20220331_z1CZsKBcQNPg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_492_20210101__20210331_zmQunTAvdIl7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zxgblojxKagg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Equipment and systems sales</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,642,572</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">2,163,468</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_zq1msl7zcWM" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Engineering and other services</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">86,049</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">181,083</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zyKWbTVoxjmc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Shipping and handling</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,806</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">21,978</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zS3sZfDod9Z1" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total revenue</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,744,427</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,366,529</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> 1642572 2163468 86049 181083 15806 21978 1744427 2366529 5485416 2839838 1162374 1880634 11179000 2217000 <p id="xdx_893_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zO5yBjE8iYz6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations expected to be recognized through 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zcWqKVqfa9i9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Remaining Performance Obligations Expected to be Recognized</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zOnw2oJ0mB3e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220331__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyThreeMember_zlUcQrCGz3d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220331_zBOYqZHi1T32" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_zr8ltAE3Jbg7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining performance obligations related to engineering only paid contracts</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0617">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0618">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0619">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_z3TwSWiaxQ0a" style="vertical-align: bottom; background-color: White"> <td style="width: 46%; text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">8,962,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">2,217,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"/><td style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right">11,179,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueRemainingPerformanceObligation_iI_zyFvgyTbBhfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,962,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,217,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,179,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 8962000 2217000 11179000 8962000 2217000 11179000 187702 186605 <p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zhJVdbm0SHea" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zKltg7YYAhW6">Accounting for Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected to be lower than initially expected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the “Black-Scholes Model”). The Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. During the three months ended March 31, 2022, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20220331__srt--RangeAxis__srt--MinimumMember_zr8u50FLrtje">158.21</span>% to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20220331__srt--RangeAxis__srt--MaximumMember_zULFB8WdTxjk">158.70</span>%; expected term in years 10 and risk-free interest rate ranged from <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20220331__srt--RangeAxis__srt--MinimumMember_zmmFbBcaJm9j">1.52</span>% to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20220331__srt--RangeAxis__srt--MaximumMember_zckd1COI5n3k">1.98</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly different forfeiture expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 27.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zoUkYdabdR9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zHTAfvY2qhV" style="display: none">Schedule of Share-based Compensation Costs</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20220331_zT36mjwgzjW1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20210331_zjrMvXXglzWb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zRg1TeQXHhf5" style="vertical-align: bottom; background-color: White"> <td style="width: 60%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">791</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,135</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zgmAUyqCCCs7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,762</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,474</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zIloMxAWbzHa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0645"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,694</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zUEddlzGZPi6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">88,964</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,833</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zYn8e5imaZ3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">92,517</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">59,136</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_8A1_z74wOWQwLHk4" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included in the expense for the three months ended March 31, 2021, is an accrual for $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zC9yRPDJEtE7">52,794</span> for the 2021 Annual Employee Incentive Compensation Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1.5821 1.5870 0.0152 0.0198 <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zoUkYdabdR9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zHTAfvY2qhV" style="display: none">Schedule of Share-based Compensation Costs</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20220331_zT36mjwgzjW1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20210331_zjrMvXXglzWb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31,</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Share-based compensation expense included in:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zRg1TeQXHhf5" style="vertical-align: bottom; background-color: White"> <td style="width: 60%">Cost of revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">791</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,135</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zgmAUyqCCCs7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advertising and marketing expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,762</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,474</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zIloMxAWbzHa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product development costs</td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0645"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,694</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zUEddlzGZPi6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">88,964</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,833</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_zYn8e5imaZ3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">92,517</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">59,136</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 791 14135 2762 6474 6694 88964 31833 92517 59136 52794 <p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zoT13O9Izs6l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zrmdcDsgbyQa">Concentrations</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One customer accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zptBUS3tNZx5" title="Concentration risk percentage">35</span>% of the Company’s revenue for the three months ended March 31, 2022. Three customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zHcQPdCi4qRa" title="Concentration risk percentage">38</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zpfxu14rEP01" title="Concentration risk percentage">16</span>%, and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zLt61dwwoZEi" title="Concentration risk percentage">11</span>% of the Company’s revenue for the three months March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zrQcu5UiZfLj">44</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zNaG6bYcyCnc">19</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z7wfRvKTZvqb">16</span>% of the Company’s accounts receivable as of March 31, 2022. Two customers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zWRWUiB7QuZj" title="Concentration risk percentage">60</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zvPnjGUbcXKj" title="Concentration risk percentage">31</span>% of the Company’s accounts receivable as of March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.35 0.38 0.16 0.11 0.44 0.19 0.16 0.60 0.31 <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zDZNWhLNTF3b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_ziMXSQHvCKI">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which requires companies to apply ASC 606, “Revenue from Contracts with Customers” to recognize and measure contract assets and contract liabilities from contracts with customers acquired in a business combination. This creates an exception to the general recognition and measurement principle in ASC 805, which uses fair value. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early adoption is permitted, and the guidance should be applied prospectively. The impact of the standard on Company’s consolidated financial statements is dependent on the size and frequency of any future acquisitions the Company may complete.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the FASB issued ASU 2021-04, <i>Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. </i>This guidance clarifies and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options due to a lack of explicit guidance in the FASB Codification. The guidance is effective for interim and annual periods beginning after December 15, 2021. Early adoption is permitted. The guidance is to be applied prospectively to modifications or exchanges occurring on or after the effective date. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FAS issued ASU No. 2020-04 “<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”).</i> ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_zzxDzf6nbpcj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – <span id="xdx_821_zJjRVsLAXvZh">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016 the FASB issued ASU 2016-02, <i>Leases (Topic 842) </i>(“ASC 842” or the “new lease standard”). The Company adopted ASC 842 as of January 1, 2019, using the effective date method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The new standard provides a number of optional practical expedients in transition. The Company has elected to apply the “package of practical expedients” which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2021, the Company entered into an agreement to lease <span id="xdx_90A_eus-gaap--AreaOfLand_iI_uSquareFoot_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zaXc3WijqPpf" title="Area of land">11,491</span> square feet of office and manufacturing space (the “New Facility Lease”), in Louisville, CO. <span id="xdx_90B_eus-gaap--LesseeOperatingLeaseDescription_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_ze4CWEG4jM1i" title="Operating lease term description">The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027</span>. From November 2021 through January 2022, the monthly rent was abated. Beginning February 2022, the monthly rent is $<span id="xdx_901_eus-gaap--PaymentsForRent_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zrPWuH1PKOwd" title="Lease rental expense">10,055</span> and will increase by <span id="xdx_90F_ecustom--IncreaseInRentPercent_pid_dp_uPure_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zPQdVv6C4vYk" title="Increase in rent percent">3</span>% annually every November through the end of the New Facility Lease term. Pursuant to the New Facility Lease, the Company made a security deposit of $<span id="xdx_90C_eus-gaap--SecurityDeposit_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_z2jDknlAXx3f" title="Security deposit">14,747</span>. The Company has the option to renew the New Facility Lease for an additional five years. Additionally, the Company pays the actual amounts for property taxes, insurance, and common area maintenance. The New Facility Lease agreement contains customary events of default, representations, warranties, and covenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon commencement of the New Facility Lease, the Company recognized on the balance sheet an operating lease right-of-use asset and lease liability in the amount of $<span id="xdx_90E_eus-gaap--OperatingLeaseLiability_iI_c20210728__us-gaap--TypeOfArrangementAxis__custom--NewFacilityLeaseMember_zql1bBeznCpa" title="Present value of minimum lease payments">582,838</span>. The lease liability was initially measured as the present value of the unpaid lease payments at commencement and the ROU asset was initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The renewal option to extend the New Facility Lease is not included in the right-of-use asset or lease liability, as the option is not reasonably certain to be exercised. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period in its lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zXZb2UQ6rAXi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zg5aAGk9vSug" style="display: none">Schedule of Lease Cost</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220331_z210FC91tRte" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of March 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zj0lEAxSRI69" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating lease right-of-use asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">540,444</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zbZ1FHK9pcLi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating lease liability, current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">112,072</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zGw7joRDjG61" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability, long-term</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">459,482</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220331_zGFdqWITEbk" title="Remaning lease term">4.8</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20220331_zelBwcHpM6r7" title="Discount rate">3.63</span></td><td style="text-align: left">%</td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Three</b></span></p> <p style="margin-top: 0; margin-bottom: 0">Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31, 2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 76%">Operating cash outflow from operating lease</td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td id="xdx_98C_eus-gaap--OperatingLeasePayments_c20220101__20220331_zYSZ7pdKAX2i" style="text-align: right; width: 20%" title="Operating cash outflow from operating lease">20,109</td><td style="text-align: left; width: 1%"> </td></tr> </table> <p id="xdx_8AF_zmAhczc4SsSk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zimdWketdHMk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future annual minimum lease payments on the Facility Lease as of March 31, 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B4_z1ctsVWb7Edh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Future Annual Minimum Lease Payments</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_494_20220331_zjfxsNAkVAog" style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzNo0_zmE9bCryS5Jf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022 (excluding the three months ended March 31, 2022)</span></td><td style="width: 2%; text-align: left"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">91,095</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzNo0_zf6rvS7ySIT3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2023</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">124,897</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzNo0_z7K0qv4Vcid6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2024</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">128,643</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzNo0_zHX6C72DXJb" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2025</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">132,503</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzNo0_ziMXok0dauui" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2026</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">136,473</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_iI_pp0p0_maLOLLPzNo0_zTkT9i4Ac2Je" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzNo0_zY9IsRVqtrK1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total minimum lease payments</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">625,265</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zSZLqNXJfch6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less imputed interest</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(53,710</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of minimum lease payments </span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">571,555</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zlR3FyoWeR01" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 11491 The New Facility Lease commenced on November 1, 2021 and continues through January 31, 2027 10055 0.03 14747 582838 <p id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zXZb2UQ6rAXi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zg5aAGk9vSug" style="display: none">Schedule of Lease Cost</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220331_z210FC91tRte" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of March 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseRightOfUseAsset_iI_zj0lEAxSRI69" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating lease right-of-use asset</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">540,444</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_iI_zbZ1FHK9pcLi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating lease liability, current</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">112,072</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zGw7joRDjG61" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability, long-term</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">459,482</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220331_zGFdqWITEbk" title="Remaning lease term">4.8</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Discount rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20220331_zelBwcHpM6r7" title="Discount rate">3.63</span></td><td style="text-align: left">%</td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Three</b></span></p> <p style="margin-top: 0; margin-bottom: 0">Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">March 31, 2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 76%">Operating cash outflow from operating lease</td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td id="xdx_98C_eus-gaap--OperatingLeasePayments_c20220101__20220331_zYSZ7pdKAX2i" style="text-align: right; width: 20%" title="Operating cash outflow from operating lease">20,109</td><td style="text-align: left; width: 1%"> </td></tr> </table> 540444 112072 459482 P4Y9M18D 0.0363 20109 <p id="xdx_89E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zimdWketdHMk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future annual minimum lease payments on the Facility Lease as of March 31, 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B4_z1ctsVWb7Edh" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Future Annual Minimum Lease Payments</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify; font-weight: bold">Years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_494_20220331_zjfxsNAkVAog" style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_maLOLLPzNo0_zmE9bCryS5Jf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022 (excluding the three months ended March 31, 2022)</span></td><td style="width: 2%; text-align: left"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">91,095</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzNo0_zf6rvS7ySIT3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2023</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">124,897</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzNo0_z7K0qv4Vcid6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2024</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">128,643</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzNo0_zHX6C72DXJb" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">2025</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">132,503</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzNo0_ziMXok0dauui" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2026</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">136,473</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_iI_pp0p0_maLOLLPzNo0_zTkT9i4Ac2Je" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzNo0_zY9IsRVqtrK1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total minimum lease payments</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">625,265</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zSZLqNXJfch6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less imputed interest</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(53,710</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of minimum lease payments </span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">571,555</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 91095 124897 128643 132503 136473 11654 625265 53710 571555 <p id="xdx_809_eus-gaap--InventoryDisclosureTextBlock_zd6j6Wj4jIvh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3 – <span id="xdx_823_zFpKbk38WgH8">Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrPriNrjJpzf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zyNsY9SHCwe5" style="display: none">Schedule of Inventory</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20220331_zmjhKbavS5kk" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20211231_zv8xWc6VIY2d" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzlUp_zJPrV5mco7ye" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finished goods</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">913,887</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">272,199</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzlUp_zkGugnTZ5Jmg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">971</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,050</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzlUp_zj9Z0q66bxq" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">186,115</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">196,456</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzlUp_znHovVyoqnNi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95,055</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(91,379</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--InventoryNet_iTI_pp0p0_mtINzlUp_zfcjT4mKBtJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,005,918</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">378,326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_z5uedFp5q5Hg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overhead expenses of $<span id="xdx_90F_eus-gaap--CostOfGoodsAndServicesSoldOverhead_pp0p0_c20220101__20220331_zYFTryQzAWLa" title="Overhead expenses">16,555</span> and $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldOverhead_pp0p0_c20210101__20211231_zyrTKSRxCWk8" title="Overhead expenses">13,589</span> were included in the inventory balance as of March 31, 2022, and December 31, 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The inventory balance at March 31, 2022 includes $<span id="xdx_90E_eus-gaap--OtherInventoryInTransit_iI_c20220331_znqG1v2rE1pb" title="Inventory in transit">692,195</span> for inventory in transit from one of our suppliers that was delivered to our customer in April of 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included approximately $<span id="xdx_902_ecustom--PrepaidInventoryExpenses_iI_c20220331_zgphshesHw4" title="Prepaid inventory expenses">1,579,000</span> and $<span id="xdx_90F_ecustom--PrepaidInventoryExpenses_iI_c20211231_zMdwesufwtuc" title="Prepaid inventory expenses">1,069,000</span> in advance payments for inventory for the periods ended March 31, 2022, and December 31, 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrPriNrjJpzf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zyNsY9SHCwe5" style="display: none">Schedule of Inventory</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20220331_zmjhKbavS5kk" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20211231_zv8xWc6VIY2d" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzlUp_zJPrV5mco7ye" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Finished goods</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">913,887</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">272,199</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzlUp_zkGugnTZ5Jmg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">971</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,050</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzlUp_zj9Z0q66bxq" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">186,115</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">196,456</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzlUp_znHovVyoqnNi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95,055</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(91,379</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--InventoryNet_iTI_pp0p0_mtINzlUp_zfcjT4mKBtJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Inventory, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,005,918</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">378,326</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 913887 272199 971 1050 186115 196456 95055 91379 1005918 378326 16555 13589 692195 1579000 1069000 <p id="xdx_80D_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zYs7TJjwNu76" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 – <span id="xdx_827_zWnDUsAKO35g">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--PropertyPlantAndEquipmentTextBlock_zUxX8Sba4Jjk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zLZVCtZSs8k5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Property and Equipment</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_492_20220331_zOwZnFn2Mcsd" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20211231_zELRHxv8drx3" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsNNtaR9Fotf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Furniture and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">271,056</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">274,472</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z0ucu74gzki2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Vehicles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zu8I1IdtcGFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0761"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0762"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzCtH_zRvenXCPvx4c" style="vertical-align: bottom; background-color: White"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">286,056</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">289,472</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzCtH_zKVIZc0mRrea" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(208,817</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(212,126</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzCtH_zfcMLKoLwlYa" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,239</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,346</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zM4hJgt7ztnd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense was $<span id="xdx_906_eus-gaap--Depreciation_pp0p0_c20220101__20220331_z82DwkZWVgpa" title="Depreciation expenses">8,556</span> for the three months ended March 31, 2022. For the three months ended March 31, 2022, $<span id="xdx_903_eus-gaap--Depreciation_c20220101__20220331__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zMPcvwbza2ul" title="Depreciation">1,214</span> was allocated to cost of sales, $<span id="xdx_90F_eus-gaap--Depreciation_c20220101__20220331__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_z29quz08HL91" title="Depreciation expenses">304</span> was allocated to inventory with the remainder recorded as selling, general, and administrative expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--PropertyPlantAndEquipmentTextBlock_zUxX8Sba4Jjk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zLZVCtZSs8k5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Property and Equipment</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_492_20220331_zOwZnFn2Mcsd" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20211231_zELRHxv8drx3" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsNNtaR9Fotf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Furniture and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">271,056</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">274,472</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z0ucu74gzki2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Vehicles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zu8I1IdtcGFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0761"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0762"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzCtH_zRvenXCPvx4c" style="vertical-align: bottom; background-color: White"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">286,056</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">289,472</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzCtH_zKVIZc0mRrea" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(208,817</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(212,126</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzCtH_zfcMLKoLwlYa" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,239</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,346</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 271056 274472 15000 15000 286056 289472 208817 212126 77239 77346 8556 1214 304 <p id="xdx_804_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z6FAffqRsV93" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 – <span id="xdx_824_zB4oArjsuSQc">Accounts Payable and Accrued Liabilities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zx6JT3pEtbHh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_ziNUfsaJHDy4" style="display: none; font-size: 10pt">Schedule of Accounts Payable and Accrued Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_496_20220331_zPmXXRGCZ8Aa" style="font-weight: bold; text-align: center">March 31,</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_492_20211231_zPl9RHgLne7l" style="text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzWYF_zQ7zfN7x1sdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">729,040</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">616,056</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzWYF_zvPoeWxbB113" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales commissions payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,107</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,592</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzWYF_zgheIvhNcnPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued payroll liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266,456</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">322,873</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzWYF_zrYmoS6Pbu6g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product warranty accrual</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,702</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">186,605</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzWYF_zUUsWw6Nohj6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">196,723</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">192,463</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzWYF_zWBeBShqxKYf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,389,028</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,345,589</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zx6JT3pEtbHh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_ziNUfsaJHDy4" style="display: none; font-size: 10pt">Schedule of Accounts Payable and Accrued Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_496_20220331_zPmXXRGCZ8Aa" style="font-weight: bold; text-align: center">March 31,</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_492_20211231_zPl9RHgLne7l" style="text-align: center; font-weight: bold">December 31,</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzWYF_zQ7zfN7x1sdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">729,040</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">616,056</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzWYF_zvPoeWxbB113" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales commissions payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,107</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,592</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzWYF_zgheIvhNcnPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued payroll liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266,456</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">322,873</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzWYF_zrYmoS6Pbu6g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product warranty accrual</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,702</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">186,605</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzWYF_zUUsWw6Nohj6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">196,723</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">192,463</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzWYF_zWBeBShqxKYf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,389,028</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,345,589</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 729040 616056 9107 27592 266456 322873 187702 186605 196723 192463 1389028 1345589 <p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zG5HyWfN64x2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 – <span id="xdx_82C_zDS0BjIhto54">Note Payable and Accrued Interest</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2021, the Company entered into a note payable with its current bank in the principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210210_zvdD1rstXny5" title="Note payable principal amount">514,200</span>, for working capital purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The loan amount bears interest at <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210210_zWdT9jbuOIp8" title="Loan interest rate">1</span>% and is due on <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20210209__20210210_zW8cYNFSHbh2" title="Loan due date">February 5, 2026</span>. The loan may be repaid in advance without penalty. The loan is also potentially forgivable in full provided proceeds are used for payment of payroll expenses, rent, utilities and mortgage interest and certain other terms and conditions are met. If any portion of the loan is not forgiven, payments will commence 10 months following the end of the 24-week deferral period. The loan has typical default provisions, including for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 30, 2021, the Company received notice from the bank that its loan received on February 10, 2021, in the principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211130_zDXvOmQgjSgk">514,200</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and all accrued interest of $<span id="xdx_902_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20211129__20211130_zzETi6xBKEuh">2,832</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, was fully forgiven. This gain on loan forgiveness was recorded as Other Income in the Statement of Operations during the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 514200 0.01 2026-02-05 514200 2832 <p id="xdx_80D_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zmfZ7hgK8Gre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – <span id="xdx_824_zXDlXi2eNXTb">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company settled a litigation with a former employee effective March 30, 2021, which included the issuance of <span id="xdx_90A_ecustom--CommonSharesIssuedInSettlementOfLegalDisputeShares_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuIEnvE2t9Hb" title="Common shares issued in settlement of legal dispute, shares">6,667</span> shares of common stock of the Company, as part of the settlement. These shares were issued on April 8, 2021, as “restricted securities,” subject to a lock-up agreement of six months, without registration rights, and pursuant to a private placement exemption. The settlement agreement also included mutual releases and no admission of liability. The cost to the Company of this settlement, $<span id="xdx_902_eus-gaap--LitigationSettlementExpense_c20220101__20220331__us-gaap--IncomeStatementLocationAxis__us-gaap--OtherExpenseMember_zWRqMfaOprM6" title="Cost of settelement">107,000</span>, in total, has been recognized in full in Other Expenses during the year ended December 31, 2021. The issuance of the <span id="xdx_907_ecustom--CommonSharesIssuedInSettlementOfLegalDisputeShares_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLY51vicp8H9" title="Common shares issued in settlement of legal dispute, shares">6,667</span> shares of common stock (valued at $<span id="xdx_90F_ecustom--CommonSharesIssuedInSettlementOfLegalDispute_c20220101__20220331_zCa9sUHchcz7" title="Common shares issued in settlement of legal dispute, value">67,000</span>) has been recognized in common stock issued during the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leases</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a lease agreement for its manufacturing and office space. Refer to <i>Note 2 Leases</i> above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other Commitments</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6667 107000 6667 67000 <p id="xdx_80E_ecustom--TemporaryEquityTextBlock_zIEAzCp8z9Bj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8 – <span id="xdx_829_zDhDVJF4d948">Temporary Equity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 28, 2021, the Company sold to an institutional investor (the “Investor”), <span id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zed6BxM3nC6k">3,300 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”), stated value $<span id="xdx_90E_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zaAKt92XbuR4">1,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, convertible into </span> shares of common stock, for an aggregate purchase price of $<span id="xdx_909_eus-gaap--TemporaryEquityAggregateAmountOfRedemptionRequirement_iI_pp0p0_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zW45h9AHnRN">3,000,000 </span>(“Consideration”). The Company received net proceeds of approximately $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pp0p0_c20210926__20210928_zXS8cXDyEhY7">1,260,000 </span>on September 28, 2021, and the balance of approximately $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_pp0p0_c20211101__20211104_zXH2fO8V1U1b">1,365,000 </span>on November 4, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series B Preferred Stock had an annual dividend of <span id="xdx_904_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zLoHsGccsoQ5" title="Dividend rate percentage">8</span>% and an initial common stock conversion price of $<span id="xdx_900_eus-gaap--CommonStockConvertibleConversionPriceIncrease_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zDgqNdvtjqac" title="Conversion price">8.55</span>. The conversion rate was subject to adjustment in various circumstances, including stock splits, stock dividends, pro rata distributions, fundamental transactions and upon a triggering event and subject to reset if the common stock of the Company sold in any subsequent equity transaction, including a qualified offering, was sold at a price below the then conversion price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series B Preferred Stock was mandatorily convertible on the third anniversary of its issuance. All conversions of the Series B Preferred Stock were subject to a blocker provision of <span id="xdx_90D_ecustom--PercentageOfPreferredStockConversionProvision_pid_dp_uPure_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zbeZxGh0GLs8" title="Dividend rate percentage">4.99</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probability of Redemption: As it was considered probable the Series B Preferred stock would become redeemable outside of the Company’s control, the Series B Preferred stock was disclosed as temporary equity and was initially adjusted as of September 30, 2021 to its redemption value of <span id="xdx_90E_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20210927__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zWMELviWMZnb">120</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the stated value of $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleLiquidationPreferencePerShare_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zQAidq9mNmz9">1,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, or $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleLiquidationPreferenceValue_iI_pp0p0_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_ztlOPCecCvj">3,960,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. As a result, the Company recorded a $<span id="xdx_902_ecustom--TemporaryEquityNonCashRedemptionValueAdjustment_pp0p0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zO9O52wQWqAa">2,262,847 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-cash redemption value adjustment during 2021. This redemption value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes; accordingly, the redemption value adjustment is therefore added to the “Net Loss” to arrive at “Net Loss Attributable to Common Shareholders<span style="background-color: white">”</span> on the Company’s Consolidated Statements of Operations. In addition, since the Company did not have a balance of retained earnings, the redemption value adjustment was recorded against additional paid-in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 16, 2022, the Company redeemed <span id="xdx_90F_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20220214__20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zdZSjBtUnk43">1,650 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its Series B Preferred Stock for payment of $<span id="xdx_900_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn3n6_c20220214__20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z9xY8elZZ0uk">2.016 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in cash, which included both principal and accrued dividends of approximately $<span id="xdx_903_eus-gaap--Dividends_c20220214__20220216_zD3TZmtLQTPg" title="Dividends">36,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 16, 2022, the remaining <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20220214__20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z5tm58zM4Mgk">1,650 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s Series B Preferred Stock were converted into <span id="xdx_909_eus-gaap--ConversionOfStockSharesConverted1_c20220214__20220216__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zIO3I6GLst54">362,306 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock and <span id="xdx_901_eus-gaap--ConversionOfStockSharesConverted1_c20220214__20220216__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zXRDYMDJedIb">703,069 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants; <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20220214__20220216__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember__us-gaap--AwardTypeAxis__custom--IndefiniteTermMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zPWk1enQY1I7">170,382 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the warrants vested immediately, have an indefinite term and an exercise price of $<span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceOfWarrantsVested_iI_c20220216__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember__us-gaap--AwardTypeAxis__custom--IndefiniteTermMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zBbdaEeOwzti">0.01 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(“pre-funded conversion warrants”),</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> the balance of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20220214__20220216__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdLUn7lYiOJi">532,688 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants also vested immediately, have a term of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20220214__20220216__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6QLV6zSP8Z2">5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and have an exercise price of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20220216__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zF5XdC2ChBN6">5.00</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The initial common stock conversion price for the shares of Series B Preferred Stock was $<span id="xdx_909_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zEXCSXjFI4Ph">8.55</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. However, the terms of the Series B preferred stock were such that the stock conversion price was to be reduced to <span id="xdx_900_ecustom--ConversionPriceReducedOfferingPricePercentage_c20220214__20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zXa8IZsc3Orl">75% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the offering price in any subsequent qualified public offering of Company equity instruments, if lower than the common stock conversion price of $<span id="xdx_907_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z7ERJWS12mY">8.55</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company’s public offering that closed on February 15, 2022, was completed at an offering price of $<span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20220215__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z1OypyHhYBWi">4.13</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Accordingly, the initial common stock conversion price for the shares of Series B Preferred Stock was reduced from $<span id="xdx_903_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zTKoG4Royngl">8.55 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to $<span id="xdx_90E_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DecreaseInCommonStockConversionPriceMember_zhxenqTRqqgc">3.0975</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, representing <span id="xdx_908_ecustom--ConversionPriceReducedOfferingPricePercentage_c20220214__20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zZlNAZaWlYfk">75% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the offering price of $<span id="xdx_90F_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20220215__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVcMAJ1lKdXd">4.13</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. As a result, the Company recognized a deemed dividend of $<span id="xdx_905_ecustom--DeemedDividendPreferredStockOnDownRound_c20220101__20220331_zGHBcBMaKUua">439,999 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to Series B Shareholders in respect of the additional shares of common stock and warrants they received on the conversion of their shares of Series B Preferred stock. As the Company does not have a balance of retained earnings, the deemed dividend was recorded against additional paid-in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has no remaining Preferred Shares outstanding as of March 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3300 1000 3000000 1260000 1365000 0.08 8.55 0.0499 1.20 1000 3960000 2262847 1650 2016000.000 36000 1650 362306 703069 170382 0.01 532688 P5Y 5.00 8.55 0.75 8.55 4.13 8.55 3.0975 0.75 4.13 439999 <p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z9hKQaNe6uTl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9 – <span id="xdx_82A_zkknSsbHWbY1">Stockholders’ Equity (Deficit)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Directors Remuneration</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, the Company issued <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20220101__20220103__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zjTbpWIvmYd8" title="Number of stock options issued">3,125</span> non-qualified stock options under the 2021 Equity Incentive Plan to each of two existing directors. The options had an exercise price of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220103__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z33IyDktxeg7" title="Exercise price">4.80</span>, vested immediately and had a term ending at the earlier of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dc_c20220101__20220103__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_znPLaNELBSU2">five years</span> after the date on which the optionee’s continuous service ends, or the tenth anniversary on which the option was granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022, the Company issued an RSU grant of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zuwW0Lf6bTXi" title="Number of stock options issued">3,367</span> shares of common stock 2021 Equity Incentive Plan to each of two new directors, <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyTwoMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zjBaPas44gj8" title="Shares, granted">1,684</span> shares of common stock vested immediately on grant date and the remaining <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__us-gaap--AwardDateAxis__custom--JanuarySeventeernTwoThousandTwentyThreeMember_zt0tmhKrQFtb" title="Shares, granted">1,683</span> shares of common stock will vest on January 17, 2023, if the recipient remains in service as an independent director. <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220112__20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--TwoDirectorsMember_zyPVqaMEhq5b" title="Shares, vested">1,684</span> shares of common stock were issued to each of the two new directors in settlement of the RSUs that vested immediately.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revised Compensation Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022, the Board of Directors revised the previously adopted compensation plan. This plan supersedes the plan adopted on August 20, 2021. The Plan is effective retroactively for the current independent directors and for independent directors elected or appointed after the Effective Date. <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220112__20220117__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_zvzDgdF3Nh16" title="Number of shares issued during the period">3,367</span> restricted stock units in respect of this plan were issued on January 17, 2022. Cash fees were paid on January 21, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse Stock Split</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022, the Company’s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty. The reverse stock split was implemented effective January 27, 2022. The par value for the Common Stock was not affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of this reverse stock split, the number of the Company’s shares of common stock issued and outstanding at December 31, 2021 was reduced from <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_pid_c20211229_zcqJmmh9KaT1" title="Common stock, shares issued"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211229_zfv3b16ADn3a" title="Common stock, shares outstanding">240,125,244</span></span> to <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231_zLiYdBb6zrYj" title="Common stock, shares issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_zZlIluW4AdUj" title="Common stock, shares outstanding">1,600,835</span></span>. All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change in Authorized Share Capital</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the aforementioned reverse stock split, the Company’s Board of Directors approved the reduction of the authorized capital of the Company to <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_z6FeamIStF6d" title="Common stock, shares authorized">200,000,000</span> shares of common stock and <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_ztkKwIH5WYY" title="Preferred stock, shares authorized">25,000,000</span> shares of preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity Raise</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2022, the Company signed a firm commitment underwriting agreement for the public offering of shares of common stock and warrants, which closed on February 15, 2022. The Company received net proceeds of approximately $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn6n6_c20220214__20220215_zcJuOMK9IDic" title="Net proceeds from sale of common stock">22</span> million for the sale of <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEAoTRS4YUbf" title="Net proceeds from sale of common stock">5,811,138</span> shares of common stock and <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220214__20220215_zhehtyTh6Fz6" title="Number of shares sold">6,572,808 </span>warrants, each warrant to purchase one share of common stock for <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dt_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zv0YgHIHeTib" title="Warrant term">five years</span>, exercisable immediately, at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zG0Bd6JWk14k" title="Exercise price, per share">5.00</span>. The Company also issued to the representative of the underwriters <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220214__20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z1yr8LhZc0ti" title="Stock issued during period, shares, issued for services">290,557</span> warrants, each warrant to purchase one share of common stock at an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z3wUZndcQMh2" title="Exercise price">5.1625</span>, during the period commencing August 9, 2022, and expiring on <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20220215__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zR3J7v9v8FM2" title="Warrants maturity date">February 10, 2027</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2022, the Company had <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20220331_z8CJUJVQRW75" title="Common stock, shares authorized">200,000,000</span> shares authorized at a $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220331_zSRnXxRXqkh4" title="Par value">.00001</span> par value. Effective March 31, 2022, <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20220331_z2spS1vfhJF8" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_c20220331_zdgVMUxPvmze" title="Common stock, shares outstanding">7,784,444</span></span> shares of common stock were issued and outstanding. <span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_do_c20220331_zMbEn3s94NMg" title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20220331_zR3vmkDK9JLe" title="Preferred stock, shares outstanding">No</span></span> shares of preferred stock are issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3125 4.80 P5Y 3367 1684 1683 1684 3367 240125244 240125244 1600835 1600835 200000000 25000000 22000000 5811138 6572808 P5Y 5.00 290557 5.1625 2027-02-10 200000000 0.00001 7784444 7784444 0 0 <p id="xdx_800_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zOOJxylOaIHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10 – <span id="xdx_820_zTmJL2bZHUYg">Equity Incentive Plans</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2017 Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zaSc0IlDr7ra" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Purchased for Award">333,333</span> shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, no shares or options were issued and <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20220331_zJMneyN0HoRl" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period">13,333</span> options were cancelled under the 2017 Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31,2022, of the <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20220101__20220331_zkwCzeWPeKDd" title="Number of shares authorized for equity awards">333,333</span> shares authorized under the 2017 Plan for equity awards, <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20220101__20220331_zQNDlpHUK8D2" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period">163,692</span> shares have been issued, awards related to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220331_zTJ3zFl6Ipse" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number">148,905</span> options remain outstanding, and <span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20220331_zzWVKsG58OUa" title="Common Stock, Capital Shares Reserved for Future Issuance">20,736</span> shares remain available for future equity awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2021 Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210322__us-gaap--AwardTypeAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z0VomdMGoeCb" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant">666,667</span> shares of common stock. The 2021 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (<i>i.e.</i>, the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityIncentivePlanMember_z7qGM3slds08" title="Issuance of shares">3,367</span> shares of its common stock to two new independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted in January 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, the Company granted awards for <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zER4HQdKFzic" title="Number of share awards granted">21,167</span> non-qualified stock options to employees under the 2021 Equity Incentive Plan as described below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, the Company granted awards for <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zbIa8H7y26x6" title="Number of share awards granted">6,250</span> non-qualified stock options to directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted in August of 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31,2022, of the <span id="xdx_903_ecustom--ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zwd00TaQKv9e" title="Number of shares authorized">666,667</span> shares authorized under the 2021 Equity Plan, <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--RestrictedSharesIssuedMember_zx4p64Ffff6b" title="Number of shares issued">10,170</span> relate to restricted shares issued, <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--NonQualifiedStockOptionMember_zjkss4SR5evi" title="Number of option remain outstanding">33,408</span> relate to outstanding non-qualified stock options, <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--IncentiveStockOptionMember_z1oSsXOZxP61" title="Number of option remain outstanding">40,816</span> relate to outstanding incentive stock options, <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--DerivativeInstrumentRiskAxis__custom--IncentiveStockOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhALff4ikwPk">3,367</span> relate to outstanding restricted stock units and <span id="xdx_90C_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20220331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zYd9sMDjBKm" title="Shares available for future equity awards">578,906</span> shares remain available for future equity awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There was $<span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20220331_z6RhopQpsyA6" title="Unrecognized compensation expense">222,707</span> in unrecognized compensation expense for unvested non-qualified stock options, incentive stock options and restricted stock units at March 31, 2022 which will be recognized over approximately <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331_ztQ9ImdxtZl8" title="Weighted Average Remaining Contractual Term">3</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-Qualified and Incentive Stock Options</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zOdn7CvPCrs4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2022, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zTZPphBQYjj6" style="display: none">Schedule of Stock Option Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise</p> <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Remaining</p> <p style="margin-top: 0; margin-bottom: 0">Contractual</p> <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdwwupaDm6wj" style="width: 10%; text-align: right" title="Number of Options, Outstanding Beginning">158,174</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zD5Kkd38n7v4" style="width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">10.99</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zUEMXQCAiG6">7.6</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zIflSGnIjNOh" style="width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">       <span style="-sec-ix-hidden: xdx2ixbrl0960"> </span>-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zkS9ZH536dFl" style="text-align: right" title="Number of Options, Granted">21,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyI0WBfHx9Pd" style="text-align: right" title="Weighted Average Exercise Price, Granted">3.55</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z89XrR8aruI8">9.8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><p id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodAggregateIntrinsicValue_pp0p0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zEEuk4w2Rz87" style="margin: 0" title="Aggregate Intrinsic Value, Exercised">4,650</p></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zjmP9YoA1Aw2" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdcdh1Pm9mjc" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0971">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExercised_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zOEve60p3Ku3"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zeaP7l6QK6j2" style="text-align: right" title="Number of Options, Forfeited">(13,333</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3zW8fpMq3Nk" style="text-align: right" title="Weighted Average Exercise Price, Forfeited">9.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3Yx9uYpCpz7">0.0</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdSzQUTcQNgc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0979">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZl2WiSLs7v" style="text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0981">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2WmwoWoCvjb"><span style="-sec-ix-hidden: xdx2ixbrl0982">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zb9nAPCkYHk2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">166,007</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFnTJBXzvy7i" style="text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">10.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zmXQiHyyCgac">8.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pdp0_c20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zh5ASVhKwgSh" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending">4,650</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z5XzCEd3rWsd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">118,828</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zkLvgGQKDBmf" style="text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">11.89</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zbOXZTzw55u6">7.6</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zc3FruzlZYik" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending">610</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zpC5WgX1HQKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, we issued a total of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesMember_zsVmlew0ca4g" title="Shares, granted">21,167</span> stock options to employees as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__srt--TitleOfIndividualAxis__custom--ThreeNewEmployeesMember_zZ2rdL9rxB34" title="Shares, granted">6,167</span> stock options were issued to three new employees. The vesting of these options ranges from immediate to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c20220101__20220331_z5Nu9Hn5DxK8" title="Vesting expected term">three years</span>, have a term of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--ThreeNewEmployeesMember_zcVsZEv3dI0k" title="Expected term years">10</span> years and an exercise price ranging from $<span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20220101__20220331__srt--TitleOfIndividualAxis__custom--ThreeNewEmployeesMember_zJbpcUxDo4C4" title="Exercise price, lower">4.80</span> to $<span id="xdx_90E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20220101__20220331__srt--TitleOfIndividualAxis__custom--ThreeNewEmployeesMember_zwoSvGQY7Zdc" title="Exercise price, upper">6.90</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220102__20220330__srt--TitleOfIndividualAxis__custom--CheifFinancialOfficerMember_zsYn3oYyK95" title="Shares, granted">15,000</span> stock options were issued to our newly appointed Chief Financial Officer. <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20220102__20220330__srt--TitleOfIndividualAxis__custom--CheifFinancialOfficerMember_zKMxCPRCkzzk" title="Description,shares">The options vest as follows: 2,000 vested immediately, 3,000 on March 11, 2023, 5,000 on March 11, 2024, and 5,000 on March 11, 2025</span>. The options have a term of <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220102__20220330__srt--TitleOfIndividualAxis__custom--CheifFinancialOfficerMember_zDzdcOQBmemj" title="Expected term years">10 </span>years and an exercise price of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220102__20220330__srt--TitleOfIndividualAxis__custom--CheifFinancialOfficerMember_z6BxRfx7KFOf" title="Exercise price">2.20</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20220331__srt--TitleOfIndividualAxis__custom--OneFormerEmployeeMember_zoL4qDNPrN58" title="Issuance of stock options vested">1,667</span> fully vested stock options and <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20220331__srt--TitleOfIndividualAxis__custom--OneFormerEmployeeMember_z0ZbYKHE1guh" title="Issuance of stock, unvested">11,667</span> unvested stock options were forfeited following the departure of one former employee<b>.</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zu4nNU6swITi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2022, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_z40mRVdcVla6" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Nonvested, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z8ABAOZjTlv5" style="width: 10%; text-align: right" title="Number of Options Nonvested, Beginning">41,846</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zWgeJ7rD4MG" style="width: 10%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning">7.65</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zOb3ZpHjTGbh" style="width: 10%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">       <span style="-sec-ix-hidden: xdx2ixbrl1028"> </span>-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zRc3irqsXqk9" style="width: 10%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning">320,122</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4GW3nhfDtmk" style="text-align: right" title="Number of Options Nonvested, Granted">21,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zkMIaSnndcsh" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">3.51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zfzkceTQguR8" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted">74,296</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zC5gi35K90h9" style="text-align: right" title="Number of Options Nonvested, Vested">(4,167</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zeKI6klJk6d2" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested">4.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zqsU1T1eJ4o5" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">(18,751</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ziQjVKChuEv2" style="text-align: right" title="Number of Options Nonvested, Forfeited">(11,667</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4rPi63gQeN9" style="text-align: right" title="Weighted Average Grant-Date Fair Value, forfeited">9.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zB23KunztgP7" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited">(105,120</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zuhW53uV03ok" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zX78Jsx43hk2" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, expired"><span style="-sec-ix-hidden: xdx2ixbrl1052">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zAEaXrKehHie" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1054">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Nonvested, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zFRTMFlKytxl" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending">47,179</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z1bLBsOHWnch" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending">5.73</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zni0EcQVecOk" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="-sec-ix-hidden: xdx2ixbrl1060">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z15X2YSBDOm" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending">270,547</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_z53vF9Y2IzDi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2022 and March 31, 2021, the Company recorded $<span id="xdx_908_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20220331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z0Qe658Pqbvk" title="Compensation expense">32,939</span> and $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20210101__20210331__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zMKzxMxZwjA4" title="Compensation expense">0</span> as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zRSvxbt9wrR4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2022, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zxImLNUU0N8" style="display: none">Schedule of Stock Option Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise</p> <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Remaining</p> <p style="margin-top: 0; margin-bottom: 0">Contractual</p> <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value ($000)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zH02GSGFPKLk" style="width: 10%; text-align: right" title="Number of Options, Outstanding Beginning">50,872</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3DNT944tCHa" style="width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">10.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHzsxIdwb55g">6.6</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKPygJdToCB2" style="width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">      <span style="-sec-ix-hidden: xdx2ixbrl1075"> </span>-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGmxlngaB1J8" style="text-align: right" title="Number of Options, Granted">6,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zP7iShQ7VtM4" style="text-align: right" title="Weighted Average Exercise Price, Granted">4.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrZ7hXzSrkc3">9.8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zCeu1kwhkvDi" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyQ7cxAZtQ91" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zb4vZ7WNvA3j" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1086">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyl1Ef5GjYfk" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHqGglCFojbc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1090">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z6sA4PeEXdv8" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zdH1x9q1t1wf"><span style="-sec-ix-hidden: xdx2ixbrl1093">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zunprd5oAWs4" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zn8wtrNvIJI" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdcMJAb7bldd">6.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pdp0_c20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHk2PQ1liZ1h" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exerciseable, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrbhT45hofn8" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zwzWloo7o8s6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqGtWkNGwP21">6.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpmRESwe6ov9" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zQJj4w3IwJO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the three months ended March 31, 2022, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p id="xdx_898_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zr9w3YwHUD6b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z9IZ8GuC2oe6" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Nonvested, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zUV1dJIFkRNd" style="text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1111">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z4mAYDicqvgh" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1113">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zi6A6MppAF9d" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsNonvested_pp0p0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvbQepSkHyS2" style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1117">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 44%">Granted</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPmEGdlYxs64" style="width: 10%; text-align: right" title="Number of Options Nonvested, Beginning">6,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zt6Gpvw2cECd" style="width: 10%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning">4.80</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_iN_di_c20220101__20220331_zCtmc7kmJ7m6" style="width: 10%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Granted">(14,313</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zeqtTnAygUVi" style="width: 10%; text-align: right" title="Grant Date Fair Value Nonvested, Granted">29,688</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZDYVhIFeg4j" style="text-align: right" title="Number of Options Nonvested, Beginning">(6,250</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zDY0McXHBgwc" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning">4.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_z4shLKisSXxh" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Vested">14,313</td><td style="text-align: left"/><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0S3yqXNHdfk" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">(29,688</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zm9VF98xAPD3" style="text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1135">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zT5oVZsWfzO4" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1137">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><p style="margin: 0">-</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zTONwgNbhl1f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1139">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zoGYEFUd3KJh" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1141">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Beginning">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Nonvested, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJKq6PKVoxd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1143">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zODn03xUD2g" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="-sec-ix-hidden: xdx2ixbrl1145">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zjAPfMXEmOwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="-sec-ix-hidden: xdx2ixbrl1147">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zspwAPGjPiQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022 and March 31, 2021, the Company incurred $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20220101__20220331__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zWWjlHcOLjyc" title="Share based compensation">29,656</span> and $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20210101__20210331__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z2AjULrrWFvk" title="Share based compensation">6,342</span> respectively, as compensation expense related to <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20220331__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zVJdunGas0U7" title="Number of options to purchase shares">6,250</span> and <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210331__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zZcGlOpTfq6" title="Number of options to purchase shares">3,333</span> vested options, respectively, issued to directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 3, 2022, the Company issued <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20220102__20220103__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOnePlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zTUguAd682bj" title="Number of options to purchase shares">6,250</span> non-qualified stock options under the 2021 Equity Plan to its then current directors. The options vested upon grant. The options have a term of <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220102__20220103__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPBEmtF3llp4" title="Expected term years">10</span> years and an exercise price equal to the closing price of the Company’s common stock on The OTC Markets on the day immediately preceding the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Restricted Stock Units</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 17,2022, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20220116__20220117__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzjULCZTrK73" title="Issuance of stock">6,734</span> restricted stock units (RSUs) under the 2021 Equity Plan to newly appointed directors.<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220116__20220117__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDR8wXvRDs9h" title="Issuance of shares"> 3,367</span> of these RSUs vested upon grant and the remining <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_c20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__custom--VestedMember_zfBiifPz59ca" title="Issuance of shares">3,367 </span>will vest on January 17, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded $<span id="xdx_901_eus-gaap--ShareBasedCompensation_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zxK6yJHBd9ha" title="Share based compensation">29,923</span> during the three months ended March 31, 2022, as compensation expense related to vested RSUs issued to directors.</span></p> <p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zaAkdz2DJt6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z8CKGpI25hb" style="display: none">Schedule of Restricted Stock Units Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Units</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1I1FbNO0Okg" style="text-align: right" title="Number of Units, beginning"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztlGA13S98R3" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9Q30Ca1Ijaa" style="text-align: right" title="Aggregate Intrinsic Value Nonvested, Beginning">     <span style="-sec-ix-hidden: xdx2ixbrl1175"> </span>-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 52%">Granted</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgZgdyEMNsb9" style="width: 12%; text-align: right" title="Number of Units, Granted">6,734</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z4eZzyDrE9ab" style="width: 12%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">7.42</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Vested and settled with share issuance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLOzhKPUa0Le" style="text-align: right" title="Number of Units, Vested and settled with share issuance">(3,367</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJjNce5uZNz1" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested">7.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Forfeited/canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFAzbdWqkVkc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6r7jxBvdKXa" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited/Canceled"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztBQzNd8pPwl" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units, ending">3,367</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqX5CYHtnQy1" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value,ending">7.42</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIDKF8rVfdd2" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value Nonvested, ending"><span style="-sec-ix-hidden: xdx2ixbrl1193">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_8AD_ztd3CnTCz7j7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 333333 13333 333333 163692 148905 20736 666667 3367 21167 6250 666667 10170 33408 40816 3367 578906 222707 P3Y <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zOdn7CvPCrs4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended March 31, 2022, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zTZPphBQYjj6" style="display: none">Schedule of Stock Option Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise</p> <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Remaining</p> <p style="margin-top: 0; margin-bottom: 0">Contractual</p> <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdwwupaDm6wj" style="width: 10%; text-align: right" title="Number of Options, Outstanding Beginning">158,174</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zD5Kkd38n7v4" style="width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">10.99</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zUEMXQCAiG6">7.6</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zIflSGnIjNOh" style="width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">       <span style="-sec-ix-hidden: xdx2ixbrl0960"> </span>-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zkS9ZH536dFl" style="text-align: right" title="Number of Options, Granted">21,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyI0WBfHx9Pd" style="text-align: right" title="Weighted Average Exercise Price, Granted">3.55</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z89XrR8aruI8">9.8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><p id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodAggregateIntrinsicValue_pp0p0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zEEuk4w2Rz87" style="margin: 0" title="Aggregate Intrinsic Value, Exercised">4,650</p></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zjmP9YoA1Aw2" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdcdh1Pm9mjc" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0971">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExercised_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zOEve60p3Ku3"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zeaP7l6QK6j2" style="text-align: right" title="Number of Options, Forfeited">(13,333</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3zW8fpMq3Nk" style="text-align: right" title="Weighted Average Exercise Price, Forfeited">9.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3Yx9uYpCpz7">0.0</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdSzQUTcQNgc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0979">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZl2WiSLs7v" style="text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl0981">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2WmwoWoCvjb"><span style="-sec-ix-hidden: xdx2ixbrl0982">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zb9nAPCkYHk2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">166,007</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFnTJBXzvy7i" style="text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">10.18</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zmXQiHyyCgac">8.2</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pdp0_c20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zh5ASVhKwgSh" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending">4,650</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z5XzCEd3rWsd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">118,828</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zkLvgGQKDBmf" style="text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">11.89</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zbOXZTzw55u6">7.6</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zc3FruzlZYik" style="text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending">610</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 158174 10.99 P7Y7M6D 21167 3.55 P9Y9M18D 4650 13333 9.15 P0Y 166007 10.18 P8Y2M12D 4650 118828 11.89 P7Y7M6D 610 21167 6167 P3Y P10Y 4.80 6.90 15000 The options vest as follows: 2,000 vested immediately, 3,000 on March 11, 2023, 5,000 on March 11, 2024, and 5,000 on March 11, 2025 P10Y 2.20 1667 11667 <p id="xdx_89C_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zu4nNU6swITi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 and 2021 Equity Plans for the three months ended March 31, 2022, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_z40mRVdcVla6" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Nonvested, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z8ABAOZjTlv5" style="width: 10%; text-align: right" title="Number of Options Nonvested, Beginning">41,846</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zWgeJ7rD4MG" style="width: 10%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning">7.65</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zOb3ZpHjTGbh" style="width: 10%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">       <span style="-sec-ix-hidden: xdx2ixbrl1028"> </span>-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zRc3irqsXqk9" style="width: 10%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning">320,122</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4GW3nhfDtmk" style="text-align: right" title="Number of Options Nonvested, Granted">21,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zkMIaSnndcsh" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">3.51</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zfzkceTQguR8" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted">74,296</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zC5gi35K90h9" style="text-align: right" title="Number of Options Nonvested, Vested">(4,167</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zeKI6klJk6d2" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested">4.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zqsU1T1eJ4o5" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">(18,751</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ziQjVKChuEv2" style="text-align: right" title="Number of Options Nonvested, Forfeited">(11,667</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4rPi63gQeN9" style="text-align: right" title="Weighted Average Grant-Date Fair Value, forfeited">9.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zB23KunztgP7" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited">(105,120</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zuhW53uV03ok" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zX78Jsx43hk2" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, expired"><span style="-sec-ix-hidden: xdx2ixbrl1052">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zAEaXrKehHie" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1054">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Nonvested, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zFRTMFlKytxl" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending">47,179</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z1bLBsOHWnch" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending">5.73</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zni0EcQVecOk" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="-sec-ix-hidden: xdx2ixbrl1060">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z15X2YSBDOm" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending">270,547</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 41846 7.65 320122 21167 3.51 74296 4167 4.50 -18751 11667 9.01 -105120 47179 5.73 270547 32939 0 <p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zRSvxbt9wrR4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the three months ended March 31, 2022, are presented in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zxImLNUU0N8" style="display: none">Schedule of Stock Option Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise</p> <p style="margin-top: 0; margin-bottom: 0">Price</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Remaining</p> <p style="margin-top: 0; margin-bottom: 0">Contractual</p> <p style="margin-top: 0; margin-bottom: 0">Term</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value ($000)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zH02GSGFPKLk" style="width: 10%; text-align: right" title="Number of Options, Outstanding Beginning">50,872</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3DNT944tCHa" style="width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning">10.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHzsxIdwb55g">6.6</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKPygJdToCB2" style="width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">      <span style="-sec-ix-hidden: xdx2ixbrl1075"> </span>-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGmxlngaB1J8" style="text-align: right" title="Number of Options, Granted">6,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zP7iShQ7VtM4" style="text-align: right" title="Weighted Average Exercise Price, Granted">4.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrZ7hXzSrkc3">9.8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zCeu1kwhkvDi" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyQ7cxAZtQ91" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zb4vZ7WNvA3j" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1086">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyl1Ef5GjYfk" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHqGglCFojbc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1090">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z6sA4PeEXdv8" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zdH1x9q1t1wf"><span style="-sec-ix-hidden: xdx2ixbrl1093">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zunprd5oAWs4" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zn8wtrNvIJI" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdcMJAb7bldd">6.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pdp0_c20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zHk2PQ1liZ1h" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exerciseable, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zrbhT45hofn8" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending">57,122</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zwzWloo7o8s6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending">9.44</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqGtWkNGwP21">6.7</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpmRESwe6ov9" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 50872 10.02 P6Y7M6D 6250 4.80 P9Y9M18D 57122 9.44 P6Y8M12D 57122 9.44 P6Y8M12D <p id="xdx_898_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zr9w3YwHUD6b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z9IZ8GuC2oe6" style="display: none">Summary of Non-vested Non-qualified Stock Option Activity</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Options</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic</p> <p style="margin-top: 0; margin-bottom: 0">Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Nonvested, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zUV1dJIFkRNd" style="text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1111">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z4mAYDicqvgh" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1113">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zi6A6MppAF9d" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsNonvested_pp0p0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvbQepSkHyS2" style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1117">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 44%">Granted</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPmEGdlYxs64" style="width: 10%; text-align: right" title="Number of Options Nonvested, Beginning">6,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zt6Gpvw2cECd" style="width: 10%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning">4.80</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_iN_di_c20220101__20220331_zCtmc7kmJ7m6" style="width: 10%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Granted">(14,313</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zeqtTnAygUVi" style="width: 10%; text-align: right" title="Grant Date Fair Value Nonvested, Granted">29,688</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZDYVhIFeg4j" style="text-align: right" title="Number of Options Nonvested, Beginning">(6,250</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zDY0McXHBgwc" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning">4.80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pdp0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_z4shLKisSXxh" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Vested">14,313</td><td style="text-align: left"/><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0S3yqXNHdfk" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested">(29,688</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zm9VF98xAPD3" style="text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1135">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zT5oVZsWfzO4" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1137">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><p style="margin: 0">-</p></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zTONwgNbhl1f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1139">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zoGYEFUd3KJh" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1141">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Beginning">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Nonvested, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJKq6PKVoxd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1143">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zODn03xUD2g" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="-sec-ix-hidden: xdx2ixbrl1145">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pdp0_c20220101__20220331__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zjAPfMXEmOwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="-sec-ix-hidden: xdx2ixbrl1147">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6250 4.80 14313 29688 6250 4.80 14313 -29688 29656 6342 6250 3333 6250 P10Y 6734 3367 3367 29923 <p id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zaAkdz2DJt6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z8CKGpI25hb" style="display: none">Schedule of Restricted Stock Units Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number of</p> <p style="margin-top: 0; margin-bottom: 0">Units</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Grant-Date</p> <p style="margin-top: 0; margin-bottom: 0">Fair Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p> <p style="margin-top: 0; margin-bottom: 0">Intrinsic Value</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td></td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding, December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1I1FbNO0Okg" style="text-align: right" title="Number of Units, beginning"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztlGA13S98R3" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl1173">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9Q30Ca1Ijaa" style="text-align: right" title="Aggregate Intrinsic Value Nonvested, Beginning">     <span style="-sec-ix-hidden: xdx2ixbrl1175"> </span>-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 52%">Granted</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgZgdyEMNsb9" style="width: 12%; text-align: right" title="Number of Units, Granted">6,734</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z4eZzyDrE9ab" style="width: 12%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted">7.42</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Vested and settled with share issuance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLOzhKPUa0Le" style="text-align: right" title="Number of Units, Vested and settled with share issuance">(3,367</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJjNce5uZNz1" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested">7.42</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Forfeited/canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFAzbdWqkVkc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6r7jxBvdKXa" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited/Canceled"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ztBQzNd8pPwl" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Units, ending">3,367</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqX5CYHtnQy1" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value,ending">7.42</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20220101__20220331__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIDKF8rVfdd2" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value Nonvested, ending"><span style="-sec-ix-hidden: xdx2ixbrl1193">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6734 7.42 3367 7.42 3367 7.42 <p id="xdx_805_ecustom--WarrantsDisclosureTextBlock_zbVLO6WEekdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11 - <span id="xdx_829_zSFKDCWUbx76">Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zXuE3HTepeW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zgdZQSWicsy5" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Remaining</p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-weight: bold">Aggregate</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> Life</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">In Months</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding at December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20220331_zIuTpdvRStW" style="width: 10%; text-align: right" title="Warrants Outstanding, Beginning Balance">227,719</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20220331_zn4iItl2NqB1" style="width: 10%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance">9.59</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20220101__20220331_zTFYE1zXHi2e" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">33</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20220101__20220331_z6uEs2cR8BB" style="width: 10%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance">         0</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F46_zc2tz5v2dfS1">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ClassOfWarrantOrRightIssued_c20220101__20220331_zhcLlmtrxu77" style="text-align: right" title="Warrants, issued">7,566,435</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20220101__20220331_zw9kJ8YTLsOi" style="text-align: right" title="Weighted Average Exercise Price, Issued">4.89</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_dtM_c20220101__20220331_fKg_____zMrqFiMDeMc7">58</span></td><td style="text-align: left">*</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_pdp0_c20220101__20220331_zPosvB8OBPGg" style="text-align: right" title="Aggregate Intrinsic Value, Issued">425,955</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercised_c20220101__20220331_zKEgFndYTfll" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20220101__20220331_zooIKaMYhKa7" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1216">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_pdp0_c20220101__20220331_zS0e8NRUrWX9" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpired_iN_di_c20220101__20220331_zu0F8pmKCtKi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1220">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20220101__20220331_zRXtdUqI9D55" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_pp0p0_c20220101__20220331_z18oK0CZlEAh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1224">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20220331_zhn36bDPgs7a" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance">7,794,154</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220101__20220331_zG0INrYydqb6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance">5.03</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331_fKg_____zsO8qF5T41Xk" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">58</span></td><td style="padding-bottom: 2.5pt; text-align: left">*</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20220101__20220331_zyu4HTtj6wkj" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance">425,955</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F00_zkn9HSOea0Zh" style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F16_zIQXD5Sder2d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE91dHN0YW5kaW5nIFdhcnJhbnRzIHRvIFB1cmNoYXNlIENvbW1vbiBTdG9jayAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220331_z1357vfZvwr2" title="Class of Warrant or Right, Number of Securities Called by Each Warrant or Right">170,382</span> warrants with an indefinite life.</span></td> </tr></table> <p id="xdx_8AE_zLOoTHfRCZhg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zeMMN9p1qcn6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants outstanding at March 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zZI6hrJgvw5g" style="display: none">Schedule of Warrants Outstanding</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom"> <td colspan="2" id="xdx_F45_zQMm9PTLk0Gh"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Warrants</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted Average</td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Exercise price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Months Outstanding</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zaSfg6elrfHi" style="width: 30%; text-align: right" title="Exercise price">9.45</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zjwHiX4QCslj" style="width: 30%; text-align: right" title="Warrants Outstanding">192,982</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 30%; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zf4o05Z3Wib" title="Weighted Average Life of Outstanding Warrants in Months">30</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zxg1goXAwO72" style="text-align: right" title="Exercise price">10.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z7MZDNLUYkxi" style="text-align: right" title="Warrants Outstanding">34,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z1uYhazbT8ul" title="Weighted Average Life of Outstanding Warrants in Months">31</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zENwABRQEh0f" style="text-align: right" title="Exercise price">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_z6k4hSy3jqR5" style="text-align: right" title="Warrants Outstanding">7,105,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zqCKaWPIb1P5" title="Weighted Average Life of Outstanding Warrants in Months">59</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_z2k7Lyjbhoqk" style="text-align: right" title="Exercise price">5.16</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zV84eld1aQe1" style="text-align: right" title="Warrants Outstanding">290,557</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zyPILhSk54H5" title="Weighted Average Life of Outstanding Warrants in Months">59</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zgqGbOcDvKfh" style="padding-bottom: 1.5pt; text-align: right" title="Exercise price">0.01</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zfjWNSxQ9L35" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants Outstanding">170,382</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1_c20220101__20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zMbvAP6SxyF6" title="Weighted Average Life of Outstanding Warrants in Months">Indefinite Life</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331_zMuw7i9Vsum4" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding">7,794,154</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331_fKg_____zzcpGvvwxtDc" title="Weighted Average Life of Outstanding Warrants in Months">58</span></td><td style="padding-bottom: 2.5pt; text-align: left">*</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"> <tr style="vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 15pt"><span id="xdx_F0D_zCrjagNBNdSc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_F11_zbllT7QZcJ1f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220331_zrVuP27wKrM4">170,382</span> warrants with an indefinite life. </span></td></tr> </table> <p id="xdx_8A2_z96vTISAGNpg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q3 2021 Warrants Issued to Series B Preferred Stockholder</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 28, 2021, the Company entered into a Securities Purchase Agreement with an institutional investor, pursuant to which the investor purchased from the Company <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zxxfApgsnSak" title="Issuance of shares">3,300</span> shares of convertible Series B Preferred Stock with a stated value of $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQPBIVAIufUf" title="Per share">1,000</span> per share, or $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqgHE3RI66s" title="Issuance of Value">3,300,000</span> of stated value in the aggregate, and a warrant to purchase up to <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zVWaEmIorAS3" title="Issuance of shares">192,982</span> shares of common stock of the Company for an aggregate purchase price of $<span id="xdx_904_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20210927__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKrOhQam6Db" title="Purchase price">3,000,000</span>. The warrant is exercisable until September 28, 2024, at an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210928__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z7CELogw02I8" title="Exercise price of warrants">9.45</span>, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q3 2021 Warrants Issued to Series B Preferred Placement Agent</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the sale of the shares of convertible Series B Preferred Stock described above, the Company issued <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210928__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--PlacementAgentWarrantsMember_zSZOTzLdCryj" title="Issuance of warrants">34,737</span> warrants to the placement agent and its designees. Half of the warrants were issued on September 28, 2021, and the second half were issued on November 3, 2021, and are exercisable commencing February 28, 2022 and May 3, 2022, respectively, until September 28, 2024 and November 3, 2024, respectively. The exercise price per share of the warrants is $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210928__us-gaap--StatementEquityComponentsAxis__custom--PlacementAgentWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z92Ewqnmyhk2" title="Exercise price of warrants">10.40</span>, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q1 2022 Investor Warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 15, 2022, the Company issued <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_uShares_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoInvestorWarrantsMember_zF1A7BUdFsjb" title="Number of warrant issuance">5,811,138</span> investment units for aggregate gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfWarrants_c20220213__20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoInvestorWarrantsMember_zigaEsa3ZQyg" title="Proceeds from warrants issuance">24,000,000</span>, or $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoInvestorWarrantsMember_zUQHPXVzPuMg" title="Issuance of per shares">4.13</span> per unit. Each unit consisted of one share of the Company’s common stock and one warrant for the purchase of one share of the Company’s common stock. The warrants vested immediately, had a term of <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoInvestorWarrantsMember_zCsmPFNtkSVg" title="Warrants term">5 years</span> and an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoInvestorWarrantsMember_zJDbri2jwN02" title="Exercise price">5.00</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q1 2022 Overallotment Warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further on February 15, 2022, in connection the Company’s issuance of <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_uShares_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoOverAllotmentWarrantsMember_zMA6CB9AQhzc" title="Number of warrant issuance">5,811,138</span> investment units for aggregate gross proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfWarrants_c20220213__20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoOverAllotmentWarrantsMember_zMTc9VEf2etk" title="Proceeds from warrants issuance">24,000,000</span>, or $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoOverAllotmentWarrantsMember_zcLC6fTaUyjj" title="Issuance of per unit">4.13</span> per unit as described above, a further <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_uShares_c20220210__20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoOverAllotmentWarrantsMember_z41diBRrAr3d" title="Issuance of shares">761,670</span> warrants were issued in connection with the subscription for substantially all of the available <span id="xdx_90A_ecustom--WarrantsPercentage_iI_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoOverAllotmentWarrantsMember_zoPzq978ipV3" title="Warrants percent">15</span>% overallotment warrants. The warrants were acquired for consideration of $<span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceOfWarrantsVested_iI_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoOverAllotmentWarrantsMember_zAfLJxlXYgsf" title="Warrant price per share">0.01</span> per warrant, vested immediately, had a term of <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_uShares_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoOverAllotmentWarrantsMember_zmhoY0rivVMa" title="Warrants term">5 years</span> and an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoOverAllotmentWarrantsMember_z4HR4J6MH814" title="Exercise price">5.00</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q1 2022 Underwriter Warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further on February 15, 2022, in connection the Company’s issuance of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_uShares_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoUnderwriterWarrantsMember_zUT9XUymH9Oa" title="Issuance of warrants">5,811,138</span> investment units for aggregate gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfWarrants_c20220213__20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoUnderwriterWarrantsMember_zPDd55jgV9Qg" title="Proceeds from warrants issuance">24,000,000</span>, or $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoUnderwriterWarrantsMember_zDIVnQEUo2Tl" title="Issuance of per unit">4.13</span> per unit described above, the Company also issued representatives of the underwriters <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_uShares_c20220213__20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoUnderwriterWarrantsMember_zRqCe5sXeUdc">290,557</span> warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220215__us-gaap--StatementEquityComponentsAxis__custom--TwoThousandTwentyTwoUnderwriterWarrantsMember_zJhrYOGzAdH4" title="Exercise price">5.1625</span>, during the period commencing August 9, 2022, and expiring on February 10, 2027.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q1 2022 Series B Preferred Shares Pre-Funded Conversion Warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 16, 2022, in connection with the conversion of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_uShares_c20220212__20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zern7usMz4ra" title="Issuance of shares">1,650</span> shares of Series B Preferred Stock into <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_uShares_c20220212__20220216__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzhQBscZ1Gw4" title="Issuance of shares">362,306</span> shares of the Company’s common stock, the Series B Preferred Shareholder was issued with <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_uShares_c20220212__20220216__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredSharesPreFundedConversionWarrantsMember_zrCKOUuq8I0k" title="Conversion warrants">170,382</span> pre-funded conversion warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220216__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredSharesPreFundedConversionWarrantsMember_zgmizmqTYDE9" title="Exercise price">0.01</span>, vested immediately and had an indefinite life.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEA Industries Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Condensed Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(in US Dollars except share numbers)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(Unaudited)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Q1 2022 Series B Preferred Shares Conversion Warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further on February 16, 2022, in connection with the conversion of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_uShares_c20220212__20220216__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zkiBHAMbIaQe" title="Issuance of shares">1,650</span> shares of Series B Preferred Stock into <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_uShares_c20220212__20220216__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO0b6zufsAbh" title="Issuance of shares">362,306</span> shares of the Company’s common stock, the Series B Preferred Shareholder was also issued with <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_uShares_c20220212__20220216__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredSharesConversionWarrantsMember_zWYZfE8qFQO7">532,688</span> Series B Preferred shares conversion warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220216__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredSharesConversionWarrantsMember_zsO9AyVmTH5c" title="Exercise price">5.00</span>, vested immediately and had a term of <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_uShares_c20220215__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPreferredSharesConversionWarrantsMember_zqoRpeN5Jc96" title="Warrants term">5 years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zXuE3HTepeW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zgdZQSWicsy5" style="display: none">Schedule of Outstanding Warrants to Purchase Common Stock</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Remaining</p></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-weight: bold">Aggregate</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> Life</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">In Months</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding at December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20220331_zIuTpdvRStW" style="width: 10%; text-align: right" title="Warrants Outstanding, Beginning Balance">227,719</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20220331_zn4iItl2NqB1" style="width: 10%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance">9.59</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20220101__20220331_zTFYE1zXHi2e" title="Weighted Average Life of Outstanding Warrants in Months, Beginning Balance">33</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20220101__20220331_z6uEs2cR8BB" style="width: 10%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance">         0</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F46_zc2tz5v2dfS1">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ClassOfWarrantOrRightIssued_c20220101__20220331_zhcLlmtrxu77" style="text-align: right" title="Warrants, issued">7,566,435</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20220101__20220331_zw9kJ8YTLsOi" style="text-align: right" title="Weighted Average Exercise Price, Issued">4.89</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_dtM_c20220101__20220331_fKg_____zMrqFiMDeMc7">58</span></td><td style="text-align: left">*</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_pdp0_c20220101__20220331_zPosvB8OBPGg" style="text-align: right" title="Aggregate Intrinsic Value, Issued">425,955</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercised_c20220101__20220331_zKEgFndYTfll" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20220101__20220331_zooIKaMYhKa7" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1216">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_pdp0_c20220101__20220331_zS0e8NRUrWX9" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpired_iN_di_c20220101__20220331_zu0F8pmKCtKi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1220">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20220101__20220331_zRXtdUqI9D55" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_pp0p0_c20220101__20220331_z18oK0CZlEAh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="-sec-ix-hidden: xdx2ixbrl1224">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220101__20220331_zhn36bDPgs7a" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance">7,794,154</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220101__20220331_zG0INrYydqb6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance">5.03</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331_fKg_____zsO8qF5T41Xk" title="Weighted Average Life of Outstanding Warrants in Months, Ending Balance">58</span></td><td style="padding-bottom: 2.5pt; text-align: left">*</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20220101__20220331_zyu4HTtj6wkj" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance">425,955</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F00_zkn9HSOea0Zh" style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F16_zIQXD5Sder2d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIE91dHN0YW5kaW5nIFdhcnJhbnRzIHRvIFB1cmNoYXNlIENvbW1vbiBTdG9jayAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220331_z1357vfZvwr2" title="Class of Warrant or Right, Number of Securities Called by Each Warrant or Right">170,382</span> warrants with an indefinite life.</span></td> </tr></table> 227719 9.59 P33M 0 7566435 4.89 P58M 425955 7794154 5.03 P58M 425955 170382 <p id="xdx_895_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zeMMN9p1qcn6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes information about warrants outstanding at March 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zZI6hrJgvw5g" style="display: none">Schedule of Warrants Outstanding</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom"> <td colspan="2" id="xdx_F45_zQMm9PTLk0Gh"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Warrants</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted Average</td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Exercise price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Months Outstanding</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zaSfg6elrfHi" style="width: 30%; text-align: right" title="Exercise price">9.45</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zjwHiX4QCslj" style="width: 30%; text-align: right" title="Warrants Outstanding">192,982</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 30%; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zf4o05Z3Wib" title="Weighted Average Life of Outstanding Warrants in Months">30</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zxg1goXAwO72" style="text-align: right" title="Exercise price">10.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z7MZDNLUYkxi" style="text-align: right" title="Warrants Outstanding">34,737</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_z1uYhazbT8ul" title="Weighted Average Life of Outstanding Warrants in Months">31</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zENwABRQEh0f" style="text-align: right" title="Exercise price">5.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_z6k4hSy3jqR5" style="text-align: right" title="Warrants Outstanding">7,105,496</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeTwoMember_zqCKaWPIb1P5" title="Weighted Average Life of Outstanding Warrants in Months">59</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_z2k7Lyjbhoqk" style="text-align: right" title="Exercise price">5.16</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zV84eld1aQe1" style="text-align: right" title="Warrants Outstanding">290,557</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeThreeMember_zyPILhSk54H5" title="Weighted Average Life of Outstanding Warrants in Months">59</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zgqGbOcDvKfh" style="padding-bottom: 1.5pt; text-align: right" title="Exercise price">0.01</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zfjWNSxQ9L35" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants Outstanding">170,382</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1_c20220101__20220331__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeFourMember_zMbvAP6SxyF6" title="Weighted Average Life of Outstanding Warrants in Months">Indefinite Life</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220331_zMuw7i9Vsum4" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding">7,794,154</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20220101__20220331_fKg_____zzcpGvvwxtDc" title="Weighted Average Life of Outstanding Warrants in Months">58</span></td><td style="padding-bottom: 2.5pt; text-align: left">*</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"> <tr style="vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 15pt"><span id="xdx_F0D_zCrjagNBNdSc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_F11_zbllT7QZcJ1f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220331_zrVuP27wKrM4">170,382</span> warrants with an indefinite life. </span></td></tr> </table> 9.45 192982 P30M 10.40 34737 P31M 5.00 7105496 P59M 5.16 290557 P59M 0.01 170382 Indefinite Life 7794154 P58M 170382 3300 1000 3300000 192982 3000000 9.45 34737 10.40 5811138 24000000 4.13 P5Y 5.00 5811138 24000000 4.13 761670 15 0.01 P5Y 5.00 5811138 24000000 4.13 290557 5.1625 1650 362306 170382 0.01 1650 362306 532688 5.00 P5Y <p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zZNftB6Z3JF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12 – <span id="xdx_82F_zzDPPRjmfQjd">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2022, the Company has U.S. federal and state net operating losses (“NOLs”) of approximately $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_c20220331_z9LD0bmeYJV3">22,514,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of which $<span id="xdx_90E_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_iI_pp0p0_c20220331_zRKQMYvfZcei" title="Net operating loss carryforward expected to expire amount">11,196,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to <span id="xdx_906_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20220331_zICUvcFBTkUl">80</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%. In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the <span id="xdx_902_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20220331_z3r8LB0Lyhd2" title="NOLs usage against taxable income percentage">80</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% limitation for NOLs arising in 2018, 2019 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company’s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220331_zThBJodB5iH7">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% within a three-year period. In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), and corresponding provisions of state law, if a corporation undergoes an “ownership change,” which is generally defined as a greater than <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220331_ztlQSyPW20dl">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% change, by value, in its equity ownership over a <span id="xdx_90A_ecustom--NolsCarryforwardsTermDescription_c20220101__20220331_zKsMEwksoGWd">three-year period</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. Our sale of securities, both in September 2021 and February 2022, will need to be considered for determination of any “ownership change” that we have undergone during a determination period. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future bottom-line operating results by effectively increasing our future tax obligations</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management’s judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of March 31, 2022 and December 31, 2021. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company’s plans. Should the actual amounts differ from the Company’s estimates, the carrying value of the Company’s deferred tax assets could be materially impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 22514000 11196000 0.80 0.80 0.50 0.50 three-year period <p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ziiLbJfp0Rw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 13 – <span id="xdx_82D_zueJ74Yso4cd">Related Party Transactions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into a manufacturer representative agreement with RSX Enterprises (“RSX”) in March 2021 to become a non-exclusive representative for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant ownership interest in RSX.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada and Mexico and may receive a commission for qualified customer leads. The agreement had an initial term through December 31, 2021 with automatic one-year renewal terms unless prior notice is given 90 days prior to each annual expiration. During the three months ended March 31, 2022, the Company paid $<span id="xdx_901_eus-gaap--PaymentsForCommissions_c20220101__20220331__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zd0vyAJItO75" title="Payments for commissions">7,555</span> in commissions under this agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 7555 <p id="xdx_806_eus-gaap--SubsequentEventsTextBlock_zdqhYDcUk6V6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 14 – <span id="xdx_823_z1xh57fdDi0l">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No material subsequent events occurred after March 31, 2022, other than as set out below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 1, 2022, <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20220329__20220401__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--TwentyOneEmployeesMember__us-gaap--AwardTypeAxis__custom--EmploymentAgreementMember_zy5TwngbcVAk" title="Non qualified stock options">31,793</span> non-qualified stock options were issued to 21 employees in respect of the Company’s 2021 Annual Incentive Awards. The options vested immediately, have a term of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20220329__20220401__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__custom--EmploymentAgreementMember_z99n8eGrq0Lc" title="Stock options vesting, period">10</span> years and an exercise price of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20220401__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--AwardTypeAxis__custom--EmploymentAgreementMember_znTI5mh7OJ8b" title="Exercise price per share">2.51</span>. The expense in respect of this issuance had been fully in fully accrued in 2021.</span></p> 31793 P10Y 2.51 Excludes 170,382 warrants with an indefinite life. Excludes 170,382 warrants with an indefinite life.  EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 188 344 1 true 84 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://ceaindustries.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://ceaindustries.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://ceaindustries.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholder's Equity (Deficit) (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit Condensed Consolidated Statements of Changes in Shareholder's Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://ceaindustries.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - General Sheet http://ceaindustries.com/role/General General Notes 7 false false R8.htm 00000008 - Disclosure - Leases Sheet http://ceaindustries.com/role/Leases Leases Notes 8 false false R9.htm 00000009 - Disclosure - Inventory Sheet http://ceaindustries.com/role/Inventory Inventory Notes 9 false false R10.htm 00000010 - Disclosure - Property and Equipment Sheet http://ceaindustries.com/role/PropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 11 false false R12.htm 00000012 - Disclosure - Note Payable and Accrued Interest Sheet http://ceaindustries.com/role/NotePayableAndAccruedInterest Note Payable and Accrued Interest Notes 12 false false R13.htm 00000013 - Disclosure - Commitments and Contingencies Sheet http://ceaindustries.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 00000014 - Disclosure - Temporary Equity Sheet http://ceaindustries.com/role/TemporaryEquity Temporary Equity Notes 14 false false R15.htm 00000015 - Disclosure - Stockholders??? Equity (Deficit) Sheet http://ceaindustries.com/role/StockholdersEquityDeficit Stockholders??? Equity (Deficit) Notes 15 false false R16.htm 00000016 - Disclosure - Equity Incentive Plans Sheet http://ceaindustries.com/role/EquityIncentivePlans Equity Incentive Plans Notes 16 false false R17.htm 00000017 - Disclosure - Warrants Sheet http://ceaindustries.com/role/Warrants Warrants Notes 17 false false R18.htm 00000018 - Disclosure - Income Taxes Sheet http://ceaindustries.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 00000019 - Disclosure - Related Party Transactions Sheet http://ceaindustries.com/role/RelatedPartyTransactions Related Party Transactions Notes 19 false false R20.htm 00000020 - Disclosure - Subsequent Events Sheet http://ceaindustries.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 00000021 - Disclosure - General (Policies) Sheet http://ceaindustries.com/role/GeneralPolicies General (Policies) Policies 21 false false R22.htm 00000022 - Disclosure - General (Tables) Sheet http://ceaindustries.com/role/GeneralTables General (Tables) Tables http://ceaindustries.com/role/General 22 false false R23.htm 00000023 - Disclosure - Leases (Tables) Sheet http://ceaindustries.com/role/LeasesTables Leases (Tables) Tables http://ceaindustries.com/role/Leases 23 false false R24.htm 00000024 - Disclosure - Inventory (Tables) Sheet http://ceaindustries.com/role/InventoryTables Inventory (Tables) Tables http://ceaindustries.com/role/Inventory 24 false false R25.htm 00000025 - Disclosure - Property and Equipment (Tables) Sheet http://ceaindustries.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://ceaindustries.com/role/PropertyAndEquipment 25 false false R26.htm 00000026 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities 26 false false R27.htm 00000027 - Disclosure - Equity Incentive Plans (Tables) Sheet http://ceaindustries.com/role/EquityIncentivePlansTables Equity Incentive Plans (Tables) Tables http://ceaindustries.com/role/EquityIncentivePlans 27 false false R28.htm 00000028 - Disclosure - Warrants (Tables) Sheet http://ceaindustries.com/role/WarrantsTables Warrants (Tables) Tables http://ceaindustries.com/role/Warrants 28 false false R29.htm 00000029 - Disclosure - Schedule of Revenue by Source (Details) Sheet http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails Schedule of Revenue by Source (Details) Details 29 false false R30.htm 00000030 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details) Sheet http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails Schedule of Remaining Performance Obligations Expected to be Recognized (Details) Details 30 false false R31.htm 00000031 - Disclosure - Schedule of Share-based Compensation Costs (Details) Sheet http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails Schedule of Share-based Compensation Costs (Details) Details 31 false false R32.htm 00000032 - Disclosure - General (Details Narrative) Sheet http://ceaindustries.com/role/GeneralDetailsNarrative General (Details Narrative) Details http://ceaindustries.com/role/GeneralTables 32 false false R33.htm 00000033 - Disclosure - Schedule of Lease Cost (Details) Sheet http://ceaindustries.com/role/ScheduleOfLeaseCostDetails Schedule of Lease Cost (Details) Details 33 false false R34.htm 00000034 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details) Sheet http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails Schedule of Future Annual Minimum Lease Payments (Details) Details 34 false false R35.htm 00000035 - Disclosure - Leases (Details Narrative) Sheet http://ceaindustries.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://ceaindustries.com/role/LeasesTables 35 false false R36.htm 00000036 - Disclosure - Schedule of Inventory (Details) Sheet http://ceaindustries.com/role/ScheduleOfInventoryDetails Schedule of Inventory (Details) Details 36 false false R37.htm 00000037 - Disclosure - Inventory (Details Narrative) Sheet http://ceaindustries.com/role/InventoryDetailsNarrative Inventory (Details Narrative) Details http://ceaindustries.com/role/InventoryTables 37 false false R38.htm 00000038 - Disclosure - Schedule of Property and Equipment (Details) Sheet http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails Schedule of Property and Equipment (Details) Details 38 false false R39.htm 00000039 - Disclosure - Property and Equipment (Details Narrative) Sheet http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://ceaindustries.com/role/PropertyAndEquipmentTables 39 false false R40.htm 00000040 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Schedule of Accounts Payable and Accrued Liabilities (Details) Details 40 false false R41.htm 00000041 - Disclosure - Note Payable and Accrued Interest (Details Narrative) Sheet http://ceaindustries.com/role/NotePayableAndAccruedInterestDetailsNarrative Note Payable and Accrued Interest (Details Narrative) Details http://ceaindustries.com/role/NotePayableAndAccruedInterest 41 false false R42.htm 00000042 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://ceaindustries.com/role/CommitmentsAndContingencies 42 false false R43.htm 00000043 - Disclosure - Temporary Equity (Details Narrative) Sheet http://ceaindustries.com/role/TemporaryEquityDetailsNarrative Temporary Equity (Details Narrative) Details http://ceaindustries.com/role/TemporaryEquity 43 false false R44.htm 00000044 - Disclosure - Stockholders??? Equity (Deficit) (Details Narrative) Sheet http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative Stockholders??? Equity (Deficit) (Details Narrative) Details http://ceaindustries.com/role/StockholdersEquityDeficit 44 false false R45.htm 00000045 - Disclosure - Schedule of Stock Option Activity (Details) Sheet http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails Schedule of Stock Option Activity (Details) Details 45 false false R46.htm 00000046 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details) Sheet http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails Summary of Non-vested Non-qualified Stock Option Activity (Details) Details 46 false false R47.htm 00000047 - Disclosure - Schedule of Restricted Stock Units Activity (Details) Sheet http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails Schedule of Restricted Stock Units Activity (Details) Details 47 false false R48.htm 00000048 - Disclosure - Equity Incentive Plans (Details Narrative) Sheet http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative Equity Incentive Plans (Details Narrative) Details http://ceaindustries.com/role/EquityIncentivePlansTables 48 false false R49.htm 00000049 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) Sheet http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails Schedule of Outstanding Warrants to Purchase Common Stock (Details) Details 49 false false R50.htm 00000050 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) (Parenthetical) Sheet http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetailsParenthetical Schedule of Outstanding Warrants to Purchase Common Stock (Details) (Parenthetical) Details 50 false false R51.htm 00000051 - Disclosure - Schedule of Warrants Outstanding (Details) Sheet http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails Schedule of Warrants Outstanding (Details) Details 51 false false R52.htm 00000052 - Disclosure - Warrants (Details Narrative) Sheet http://ceaindustries.com/role/WarrantsDetailsNarrative Warrants (Details Narrative) Details http://ceaindustries.com/role/WarrantsTables 52 false false R53.htm 00000053 - Disclosure - Income Taxes (Details Narrative) Sheet http://ceaindustries.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://ceaindustries.com/role/IncomeTaxes 53 false false R54.htm 00000054 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://ceaindustries.com/role/RelatedPartyTransactions 54 false false R55.htm 00000055 - Disclosure - Subsequent Events (Details Narrative) Sheet http://ceaindustries.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://ceaindustries.com/role/SubsequentEvents 55 false false All Reports Book All Reports form10-q.htm cead-20220331.xsd cead-20220331_cal.xml cead-20220331_def.xml cead-20220331_lab.xml cead-20220331_pre.xml ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 72 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 19, "contextCount": 188, "dts": { "calculationLink": { "local": [ "cead-20220331_cal.xml" ] }, "definitionLink": { "local": [ "cead-20220331_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "cead-20220331_lab.xml" ] }, "presentationLink": { "local": [ "cead-20220331_pre.xml" ] }, "schema": { "local": [ "cead-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 548, "entityCount": 1, "hidden": { "http://ceaindustries.com/20220331": 53, "http://fasb.org/us-gaap/2022": 62, "http://xbrl.sec.gov/dei/2022": 7, "total": 122 }, "keyCustom": 70, "keyStandard": 274, "memberCustom": 56, "memberStandard": 26, "nsprefix": "CEAD", "nsuri": "http://ceaindustries.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://ceaindustries.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Property and Equipment", "role": "http://ceaindustries.com/role/PropertyAndEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Accounts Payable and Accrued Liabilities", "role": "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities", "shortName": "Accounts Payable and Accrued Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Note Payable and Accrued Interest", "role": "http://ceaindustries.com/role/NotePayableAndAccruedInterest", "shortName": "Note Payable and Accrued Interest", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Commitments and Contingencies", "role": "http://ceaindustries.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:TemporaryEquityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Temporary Equity", "role": "http://ceaindustries.com/role/TemporaryEquity", "shortName": "Temporary Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:TemporaryEquityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Stockholders\u2019 Equity (Deficit)", "role": "http://ceaindustries.com/role/StockholdersEquityDeficit", "shortName": "Stockholders\u2019 Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Equity Incentive Plans", "role": "http://ceaindustries.com/role/EquityIncentivePlans", "shortName": "Equity Incentive Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:WarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Warrants", "role": "http://ceaindustries.com/role/Warrants", "shortName": "Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:WarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Income Taxes", "role": "http://ceaindustries.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Related Party Transactions", "role": "http://ceaindustries.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://ceaindustries.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Subsequent Events", "role": "http://ceaindustries.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - General (Policies)", "role": "http://ceaindustries.com/role/GeneralPolicies", "shortName": "General (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - General (Tables)", "role": "http://ceaindustries.com/role/GeneralTables", "shortName": "General (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Leases (Tables)", "role": "http://ceaindustries.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Inventory (Tables)", "role": "http://ceaindustries.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Property and Equipment (Tables)", "role": "http://ceaindustries.com/role/PropertyAndEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "role": "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Equity Incentive Plans (Tables)", "role": "http://ceaindustries.com/role/EquityIncentivePlansTables", "shortName": "Equity Incentive Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Warrants (Tables)", "role": "http://ceaindustries.com/role/WarrantsTables", "shortName": "Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Schedule of Revenue by Source (Details)", "role": "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails", "shortName": "Schedule of Revenue by Source (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_EquipmentAndSystemsSalesMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://ceaindustries.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "CEAD:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)", "role": "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "shortName": "Schedule of Remaining Performance Obligations Expected to be Recognized (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "CEAD:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Schedule of Share-based Compensation Costs (Details)", "role": "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "shortName": "Schedule of Share-based Compensation Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_us-gaap_CostOfSalesMember", "decimals": "0", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-02-142022-02-15", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - General (Details Narrative)", "role": "http://ceaindustries.com/role/GeneralDetailsNarrative", "shortName": "General (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "CEAD:ReverseStockSplitPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "lang": "en-US", "name": "us-gaap:StockholdersEquityReverseStockSplit", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Schedule of Lease Cost (Details)", "role": "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails", "shortName": "Schedule of Lease Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": null, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)", "role": "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails", "shortName": "Schedule of Future Annual Minimum Lease Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Leases (Details Narrative)", "role": "http://ceaindustries.com/role/LeasesDetailsNarrative", "shortName": "Leases (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-07-28_custom_NewFacilityLeaseMember", "decimals": "INF", "lang": null, "name": "us-gaap:AreaOfLand", "reportCount": 1, "unique": true, "unitRef": "SquareFoot", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Schedule of Inventory (Details)", "role": "http://ceaindustries.com/role/ScheduleOfInventoryDetails", "shortName": "Schedule of Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Inventory (Details Narrative)", "role": "http://ceaindustries.com/role/InventoryDetailsNarrative", "shortName": "Inventory (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Schedule of Property and Equipment (Details)", "role": "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "Schedule of Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Property and Equipment (Details Narrative)", "role": "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "Property and Equipment (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "role": "http://ceaindustries.com/role/StatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)", "role": "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails", "shortName": "Schedule of Accounts Payable and Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Note Payable and Accrued Interest (Details Narrative)", "role": "http://ceaindustries.com/role/NotePayableAndAccruedInterestDetailsNarrative", "shortName": "Note Payable and Accrued Interest (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "CEAD:CommonSharesIssuedInSettlementOfLegalDispute", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Commitments and Contingencies (Details Narrative)", "role": "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "CEAD:CommonSharesIssuedInSettlementOfLegalDispute", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Temporary Equity (Details Narrative)", "role": "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "shortName": "Temporary Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "CEAD:TemporaryEquityTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-11-012021-11-04", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Stockholders\u2019 Equity (Deficit) (Details Narrative)", "role": "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "shortName": "Stockholders\u2019 Equity (Deficit) (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-02-142022-02-15", "decimals": "INF", "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Schedule of Stock Option Activity (Details)", "role": "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "shortName": "Schedule of Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)", "role": "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails", "shortName": "Summary of Non-vested Non-qualified Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Schedule of Restricted Stock Units Activity (Details)", "role": "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "shortName": "Schedule of Restricted Stock Units Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - Equity Incentive Plans (Details Narrative)", "role": "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "shortName": "Equity Incentive Plans (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)", "role": "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "shortName": "Schedule of Outstanding Warrants to Purchase Common Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "lang": "en-US", "name": "CEAD:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholder's Equity (Deficit) (Unaudited)", "role": "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "shortName": "Condensed Consolidated Statements of Changes in Shareholder's Equity (Deficit) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details) (Parenthetical)", "role": "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetailsParenthetical", "shortName": "Schedule of Outstanding Warrants to Purchase Common Stock (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "CEAD:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - Schedule of Warrants Outstanding (Details)", "role": "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails", "shortName": "Schedule of Warrants Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31_custom_WarrantsRangeMember", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - Warrants (Details Narrative)", "role": "http://ceaindustries.com/role/WarrantsDetailsNarrative", "shortName": "Warrants (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "CEAD:WarrantsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-02-132022-02-15_custom_TwoThousandTwentyTwoInvestorWarrantsMember", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - Income Taxes (Details Narrative)", "role": "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative", "shortName": "Income Taxes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_ConsultingAgreementMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForCommissions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - Related Party Transactions (Details Narrative)", "role": "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "Related Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_custom_ConsultingAgreementMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForCommissions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - Subsequent Events (Details Narrative)", "role": "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent Events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-03-292022-04-01_us-gaap_SubsequentEventMember_custom_EmploymentAgreementMember", "decimals": null, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://ceaindustries.com/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - General", "role": "http://ceaindustries.com/role/General", "shortName": "General", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Leases", "role": "http://ceaindustries.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Inventory", "role": "http://ceaindustries.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 84, "tag": { "CEAD_AdjustmentsToAdditionalPaidInCapitalDividendsOnPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Dividends on series B preferred stock", "label": "Dividends on series B preferred stock" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalDividendsOnPreferredStock", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of restricted stock units issued to directors", "label": "Fair value of restricted stock units issued to directors" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfRestrictedStockUnitsIssuedToDirectors", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of vested stock options granted to employees", "label": "Fair value of vested stock options granted to directors" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToDirectors", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of vested stock options granted to employees", "label": "Fair value of vested stock options granted to employees" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptionsGrantedToEmployees", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_AdvertisingAndMarketingExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advertising and Marketing Expenses [Member]", "label": "Advertising and Marketing Expenses [Member]" } } }, "localname": "AdvertisingAndMarketingExpensesMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "CEAD_CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash proceeds from sale of preferred stock and warrants, net of issuance costs.", "label": "Cash proceeds on sale of common stock and warrants, net of expenses" } } }, "localname": "CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_CheifFinancialOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cheif Financial Officer [Member]", "label": "Cheif Financial Officer [Member]" } } }, "localname": "CheifFinancialOfficerMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_ClassOfWarrantOrRightExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right Exercised", "label": "Warrants, Exercised" } } }, "localname": "ClassOfWarrantOrRightExercised", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate intrinsic value of warrants exercised.", "label": "Aggregate Intrinsic Value, Exercised [Default Label]", "verboseLabel": "Aggregate Intrinsic Value, Exercised" } } }, "localname": "ClassOfWarrantOrRightExercisedAggregateIntrinsicValue", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_ClassOfWarrantOrRightExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right Expired.", "label": "ClassOfWarrantOrRightExpired", "negatedLabel": "Warrants, Expired" } } }, "localname": "ClassOfWarrantOrRightExpired", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate intrinsic value of warrants expired.", "label": "Aggregate Intrinsic Value, Expired" } } }, "localname": "ClassOfWarrantOrRightExpiredAggregateIntrinsicValue", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_ClassOfWarrantOrRightIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right Issued.", "label": "Warrants, issued" } } }, "localname": "ClassOfWarrantOrRightIssued", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "sharesItemType" }, "CEAD_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate intrinsic value of warrants issued.", "label": "Aggregate Intrinsic Value, Issued" } } }, "localname": "ClassOfWarrantOrRightIssuedAggregateIntrinsicValue", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate intrinsic value of outstanding warrants.", "label": "Aggregate intrinsic value of outstanding warrants", "periodEndLabel": "Aggregate Intrinsic Value, Ending Balance", "periodStartLabel": "Aggregate Intrinsic Value, Beginning Balance" } } }, "localname": "ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of warrants exercised.", "label": "Weighted Average Exercise Price, Exercised [Default Label]", "verboseLabel": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercised", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "perShareItemType" }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of warrants expired.", "label": "Weighted Average Exercise Price, Expired [Default Label]", "verboseLabel": "Weighted Average Exercise Price, Expired" } } }, "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExpired", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "perShareItemType" }, "CEAD_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price of warrants issued.", "label": "Weighted Average Exercise Price, Issued" } } }, "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceIssued", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "perShareItemType" }, "CEAD_CommonSharesIssuedInSettlementOfLegalDispute": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common shares issued in settlement of legal dispute, value.", "label": "Common shares issued in settlement of legal dispute, value" } } }, "localname": "CommonSharesIssuedInSettlementOfLegalDispute", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_CommonSharesIssuedInSettlementOfLegalDisputeShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares issued in settlement of legal dispute, shares.", "label": "Common shares issued in settlement of legal dispute, shares" } } }, "localname": "CommonSharesIssuedInSettlementOfLegalDisputeShares", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "CEAD_CommonSharesToBeIssuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Shares To Be Issued [Member]", "label": "Common Shares To Be Issued [Member]" } } }, "localname": "CommonSharesToBeIssuedMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "CEAD_CommonStock0.00001ParValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, $0.00001 Par Value [Member]", "label": "Common Stock, $0.00001 Par Value [Member]" } } }, "localname": "CommonStock0.00001ParValueMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "domainItemType" }, "CEAD_CommonStockIssuedForOtherExpense": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Common stock issued for other expense.", "label": "Common stock issued for other expense" } } }, "localname": "CommonStockIssuedForOtherExpense", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_ConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting Agreement [Member]", "label": "Consulting Agreement [Member]" } } }, "localname": "ConsultingAgreementMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_ConversionPriceReducedOfferingPricePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion price reduced offering price, percentage", "label": "Conversion price reduced offering price, percentage" } } }, "localname": "ConversionPriceReducedOfferingPricePercentage", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "CEAD_ConvertiblePreferredStockConvertedToSecurities": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Series B Stock Dividends.", "label": "ConvertiblePreferredStockConvertedToSecurities", "negatedLabel": "Convertible preferred series B stock dividends" } } }, "localname": "ConvertiblePreferredStockConvertedToSecurities", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "CEAD_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_CustomerThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Three [Member]", "label": "Customer Three [Member]" } } }, "localname": "CustomerThreeMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_DecreaseInCommonStockConversionPriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Decrease In Common Stock Conversion Price [Member]" } } }, "localname": "DecreaseInCommonStockConversionPriceMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_DeemedDividendPreferredStockOnDownRound": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deemed dividend on series B preferred stock on down round.", "label": "Deemed dividend on series B preferred stock on down round", "negatedLabel": "Deemed dividend on convertible preferred series B stock on down round" } } }, "localname": "DeemedDividendPreferredStockOnDownRound", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_DescriptionOfBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description Of Business [Policy Text Block]", "label": "Description of Business" } } }, "localname": "DescriptionOfBusinessPolicyTextBlock", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_DirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Directors [Member]", "label": "Directors [Member]" } } }, "localname": "DirectorsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases", "terseLabel": "Schedule Of Future Annual Minimum Lease Payments", "verboseLabel": "Schedule Of Lease Cost" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://ceaindustries.com/20220331", "xbrltype": "stringItemType" }, "CEAD_DisclosureTemporaryEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity" } } }, "localname": "DisclosureTemporaryEquityAbstract", "nsuri": "http://ceaindustries.com/20220331", "xbrltype": "stringItemType" }, "CEAD_DisclosureWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants", "terseLabel": "Schedule Of Outstanding Warrants To Purchase Common Stock Details", "verboseLabel": "Schedule Of Outstanding Warrants To Purchase Common Stock" } } }, "localname": "DisclosureWarrantsAbstract", "nsuri": "http://ceaindustries.com/20220331", "xbrltype": "stringItemType" }, "CEAD_EmployeesAndConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees And Consultants [Member]", "label": "Employees And Consultants [Member]" } } }, "localname": "EmployeesAndConsultantsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_EmployeesDirectorsandConsultantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees, Directors and Consultants [Member]", "label": "Employees, Directors and Consultants [Member]" } } }, "localname": "EmployeesDirectorsandConsultantsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees [Member]", "label": "Employees [Member]" } } }, "localname": "EmployeesMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_EmploymentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employment Agreement [Member]", "label": "Employment Agreement [Member]" } } }, "localname": "EmploymentAgreementMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_EngineeringAndOtherServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Engineering and Other Services [Member]", "label": "Engineering and Other Services [Member]" } } }, "localname": "EngineeringAndOtherServicesMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "CEAD_EquipmentAndSystemsSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equipment And Systems Sales [Member]" } } }, "localname": "EquipmentAndSystemsSalesMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "CEAD_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Impact Of Covid19 Pandemic On Our Business [Policy Text Block]", "label": "Impact of the COVID-19 Pandemic on Our Business" } } }, "localname": "ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_IncentiveStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incentive Stock Option [Member]", "label": "Incentive Stock Option [Member]" } } }, "localname": "IncentiveStockOptionMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_IncreaseDecreaseInDeferredCompensationAccruedEquityCompensation": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in deferred compensation accrued equity compensation.", "label": "IncreaseDecreaseInDeferredCompensationAccruedEquityCompensation", "verboseLabel": "Accrued equity compensation" } } }, "localname": "IncreaseDecreaseInDeferredCompensationAccruedEquityCompensation", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_IncreaseDecreaseInLeaseDeposit": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in lease deposit.", "label": "Lease deposit" } } }, "localname": "IncreaseDecreaseInLeaseDeposit", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_IncreaseInRentPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase in rent percent.", "label": "Increase in rent percent" } } }, "localname": "IncreaseInRentPercent", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "percentItemType" }, "CEAD_IndefiniteTermMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indefinite Term [Member]", "label": "Indefinite Term [Member]" } } }, "localname": "IndefiniteTermMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_InventoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventory [Member]", "label": "Inventory [Member]" } } }, "localname": "InventoryMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_JanuarySeventeernTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January 17, 2023 [Member]", "label": "January 17, 2023 [Member]" } } }, "localname": "JanuarySeventeernTwoThousandTwentyThreeMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_JanuarySeventeernTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January 17, 2022 [Member]", "label": "January 17, 2022 [Member]" } } }, "localname": "JanuarySeventeernTwoThousandTwentyTwoMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Therafter", "label": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_NetOperatingLossCarryForwardExpectedToExpireAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net operating loss carry forward expected to expire amount.", "label": "Net operating loss carryforward expected to expire amount" } } }, "localname": "NetOperatingLossCarryForwardExpectedToExpireAmount", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_NewFacilityLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Facility Lease [Member]", "label": "New Facility Lease [Member]" } } }, "localname": "NewFacilityLeaseMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_NolsCarryforwardsTermDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nols carryforwards term description.", "label": "Nols carryforwards term description" } } }, "localname": "NolsCarryforwardsTermDescription", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "CEAD_NolsUsageAgainstTaxableIncomePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NOLs usage against taxable income percentage.", "label": "NOLs usage against taxable income percentage" } } }, "localname": "NolsUsageAgainstTaxableIncomePercentage", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "CEAD_NonQualifiedStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non Qualified Stock Option [Member]", "label": "Non Qualified Stock Option [Member]" } } }, "localname": "NonQualifiedStockOptionMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_NonQualifiedStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-qualified Stock Options [Member]", "label": "Non-Qualified Stock Options [Member]" } } }, "localname": "NonQualifiedStockOptionsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of series B preferred stock.", "label": "Conversion of series B preferred stock" } } }, "localname": "NoncashInvestingAndFinancingActivitiesConversionOfSeriesBPreferredStock", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deemed dividend on series B preferred stock arising on down round.", "label": "Deemed dividend on series B preferred stock arising on down round" } } }, "localname": "NoncashInvestingAndFinancingActivitiesDeemedDividendPreferredStockArisingOnDownRound", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_OneFormerEmployeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Former Employee [Member]", "label": "One Former Employee [Member]" } } }, "localname": "OneFormerEmployeeMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_PaymentsForRedemptionOfPreferredStock": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redemption of series B preferred stock", "label": "Redemption of series B preferred stock", "negatedLabel": "Redemption of series B preferred stock" } } }, "localname": "PaymentsForRedemptionOfPreferredStock", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "CEAD_PercentageOfPreferredStockConversionProvision": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of preferred stock conversion provision.", "label": "Percentage of preferred stock conversion provision", "verboseLabel": "Dividend rate percentage" } } }, "localname": "PercentageOfPreferredStockConversionProvision", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "CEAD_PlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Placement Agent Warrants [Member]", "label": "Placement Agent Warrants [Member]" } } }, "localname": "PlacementAgentWarrantsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_PrepaidInventoryExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid inventory expenses", "label": "Prepaid inventory expenses" } } }, "localname": "PrepaidInventoryExpenses", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/InventoryDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_ProductDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Development Costs [Member]", "label": "Product Development Costs [Member]" } } }, "localname": "ProductDevelopmentCostsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "CEAD_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining performance obligations related to engineering only paid contracts.", "label": "Remaining performance obligations related to engineering only paid contracts" } } }, "localname": "RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining performance obligations related to partial equipment paid contracts.", "label": "Remaining performance obligations related to partial equipment paid contracts" } } }, "localname": "RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_RestrictedSharesIssuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Shares Issued [Member]", "label": "Restricted Shares Issued [Member]" } } }, "localname": "RestrictedSharesIssuedMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_ReverseStockSplitPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ReverseStockSplit [Policy Text Block]", "label": "Reverse Stock Split" } } }, "localname": "ReverseStockSplitPolicyTextBlock", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Outstanding Warrants to Purchase Common Stock [Table Text Block]", "label": "Schedule of Outstanding Warrants to Purchase Common Stock" } } }, "localname": "ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/WarrantsTables" ], "xbrltype": "textBlockItemType" }, "CEAD_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member]", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_SeriesBPreferredSharesConversionWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B Preferred Shares Conversion Warrants [Member]", "label": "Series B Preferred Shares Conversion Warrants [Member]" } } }, "localname": "SeriesBPreferredSharesConversionWarrantsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_SeriesBPreferredSharesPreFundedConversionWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B Preferred Shares Pre Funded Conversion Warrants [Member]", "label": "Series B Preferred Shares Pre Funded Conversion Warrants [Member]" } } }, "localname": "SeriesBPreferredSharesPreFundedConversionWarrantsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_SeriesBRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B Redeemable Convertible Preferred Stock [Member]", "label": "Series B Redeemable Convertible Preferred Stock [Member]" } } }, "localname": "SeriesBRedeemableConvertiblePreferredStockMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, number of shares authorized.", "label": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangemenByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceOfWarrantsVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price, per share", "label": "Exercise price, per share", "verboseLabel": "Warrant price per share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePriceOfWarrantsVested", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "CEAD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options exercised in period aggregate intrinsic value.", "label": "Aggregate Intrinsic Value, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodAggregateIntrinsicValue", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Life of Outstanding Warrants in Months, Issued.", "label": "Weighted Average Life of Outstanding Warrants in Months, Issued" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average life of outstanding warrants in months, ending balance.", "label": "Weighted Average Life of Outstanding Warrants in Months, Ending Balance", "verboseLabel": "Weighted Average Life of Outstanding Warrants in Months" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Life of Outstanding Warrants in Months.", "label": "Weighted Average Life of Outstanding Warrants in Months" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average life of outstanding warrants in months, beginning balance.", "label": "Weighted Average Life of Outstanding Warrants in Months, Beginning Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.", "label": "Grant Date Fair Value Nonvested, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Aggregated Intrinsic Value, Nonvested Beginning", "periodEndLabel": "Aggregated Intrinsic Value, Nonvested Ending", "periodStartLabel": "Aggregated Intrinsic Value, Nonvested Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.", "label": "Aggregated Intrinsic Value, Nonvested Beginning [Default Label]", "periodEndLabel": "Grant Date Fair Value Nonvested, Ending", "periodStartLabel": "Grant Date Fair Value Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.", "label": "Grant Date Fair Value Nonvested, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.", "label": "Grant Date Fair Value Nonvested, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Options, price per share", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue", "verboseLabel": "Weighted Average Grant-Date Fair Value, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpiredWeightedAverageGrantDateFairValue", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired", "label": "Grant Date Fair Value Nonvested, Expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Options, Expired.", "label": "Number of Options Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term, Ending.", "label": "Weighted Average Remaining Contractual Term, Outstanding Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term,Exercised.", "label": "Weighted Average Remaining Contractual Term,Exercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExercised", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term,Expired.", "label": "Weighted Average Remaining Contractual Term,Expired" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term,Forfeited.", "label": "Weighted Average Remaining Contractual Term,Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term, granted.", "label": "Weighted Average Remaining Contractual Term, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "CEAD_SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsNonvested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Grant Date Fair Value Nonvested, Beginning.", "label": "Grant Date Fair Value Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsNonvested", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "CEAD_StockIssuedDuringPeriodSharesCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares issued in settlement of restricted stock units issued to directors", "label": "Common shares issued in settlement of restricted stock units issued to directors, shares" } } }, "localname": "StockIssuedDuringPeriodSharesCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "CEAD_StockIssuedDuringPeriodSharesCommonSharesToBeIssuedInSettlementOfLegalDispute": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares to be issued in settlement of legal dispute", "label": "Common shares to be issued in settlement of legal dispute, shares" } } }, "localname": "StockIssuedDuringPeriodSharesCommonSharesToBeIssuedInSettlementOfLegalDispute", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "CEAD_StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common shares issued in settlement of restricted stock units issued to directors.", "label": "Common shares issued in settlement of restricted stock units issued to directors" } } }, "localname": "StockIssuedDuringPeriodValueCommonSharesIssuedInSettlementOfRestrictedStockUnitsIssuedToDirectors", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_StockIssuedDuringPeriodValueCommonSharesToBeIssuedInSettlementOfLegalDispute": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common shares to be issued in settlement of legal dispute", "label": "Common shares to be issued in settlement of legal dispute" } } }, "localname": "StockIssuedDuringPeriodValueCommonSharesToBeIssuedInSettlementOfLegalDispute", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_StockIssuedDuringPeriodValueReverseStockSplits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common shares to round up partial shares following reverse split", "label": "Issuance of common shares to round up partial shares following reverse split" } } }, "localname": "StockIssuedDuringPeriodValueReverseStockSplits", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "CEAD_TemporaryEquityNonCashRedemptionValueAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary equity noncash redemption value adjustment.", "label": "Temporary equity noncash redemption value adjustment" } } }, "localname": "TemporaryEquityNonCashRedemptionValueAdjustment", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "CEAD_TemporaryEquityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity [Policy Text Block]", "label": "TemporaryEquityPolicyTextBlock", "verboseLabel": "Temporary Equity" } } }, "localname": "TemporaryEquityPolicyTextBlock", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "CEAD_TemporaryEquityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity [Text Block]", "label": "Temporary Equity [Text Block]", "verboseLabel": "Temporary Equity" } } }, "localname": "TemporaryEquityTextBlock", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/TemporaryEquity" ], "xbrltype": "textBlockItemType" }, "CEAD_ThreeNewEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Three New Employees [Member]", "label": "Three New Employees [Member]" } } }, "localname": "ThreeNewEmployeesMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwentyOneEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "21 Employees [Member]", "label": "21 Employees [Member]" } } }, "localname": "TwentyOneEmployeesMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Directors [Member]", "label": "Two Directors [Member]" } } }, "localname": "TwoDirectorsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Equity Plan and 2021 Equity Plan [Member]", "label": "2017 Equity Plan and 2021 Equity Plan [Member]" } } }, "localname": "TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndSeventeenEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 Equity Incentive Plan [Member]", "label": "2017 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandAndSeventeenEquityPlanMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndTwentyOneEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Equity Plan [Member]", "label": "2021 Equity Plan [Member]" } } }, "localname": "TwoThousandAndTwentyOneEquityPlanMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndTwentyOnePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Plan [Member]", "label": "2021 Plan [Member]" } } }, "localname": "TwoThousandAndTwentyOnePlanMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2023 [Member]", "label": "2023 [Member]" } } }, "localname": "TwoThousandAndTwentyThreeMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandAndTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2022 [Member]", "label": "2022 [Member]" } } }, "localname": "TwoThousandAndTwentyTwoMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Annual Employee Incentive Compensation Plan [Member]", "label": "2021 Annual Employee Incentive Compensation Plan [Member]" } } }, "localname": "TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandTwentyOneEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Equity Incentive Plan [Member]", "label": "2021 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandTwentyOneEquityIncentivePlanMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandTwentyOneEquityPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Equity Plan [Member]", "label": "2021 Equity Plan [Member] [Default Label]", "verboseLabel": "2021 Equity Plan [Member]" } } }, "localname": "TwoThousandTwentyOneEquityPlanMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandTwentyTwoInvestorWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2022 Investor Warrants [Member]", "label": "2022 Investor Warrants [Member]" } } }, "localname": "TwoThousandTwentyTwoInvestorWarrantsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandTwentyTwoOverAllotmentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2022 OverAllotment Warrants [Member]", "label": "2022 OverAllotment Warrants [Member]" } } }, "localname": "TwoThousandTwentyTwoOverAllotmentWarrantsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_TwoThousandTwentyTwoUnderwriterWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2022 UnderwriterWarrants [Member]", "label": "2022 UnderwriterWarrants [Member]" } } }, "localname": "TwoThousandTwentyTwoUnderwriterWarrantsMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_UnderwritersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriters [Member]", "label": "Underwriters [Member]" } } }, "localname": "UnderwritersMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_VestedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vested [Member]", "label": "Vested [Member]" } } }, "localname": "VestedMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_WarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant One [Member]", "label": "Warrant One [Member]" } } }, "localname": "WarrantOneMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Disclosure [Text Block]", "label": "WarrantsDisclosureTextBlock", "verboseLabel": "Warrants" } } }, "localname": "WarrantsDisclosureTextBlock", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/Warrants" ], "xbrltype": "textBlockItemType" }, "CEAD_WarrantsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants percent.", "label": "Warrants percent" } } }, "localname": "WarrantsPercentage", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "percentItemType" }, "CEAD_WarrantsRangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range Four [Member]", "label": "Warrants Range Four [Member]" } } }, "localname": "WarrantsRangeFourMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsRangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range [Member]", "label": "Warrants Range [Member]" } } }, "localname": "WarrantsRangeMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range One [Member]", "label": "Warrants Range One [Member]" } } }, "localname": "WarrantsRangeOneMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range Three [Member]", "label": "Warrants Range Three [Member]" } } }, "localname": "WarrantsRangeThreeMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Range Two [Member]", "label": "Warrants Range Two [Member]" } } }, "localname": "WarrantsRangeTwoMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "CEAD_WarrantsToPurchaseCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants to Purchase Common Stock [Member]", "label": "Warrants to Purchase Common Stock [Member]" } } }, "localname": "WarrantsToPurchaseCommonStockMember", "nsuri": "http://ceaindustries.com/20220331", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r490" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r490" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r487", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r491" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r490" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ceaindustries.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r157", "r274", "r278", "r458" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r196", "r198", "r199", "r200", "r219", "r243", "r284", "r285", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r456", "r459", "r473", "r474" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r196", "r198", "r199", "r200", "r219", "r243", "r284", "r285", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r456", "r459", "r473", "r474" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r157", "r274", "r278", "r458" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r155", "r198", "r199", "r274", "r277", "r417", "r455", "r457" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r155", "r198", "r199", "r274", "r277", "r417", "r455", "r457" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r189", "r196", "r198", "r199", "r200", "r219", "r243", "r282", "r284", "r285", "r320", "r321", "r322", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r456", "r459", "r473", "r474" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r189", "r196", "r198", "r199", "r200", "r219", "r243", "r282", "r284", "r285", "r320", "r321", "r322", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r456", "r459", "r473", "r474" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r158", "r398" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities", "totalLabel": "Total" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r37", "r404" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r159", "r160" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable (net of allowance for doubtful accounts of $159,744 and $181,942, respectively)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [ "r6", "r41" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales commissions payable" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r14", "r183" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r52", "r53", "r372", "r373", "r374", "r375", "r376", "r377" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r23", "r404" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r94", "r95", "r96", "r331", "r332", "r333", "r364" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Total share-based compensation expense included in consolidated statement of operations", "verboseLabel": "Share-Based Payment Arrangement, Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r28", "r161", "r166" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance for doubtful accounts, net" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r17", "r90", "r144", "r147", "r153", "r164", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r352", "r355", "r370", "r402", "r404", "r433", "r446" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r36", "r90", "r164", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r352", "r355", "r370", "r402", "r404" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r90", "r164", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r352", "r355", "r370", "r402" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total Noncurrent Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncurrent Assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r290", "r291", "r292", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r312", "r314", "r315", "r319", "r320", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r290", "r291", "r292", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r312", "r314", "r315", "r319", "r320", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r290", "r291", "r292", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r312", "r314", "r315", "r319", "r320", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Financial Statement Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r12", "r404", "r466", "r467" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash balance, amount" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r12", "r77" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r78", "r431" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash, Cash Equivalents and Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r70", "r77", "r83" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r70", "r371" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Federal insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r20", "r21", "r22", "r87", "r90", "r110", "r111", "r114", "r117", "r119", "r125", "r126", "r127", "r164", "r206", "r210", "r211", "r212", "r215", "r216", "r240", "r241", "r245", "r249", "r255", "r370", "r492" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "periodEndLabel": "Weighted Average Exercise Price, Ending Balance", "periodStartLabel": "Weighted Average Exercise Price, Beginning Balance", "verboseLabel": "Exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetailsParenthetical", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Issuance of warrants" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Warrants Outstanding", "periodEndLabel": "Warrants Outstanding, Ending Balance", "periodStartLabel": "Warrants Outstanding, Beginning Balance", "verboseLabel": "Issuance of warrants" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails", "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r45", "r435", "r450" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies (Note 7)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r191", "r192", "r193", "r201", "r469" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Shares available for future equity awards" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockConvertibleConversionPriceIncrease": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision.", "label": "Conversion price" } } }, "localname": "CommonStockConvertibleConversionPriceIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r94", "r95", "r364" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued", "verboseLabel": "Common stock issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r255" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding", "verboseLabel": "Common stock outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r22", "r404" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.00001 par value; 200,000,000 and 850,000,000 shares authorized, respectively; 7,784,444 and 1,600,835 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r134", "r135", "r157", "r368", "r369", "r468" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r134", "r135", "r157", "r368", "r369", "r465", "r468" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r134", "r135", "r157", "r368", "r369", "r465", "r468" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r130", "r445" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r134", "r135", "r157", "r368", "r369" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r134", "r135", "r157", "r368", "r369", "r468" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r84", "r354" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r261", "r262", "r275" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred revenue", "verboseLabel": "Contract with Customer, Liability, Current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r276" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r80", "r81", "r82" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r240", "r241", "r245" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSoldOverhead": { "auth_ref": [ "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indirect cost incurred related to good produced and service rendered.", "label": "Overhead expenses" } } }, "localname": "CostOfGoodsAndServicesSoldOverhead", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/InventoryDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r61", "r90", "r164", "r206", "r207", "r208", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r370" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r133", "r157" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r86", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r231", "r234" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Note Payable and Accrued Interest" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/NotePayableAndAccruedInterest" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Per share excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share.", "label": "Debt Instrument, Convertible, Liquidation Preference, Per Share" } } }, "localname": "DebtInstrumentConvertibleLiquidationPreferencePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue": { "auth_ref": [ "r221" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share.", "label": "Debt Instrument, Convertible, Liquidation Preference, Value" } } }, "localname": "DebtInstrumentConvertibleLiquidationPreferenceValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r217", "r232", "r233", "r379", "r380", "r381" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Note payable principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/NotePayableAndAccruedInterestDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/NotePayableAndAccruedInterestDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r43", "r218" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Loan interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/NotePayableAndAccruedInterestDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r44", "r219", "r367" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Loan due date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/NotePayableAndAccruedInterestDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredCompensationLiabilityCurrent": { "auth_ref": [ "r280", "r281" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Accrued equity compensation" } } }, "localname": "DeferredCompensationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r16" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Deposits" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r75", "r181" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expenses" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r75", "r142" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation and intangible asset amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r49", "r358", "r359", "r360", "r362" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Schedule of Revenue by Source" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r289", "r290", "r326", "r327", "r329", "r335" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Equity Incentive Plans" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r257", "r443" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "Dividends" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r57", "r99", "r100", "r101", "r102", "r103", "r108", "r110", "r117", "r118", "r119", "r122", "r123", "r365", "r366", "r438", "r452" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Loss per common share \u2013 basic and dilutive" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r120", "r121" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Income (Loss) Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll liabilities" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r328" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r52", "r53", "r54", "r94", "r95", "r96", "r98", "r104", "r106", "r124", "r165", "r255", "r257", "r331", "r332", "r333", "r342", "r343", "r364", "r372", "r373", "r374", "r375", "r376", "r377", "r393", "r460", "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_FederalDepositInsuranceCorporationPremiumExpense": { "auth_ref": [ "r440" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance.", "label": "Federal deposit insurance corporation premium expense" } } }, "localname": "FederalDepositInsuranceCorporationPremiumExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r75", "r180", "r186" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "negatedLabel": "Loss on disposal of assets" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r15", "r171", "r172", "r173", "r175", "r404", "r432" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r174", "r177" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r60", "r90", "r144", "r146", "r149", "r152", "r154", "r164", "r206", "r207", "r208", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r370" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Impaired Assets to be Disposed of by Method Other than Sale [Line Items]" } } }, "localname": "ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleTable": { "auth_ref": [ "r179", "r185" ], "lang": { "en-us": { "role": { "documentation": "When an entity determines it will dispose of a long-lived asset by a method other than sale (for example, by abandonment, distribution in a spin-off), impairment of such assets is separately disclosed from those assets held and used.", "label": "Impaired Assets to be Disposed of by Method Other than Sale [Table]" } } }, "localname": "ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r55", "r144", "r146", "r149", "r152", "r154", "r430", "r436", "r441", "r453" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r187", "r190" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r91", "r338", "r339", "r340", "r344", "r346", "r348", "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r92", "r105", "r106", "r143", "r337", "r345", "r347", "r454" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r79" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable": { "auth_ref": [ "r74" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.", "label": "Increase (Decrease) in Accounts and Notes Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsAndNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r74" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r74", "r415" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r74" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Accrued interest" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r74" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r74", "r386" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liability, net" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r74" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses and other" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "auth_ref": [ "r112", "r113", "r119" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.", "label": "Potentially dilutive equity instruments that are convertible into common stock" } } }, "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r176", "r178" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r439" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income (expense),net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r69", "r71", "r79" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r29" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r35", "r404" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, net", "totalLabel": "Inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r31" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r35", "r169" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Allowance for excess & obsolete inventory" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r30" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work in progress" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r168" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Provision for excess and obsolete inventory" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Schedule of Lease Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r182" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeOperatingLeaseDescription": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Description of lessee's operating lease.", "label": "Operating lease term description" } } }, "localname": "LesseeOperatingLeaseDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of Future Annual Minimum Lease Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r390" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r390" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r390" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r390" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r390" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r390" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "2022 (excluding the three months ended March 31, 2022)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r390" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "verboseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r40", "r90", "r148", "r164", "r206", "r207", "r208", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r353", "r355", "r356", "r370", "r402", "r403" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r27", "r90", "r164", "r370", "r404", "r434", "r448" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r5", "r42", "r90", "r164", "r206", "r207", "r208", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r353", "r355", "r356", "r370", "r402", "r403", "r404" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r9", "r10", "r11", "r18", "r19", "r90", "r164", "r206", "r207", "r208", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r353", "r355", "r356", "r370", "r402", "r403" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Noncurrent Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NONCURRENT LIABILITIES" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Cost of settelement" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r194", "r195", "r196", "r197", "r198", "r203", "r204" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_MarketingAndAdvertisingExpense": { "auth_ref": [ "r62" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.", "label": "Advertising and marketing expenses" } } }, "localname": "MarketingAndAdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r70" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r70" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r70", "r73", "r76" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash (used in)/provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r50", "r51", "r54", "r56", "r76", "r90", "r97", "r99", "r100", "r101", "r102", "r105", "r106", "r115", "r144", "r146", "r149", "r152", "r154", "r164", "r206", "r207", "r208", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r366", "r370", "r437", "r451" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r99", "r100", "r101", "r102", "r108", "r109", "r116", "r119", "r144", "r146", "r149", "r152", "r154" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net Loss Available to Common Shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r63" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r144", "r146", "r149", "r152", "r154" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r383" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of minimum lease payments" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r383" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion of operating lease liability", "verboseLabel": "Operating lease liability, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r383" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability, net of current portion", "verboseLabel": "Operating lease liability, long-term" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r384", "r386" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating cash outflow from operating lease" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r382" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r75" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Amortization of ROU asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r388", "r391" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r387", "r391" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Remaning lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfLeaseCostDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r93", "r107", "r139", "r357" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "General" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/General" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherExpenseMember": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other expense.", "label": "Other Expense [Member]" } } }, "localname": "OtherExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInventoryInTransit": { "auth_ref": [ "r32" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported.", "label": "Inventory in transit" } } }, "localname": "OtherInventoryInTransit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/InventoryDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r41", "r404" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r64" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other receivables" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForCommissions": { "auth_ref": [ "r72" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for commissions during the current period.", "label": "Payments for commissions" } } }, "localname": "PaymentsForCommissions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r72" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Lease rental expense" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "auth_ref": [ "r68" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "negatedLabel": "Payment of dividends on series B preferred stock" } } }, "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r65" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r290", "r291", "r292", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r312", "r314", "r315", "r319", "r320", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r290", "r291", "r292", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r312", "r314", "r315", "r319", "r320", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConvertibleConversionPrice": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Per share conversion price of preferred stock.", "label": "Preferred Stock, Convertible, Conversion Price" } } }, "localname": "PreferredStockConvertibleConversionPrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Dividend rate percentage" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r21", "r240" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r21", "r240" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r21", "r404" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock; 25,000,000 and 150,000,000 shares authorized, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of common stock", "verboseLabel": "Net proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.", "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock" } } }, "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from warrants issuance" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r67" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from issuance of note payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r41", "r202", "r205" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "verboseLabel": "Product warranty accrual" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r188", "r470", "r471", "r472" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r13", "r182" ], "calculation": { "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment [Member]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r184", "r404", "r442", "r449" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r182" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/PropertyAndEquipmentDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r58", "r167" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r236", "r237", "r238", "r239" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "totalLabel": "Total Temporary Equity" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount": { "auth_ref": [ "r236", "r237", "r238", "r239" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of preferred shares (regardless of class), preferred partnership units (regardless of class), preferential membership interests, or any other form of preferred equity regardless of investee entity legal form.", "label": "Series B Redeemable Convertible Preferred Stock, $0.00001 par value; 0 and 3,300 issued and outstanding, respectively" } } }, "localname": "RedeemableNoncontrollingInterestEquityPreferredCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r283", "r396", "r397" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r283", "r396", "r399", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r394", "r395", "r397", "r400", "r401" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r336", "r416", "r475" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Product development costs" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r24", "r257", "r404", "r447", "r463", "r464" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r94", "r95", "r96", "r98", "r104", "r106", "r165", "r331", "r332", "r333", "r342", "r343", "r364", "r460", "r462" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r140", "r141", "r145", "r150", "r151", "r155", "r156", "r157", "r273", "r274", "r417" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue, net", "verboseLabel": "Total revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails", "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r85", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r279" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r263" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Total remaining performance obligations", "verboseLabel": "Revenue remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.", "label": "Schedule of Remaining Performance Obligations Expected to be Recognized" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Number of shares sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r134", "r157" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r7", "r32", "r33", "r34" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.", "label": "Summary of Non-vested Non-qualified Stock Option Activity" } } }, "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r303", "r310", "r313" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "Schedule of Share-based Compensation Costs" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r286", "r287", "r290", "r291", "r292", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r312", "r314", "r315", "r319", "r320", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of Restricted Stock Units Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r294", "r310", "r313" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r259", "r288" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Warrants Outstanding" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/WarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r16" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r62" ], "calculation": { "http://ceaindustries.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r20", "r21", "r255" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r20", "r21", "r255" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r74" ], "calculation": { "http://ceaindustries.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based compensation", "verboseLabel": "Share based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r290" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Stock options vesting, period", "verboseLabel": "Expected term years" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": { "auth_ref": [ "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.", "label": "Description,shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Number of Units, Forfeited/canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Weighted Average Grant-Date Fair Value, Forfeited/Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Number of Units, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Weighted Average Grant-Date Fair Value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Issuance of shares", "periodEndLabel": "Number of Units, ending", "periodStartLabel": "Number of Units, beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted Average Grant-Date Fair Value,ending", "periodStartLabel": "Weighted Average Grant-Date Fair Value, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Number of Units, Vested and settled with share issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Weighted Average Grant-Date Fair Value, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "verboseLabel": "Exercise price per share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/EquityIncentivePlansTables", "http://ceaindustries.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Number of shares authorized for equity awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Shares, granted", "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Number of Options, Exercisable Ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Exercisable Ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r302" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Number of Options, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Number of Options, Forfeited/Cancelled", "negatedLabel": "Number of Options, Forfeited", "verboseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value", "negatedLabel": "Aggregated Intrinsic Value, Nonvested Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of Options, Granted", "terseLabel": "Issuance of shares", "verboseLabel": "Number of Options Nonvested, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted Average Grant-Date Fair Value, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r330" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Aggregate Intrinsic Value, Outstanding Ending", "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r295", "r296" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Number of option remain outstanding", "periodEndLabel": "Number of Options, Outstanding Ending", "periodStartLabel": "Number of Options, Outstanding Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r295", "r296" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Outstanding Ending", "periodStartLabel": "Weighted Average Exercise Price, Outstanding Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Number of stock options issued", "verboseLabel": "Number of shares issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased for issuance under share-based payment arrangement.", "label": "Number of options to purchase shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r290", "r291", "r292", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r311", "r312", "r314", "r315", "r319", "r320", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r300" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r302" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Weighted Average Exercise Price, Expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted Average Exercise Price, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Exercise price", "verboseLabel": "Weighted Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r293", "r317", "r318", "r319", "r320", "r323", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Accounting for Share-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Exercise price, lower" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Exercise price, upper" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "periodEndLabel": "Aggregate Intrinsic Value Nonvested, ending", "periodStartLabel": "Aggregate Intrinsic Value Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r330" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value, Exercisable Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Issuance of stock, unvested", "periodEndLabel": "Number of Options Nonvested, Beginning", "periodStartLabel": "Number of Options Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Number of Options Nonvested, Forfeited", "verboseLabel": "Number of Options Nonvested, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value", "verboseLabel": "Weighted Average Grant-Date Fair Value, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Grant-Date Fair Value, Ending", "periodStartLabel": "Weighted Average Grant-Date Fair Value, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Expected term years" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r312" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Aggregated Intrinsic Value, Nonvested Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Shares, vested", "negatedLabel": "Number of Options Nonvested, Beginning", "verboseLabel": "Number of options to purchase shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value", "verboseLabel": "Weighted Average Grant-Date Fair Value, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Issuance of per unit" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfRevenueBySourceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r20", "r21", "r22", "r87", "r90", "r110", "r111", "r114", "r117", "r119", "r125", "r126", "r127", "r164", "r206", "r210", "r211", "r212", "r215", "r216", "r240", "r241", "r245", "r249", "r255", "r370", "r492" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r48", "r52", "r53", "r54", "r94", "r95", "r96", "r98", "r104", "r106", "r124", "r165", "r255", "r257", "r331", "r332", "r333", "r342", "r343", "r364", "r372", "r373", "r374", "r375", "r376", "r377", "r393", "r460", "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r94", "r95", "r96", "r124", "r417" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/Cover", "http://ceaindustries.com/role/ScheduleOfShare-basedCompensationCostsDetails", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of preferred stock and warrants for common stock issued.", "label": "Purchase price" } } }, "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r47", "r228", "r255", "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Common shares and warrants issued on conversion of series B preferred stock, shares", "verboseLabel": "Issuance of shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r21", "r22", "r255", "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Shares, Conversion of Units" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock issued during period, shares, issued for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r21", "r22", "r255", "r257" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common shares and warrants issued for cash, shares", "terseLabel": "Issuance of shares", "verboseLabel": "Number of shares issued during the period" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split.", "label": "Issuance of common shares to round up partial shares following reverse split, shares" } } }, "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Non qualified stock options" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r21", "r22", "r255", "r257", "r300" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Number of Options, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r48", "r255", "r257" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Common shares and warrants issued on conversion of series B preferred stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r21", "r22", "r255", "r257" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Common shares and warrants issued for cash", "verboseLabel": "Issuance of Value" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r21", "r22", "r255", "r257" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Issuance of stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/EquityIncentivePlansDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Shares" } } }, "localname": "StockRedeemedOrCalledDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "auth_ref": [ "r255" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Value" } } }, "localname": "StockRedeemedOrCalledDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r22", "r25", "r26", "r90", "r162", "r164", "r370", "r404" ], "calculation": { "http://ceaindustries.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Shareholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets", "http://ceaindustries.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r88", "r241", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r257", "r260", "r363" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Reverse stock split description" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r378", "r406" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r378", "r406" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r378", "r406" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r378", "r406" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r405", "r407" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TEMPORARY EQUITY" } } }, "localname": "TemporaryEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.", "label": "Temporary Equity, Aggregate Amount of Redemption Requirement" } } }, "localname": "TemporaryEquityAggregateAmountOfRedemptionRequirement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r8", "r235" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary equity, par value", "verboseLabel": "Temporary Equity, Par or Stated Value Per Share" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/LeasesDetailsNarrative", "http://ceaindustries.com/role/RelatedPartyTransactionsDetailsNarrative", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r128", "r129", "r131", "r132", "r136", "r137", "r138" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/GeneralPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/TemporaryEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrants maturity date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrant term", "verboseLabel": "Warrants term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StockholdersEquityDeficitDetailsNarrative", "http://ceaindustries.com/role/WarrantsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r108", "r119" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding, basic and dilutive" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ceaindustries.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r107": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r139": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r188": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r193": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r201": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907644&loc=d3e11281-110244" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12524-110249" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r234": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r279": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r335": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r357": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r392": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r401": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r407": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r476": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r477": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r478": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r479": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r481": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r482": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r483": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r484": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r485": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r486": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r487": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r488": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r489": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r490": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r491": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r492": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r493": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r494": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r495": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r496": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r93": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" } }, "version": "2.1" } ZIP 73 0001493152-22-013013-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-22-013013-xbrl.zip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

-N!.(*#%P@W5 PFI"H#=1.1 M)0W'6-X4WZR]H<$9:T+-M.[*[#. 'V90.YYRXPR._5'J]N%*?Q:UE& ]=\=5 M'_/:79<13L@R3FU3!2S.$MQM#-Q4[:<33+-5*TL%O.VN:X(#-MW[(L&XIFGL M,(V"EXHE^$ 0U1.SN+9!,\:[SKI%;_(7!XGU7F]S@D:0'/T!,L$,AHD,D6;P M^FB65^]_2]M6OX3MK?!0>ZX;D*XSCXI+V9*W@/N%/&VR:F?Q&^"X&="-[ M$P<83^&DIN0'*B;$&JE!&2_L,D6^Y30G4)73XYONEC6E@=[[.9!);>DH1T4, M!EHV#4V>:TO7BKLL"?4R>I/0E,4B/&QYWOXNN2L/O 6BL\;:$Q+V\MU,^\KU M-RAH5C@KHT?E'1T5E;?]6+V*S5ZI3!)\>)KUTG;U5E &.P@;4P[\,DH(#W07 MU+5LQ/:KYM*!>%Y%O=?MY=-PW$,HPS70$XL-/B, W#T4D]P9*RM/"FKK'[7-PV76SR M7=;/$1\MQ5LD--[$9J8=+B(X" _36WJS#967WJ5K?(--D?ESJS^ #K,F#TJW?B 0'&0 MLA+^EM<%VC%V% E^5 H!*.$2ZB4 I0@^ XN'?G[$Y5,>7_$G?5@ NGS):(SQ ME&RU\!S![W-^'FQ6>[IV9@Z.UK$:2Z\)4DWK2(4E%C"B2V,N<-7EP_-SM'@K\]QW5 M[>*9_I?QJIR2U.N9B$'9SF:*@@X,;@S*2;=*&E+$:>' M26D#@J[AW6XR*VA'TK7;E:.0KP.+S4+UYC/UNFN)#QSCO) M%GEPX'VX$7(TEZ&_[Z(T62HN<,'P8^X_R2Y*\\O<;[RULOT6_RI[TBWU^*NL#[-15>5Z&^"W_<-;E$] M:V_%=[_[CO[G_4TD,*GI.1L#K&YSU%:JD-/JGA/TSQ4KHKSB%DO0+KNCLP@N M3F]QC/&&+>M:)^'=7&Q-%PX5 *M+1VHO3=%<##I%>T&H)0DUH@8,TL,3U93N M102O!J]DY/*=R.9@0G\:,+# PIZSOJ9)8%M/ BOA90KA9416RN]">)3]Z<9R MW1U"^X2;&Y(_)X5J*W\0-ZS^'*.ZXD)J)8.G'#=N0RP45XT<^E,E*$@?W^/- M-B<1>17'7711>Q853\SYB62Z+.*AS!#JNG1^DNAW_*.*".&*I:HLES M$N,L-KOL T*"'Z(D8[E RVSOC/BG578;B+T% %:%&X1I*6&!R:9F'S>,'E$G MT'+Z+-VTQDUO;@BR=C#GU0O'5]D=+LN4[V,LU]?X,4K/DV*[ M*^4TIRF%PP+"#)9IEIPB"F1AX@.NWCAG-5>*1AA#5,K$H5C("P&C_51)35[$ M<<(:+DIOHH0:?A9MDS)*F\VMY5JDZ+>*Y14_L&B8IS1NMFG^BA6ST S?@ 6J M^0SL8XM)J2(3BIYG+JA[D($>A2R>%EI+.VYDG2<$K^A<.R>RFF^\563U#?SM M(.N6VD*25=TPG[.D+H P(;2 MO^3W3_FNB++X_H4VSNLRPV*Q>96Q[8'D&;,*L9H=V4'$V7(BQ!=UH=X%ZLPI<9MWUYBC7H)4&J\^G,*6/@8:>+: @+9G^9Y3M(O)Z MAUGZ$\8DDQ!_3Y?QNN.R0=RP>GF,ZOU>K62@]W\\0724?PQ[<.:XBE.MX,:% M [-_$19B?)EK7COK5LWN 428#?J7O9WZ,*%' JO_M?I).^DO.6HH(?J$^KJY M1Z?!,N6,_3OI1H.<@TXYZ MSYX_6/-"$I8AK8DO9!)8?:K5K]\Q;4(HZ94"8Y)75P@"K M0QRUU8T;/MU6 X;=;\P9*R]107F#!.%7V8K@J,#G6/SO578M_KK-BT1.BC&3 MP^HK)UVEZ;-B0G'%Q1Q;6OT+9P323>?5/E$G W^U(A1:8F.Q_8-#/PZ2![VC MQQCCA(2XWIU;M02@2(BNLZ3:OX5)AXJ*IW:%VKLHE?+]6F6K62V>=1TWGN6% M(JP^6"(LQ$QECN3G67+K?;?+GJQ.UVU0&)?I4-=$QE-&"EFNG.DCJIRW8F;XE_S@;L<\9M M'+ @Z:JNIGH']V45)[3CK4\BAUF4/:++9.KG+Y.,>EWVYU69/(L'3UJ%-ZL+ M.)8>GD@N+!Q,:Y0Z[=B6-AID&G0X"WS)QQ^!UKRP>GNXXI;CSP]!]R):VE/< MUE9E8@7@EIQBXH/5=\.4EA-2WO\18$)*UZA>NHUS#VKY(/>@36E32E'P?@M3 MV!94;X[6W[7 +;)6N TR<8;!]J2%AI*6/UC4U.QG*CH4<,0=!IL86FY/MT528:+XB9/D]7K M/?Y2GJ:J=:0+$ZQ^&J"QE 2[9T7+-:J9T=\$.V+\B L(TH%7FVVT*MG3&\]) M_/[[&QJ:X4VR6F;+'7'MSQ$R8'7O> .D(Q4NB75T)0O5PM"2]O^.@ . ;6M6 MMS/;O*#+,R46N_(I)\D_1NQY#_T +.C,9)U4VH:1O7M@4GH'<_L]=/3P*O:T M*[IMM5,9L>^=H(Q_!M96VV,CLUW60B MAM4]#IKVNV7/@@0/$DQA]R/R[#_K@J:M:Y^:_C%2P^H@%U55Y5T;IJJVAV + MVD?-MJ.]@_2DL'K'JJ@73+TU?]'Z'U0%JY:3C[YHJ[&+1\_X9LQ>^<;QXQB1ZQ+=X$R49 M_?>S/"M)M"KIL&&;QE7Y$/7J/H0FL$ 9NAFDXJ25$!0)*8C48E@ELUH.W]4_ MJN#;05.VKX44L NN>@O> ?_(U@5OG(2VA=?NLH[C?$ M(7!N9/U& "VR0B# N=+DMP[F;C,< N5*4A @-_L<-.JOSLK9U0#;QHZ*&A8@ M7%35;_I0)M3B.NJERZ<\$S4)Z[]7!VG+^G+(/([%[;.P0./59FG/I3ENK,AI MR!;0,TS0%N*"T54FJ@XT-Y/>SX$UW;?>', LAIKK1];U2+,:J+^C&%NENYCZ MO.JF*LLY)-R*HKJ+7CY%6L)F1_M2O.1,F06Y'O[W!1']S0Z* A2B=>E(B7$6'6-FI MH-4@:H4-!0,5-$!;W5K\;]_NC/1M!!+SQ0JP>GEJLTPY2NTOH$4W1ZE-5]^F M7(@@'G<^^#]#9/&FFZV MM]S:OG:MABKTME ^46MX#"<04P/Q30^N2+.'%N;*\\MEM$K2I'SE9>9TV61* M,EA(,NHH7T]^034UXN2PU[W%? M?9]&PNGMRNZ17 E6#M3VOG>+'),M")2Q< MXZ+ >']9GV'X.HD>.*0K#D@.,;+ Z:I#.VG2!D]8['A&@S('&.VCO M3'5^A]4U:N7DVU&U0PMZII5&1=$4UER26W;$*>XXRF=;>EI8'6!75#KK8ASL MF+GB03E!G*NZ[QGFA%=E1EW=U+%[&O(CZ*&^KNZ=U' "ZB;U+H^)^"BZR+0[ M8NJ@<.E 2D-ZJ9*=.L-#W)]=SA'TJK,1UJLGN%-[F4&AK@I>/11Q' @8Z&2= M1!TY#FS.>0@4ZI^.!@T#?+F#H*-'@E/ZN!,.CC!)]%.>C]D4/4O3A66(L9/R2BAVGPYL \ MRGSK-9[K"L>MH5+'Z1S'/U8X#KC@#>((8+CD-P?BZ6\*#W7(6/P4TALK8ZM6 MRRP>'PE^C$I\15LBR8IDQ4\3W2)-NQQ8H#K,B#XL&FKV-(L@;UT644 ##@"$ MASVH[XTBCJ#;7?0?U.-@MQF:=?-!_6V3<@1=[FC"N%X'N*-0+9,/[':3C*/H M= <#QG9YN,V#.FZ^9?&0YHA200.KP_0*2B%8W>:<-.AY94?I9>;4^ T9X/;O MZVCI DH.IQM,]R%UA("[PGXSLM<9 .Y'XM6.\,?K;FC;/-%5F>W1#"L'K YR M55?*UV[X4,T(Y#6-FS1:<2T6C_2_:D1I>LM$#*NC'#25,OQJ%L1Y]IM2H#.O MY]@!F;"\Q$%JP()4T#:8:%LUS*L+>+/-241>12E3_:,N.D)8.+!H*>5LU^1U M)=>_!7Y]I5X9V8)6V.&J8Z :/$*]RF*\IB.[Q&PX:]-(92)8K6[04$XHK4EY M<38 B=@B#C 'HEI*6/U@4U.=85U%-1#BS5O,'J<6;S?<;=.DM+WT96. U3^. MVLKON_38H#S5U9OL;)UE)H?554ZZVF=S&/T4HGJG+CAAP4,-V45=]L^ GH[I%);6_;/2'T$_6$I!TA[XT/@2*H:NC>8 MK'.R8=DERX>1F%K%4%A].Z%% MIQ@LC%I(-0M!4?X*5F^1<@P*@U=*C[7+*2MW>8/"^J MKK3Z;HUY=JV9Q:$_XC91P^HS%U7E,C:"LK!L2KTLLFQ'(ZG*0S=O^+9W4@8^VCY( M(JRNGLH<9;D<(:B9#-'^O>1.:<'@576HS9+6PE5VA\LRY1O)R_4U M?HS2\Z38[DI%4O< 9F#]-%QSJ0NY"/&H2GTO@V7$%(T8EC>3,D$H%I).1)[W M<5T^U%2P<(-JDHY[D(6N9+"-^)$^1!O(:HKJ^9B]L_PFIOA6;] M9A8D(&X9T'EFE>;%CF!]!H2!%E;3VQ757C?8LP1/9KQ;/>%XE^+ENGU87BEZ MG]?)]E48P=)K[J.'U-!_APJ$U>C?8$6TT&JX>-.MHN# 5^R*ZC.RM[[=(/>SK '2$I:>D)1@]K!X[^PQ6/ M7'-BN13DS@JKPP;KK

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�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end